10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

ý Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2018

or

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to .

Commission file number: 001-37497

LIVE OAK BANCSHARES, INC.

(Exact name of registrant as specified in its charter)

North Carolina	26-4596286
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
1741 Tiburon Drive Wilmington, North Carolina	28403
(Address of principal executive offices)	(Zip Code)

(910) 790-5867

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  ý    NO  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    YES  ý    NO  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	x
Non-accelerated filer	¨	Smaller reporting company	¨
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    YES  ¨    NO  ý

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of November 6, 2018, there were 35,503,535 shares of the registrant’s voting common stock outstanding and 4,643,530 shares of the registrant’s non-voting common stock outstanding.

Live Oak Bancshares, Inc. and Subsidiaries

Form 10-Q

For the Quarterly Period Ended September 30, 2018

TABLE OF CONTENTS

		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets as of September 30, 2018 and December 31, 2017	1
	Condensed Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2018 and 2017	2
	Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2018 and 2017	3
	Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Nine Months Ended September 30, 2018 and 2017	4
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2018 and 2017	5
	Notes to Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	44
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	63
Item 4.	Controls and Procedures	63
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	64
Item 1A.	Risk Factors	64
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	64
Item 3.	Defaults Upon Senior Securities	64
Item 4.	Mine Safety Disclosures	64
Item 5.	Other Information	64
Item 6.	Exhibits	64
	Signatures	65
	Index to Exhibits	66

PART I. FINANCIAL INFORMATION

Item 1.        Financial Statements

Live Oak Bancshares, Inc.

Condensed Consolidated Balance Sheets

As of September 30, 2018 (unaudited) and December 31, 2017*

(Dollars in thousands)

	September 30, 2018			December 31, 2017*
Assets
Cash and due from banks	$	368,565		$	295,271
Certificates of deposit with other banks	750			3,000
Investment securities available-for-sale	374,284			93,355
Loans held for sale	646,475			680,454
Loans and leases held for investment	1,631,337			1,343,973
Allowance for loan and lease losses	(26,797		)	(24,190		)
Net loans and leases	1,604,540			1,319,783
Premises and equipment, net	263,861			178,790
Foreclosed assets	1,429			1,281
Servicing assets	49,261			52,298
Other assets	135,592			134,242
Total assets	$	3,444,757		$	2,758,474
Liabilities and Shareholders’ Equity
Liabilities
Deposits:
Noninterest-bearing	$	48,622		$	57,868
Interest-bearing	2,875,666			2,202,395
Total deposits	2,924,288			2,260,263
Long term borrowings	1,506			26,564
Other liabilities	41,733			34,714
Total liabilities	2,967,527			2,321,541
Shareholders’ equity
Preferred stock, no par value, 1,000,000 authorized, none issued or outstanding at September 30, 2018 and December 31, 2017	—			—
Class A common stock, no par value, 100,000,000 shares authorized, 35,496,887 and 35,252,053 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively	276,831			268,557
Class B common stock, no par value, 10,000,000 shares authorized, 4,643,530 shares issued and outstanding at September 30, 2018 and December 31, 2017	49,168			49,168
Retained earnings	157,839			120,241
Accumulated other comprehensive loss	(6,608		)	(1,033		)
Total equity	477,230			436,933
Total liabilities and shareholders’ equity	$	3,444,757		$	2,758,474

*    Derived from audited consolidated financial statements.

See Notes to Unaudited Condensed Consolidated Financial Statements

1

Live Oak Bancshares, Inc.

Condensed Consolidated Statements of Income

For the three and nine months ended September 30, 2018 and 2017 (unaudited)

(Dollars in thousands, except per share data)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
Interest income
Loans and fees on loans	$	37,724		$	26,977		$	106,682		$	70,290
Investment securities, taxable	2,528			325			6,175			964
Other interest earning assets	1,638			870			5,032			1,682
Total interest income	41,890			28,172			117,889			72,936
Interest expense
Deposits	14,165			6,758			38,510			16,893
Borrowings	1			389			131			985
Total interest expense	14,166			7,147			38,641			17,878
Net interest income	27,724			21,025			79,248			55,058
Provision for (recovery of) loan and lease losses	(243		)	2,426			6,236			5,481
Net interest income after provision for loan and lease losses	27,967			18,599			73,012			49,577
Noninterest income
Loan servicing revenue	7,506			6,490			21,369			18,587
Loan servicing asset revaluation	(9,380		)	(3,691		)	(18,138		)	(6,864		)
Net gains on sales of loans	22,004			18,148			69,483			55,276
Lease income	2,194			682			5,722			691
Construction supervision fee income	578			362			1,954			1,077
Title insurance income	479			1,968			2,775			5,803
Other noninterest income	950			1,101			2,535			2,910
Total noninterest income	24,331			25,060			85,700			77,480
Noninterest expense
Salaries and employee benefits	20,553			19,037			62,908			55,687
Travel expense	2,003			2,289			5,887			6,035
Professional services expense	1,228			1,068			3,645			4,228
Advertising and marketing expense	1,462			1,516			4,992			4,977
Occupancy expense	1,588			1,473			5,327			4,018
Data processing expense	3,661			1,982			9,404			5,536
Equipment expense	3,649			2,228			10,094			5,005
Other loan origination and maintenance expense	1,742			1,601			4,485			3,587
FDIC insurance	1,105			858			2,687			2,308
Title insurance closing services expense	114			687			912			1,877
Impairment expense on goodwill and other intangibles, net	2,680			—			2,680			—
Other expense	1,459			3,117			7,125			8,883
Total noninterest expense	41,244			35,856			120,146			102,141
Income before taxes	11,054			7,803			38,566			24,916
Income tax benefit	(3,198		)	(5,059		)	(2,392		)	(3,853		)
Net income	$	14,252		$	12,862		$	40,958		$	28,769
Basic earnings per share	$	0.36		$	0.34		$	1.02		$	0.81
Diluted earnings per share	$	0.34		$	0.33		$	0.98		$	0.78

See Notes to Unaudited Condensed Consolidated Financial Statements

2

Live Oak Bancshares, Inc.

Condensed Consolidated Statements of Comprehensive Income

For the three and nine months ended September 30, 2018 and 2017 (unaudited)

(Dollars in thousands)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
Net income	$	14,252		$	12,862		$	40,958		$	28,769
Other comprehensive (loss) income before tax:
Net unrealized (loss) gain on investment securities arising during the period	(2,094		)	(168		)	(7,014		)	52
Reclassification adjustment for (gain) loss on sale of securities available-for-sale included in net income	—			—			—			—
Other comprehensive (loss) income before tax	(2,094		)	(168		)	(7,014		)	52
Income tax benefit (expense)	502			65			1,683			(20		)
Other comprehensive (loss) income, net of tax	(1,592		)	(103		)	(5,331		)	32
Total comprehensive income	$	12,660		$	12,759		$	35,627		$	28,801

See Notes to Unaudited Condensed Consolidated Financial Statements

3

Live Oak Bancshares, Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity

For the nine months ended September 30, 2018 and 2017 (unaudited)

(Dollars in thousands)

	Common stock						Retained earnings			Accumulated other comprehensive loss			Total equity
	Shares
	Class A	Class B		Amount
Balance at December 31, 2016	29,530,072	4,723,530		$	199,981		$	23,518		$	(652	)	$	222,847
Net income	—	—		—			28,769			—			28,769
Other comprehensive income	—	—		—			—			32			32
Issuance of restricted stock	306,902	—		—			—			—			—
Withholding cash issued in lieu of restricted stock issuance	—	—		(4,891		)	—			—			(4,891		)
Employee stock purchase program	22,634	—		445			—			—			445
Stock option exercises	76,285	—		602			—			—			602
Stock option based compensation expense	—	—		1,496			—			—			1,496
Restricted stock expense	—	—		4,210			—			—			4,210
Stock issued in acquisition of Reltco, Inc.	27,724	—		565			—			—			565
Non-voting common stock converted to voting common stock-private sale	80,000	(80,000	)	—			—			—			—
Issuance of common stock in connection with secondary offering, net of issue costs	5,175,000	—		113,096			—			—			113,096
Cash dividends ($0.07 per share)	—	—		—			(2,580		)	—			(2,580		)
Balance at September 30, 2017	35,218,617	4,643,530		$	315,504		$	49,707		$	(620	)	$	364,591
Balance at December 31, 2017	35,252,053	4,643,530		$	317,725		$	120,241		$	(1,033	)	$	436,933
Net income	—	—		—			40,958			—			40,958
Other comprehensive loss	—	—		—			—			(5,331		)	(5,331		)
Issuance of restricted stock	59,162	—		—			—			—			—
Withholding cash issued in lieu of restricted stock issuance	—	—		(708		)	—			—			(708		)
Employee stock purchase program	14,339	—		342			—			—			342
Stock option exercises	171,333	—		1,587			—			—			1,587
Stock option based compensation expense	—	—		1,310			—			—			1,310
Restricted stock expense	—	—		5,743			—			—			5,743
Reclassification of accumulated other comprehensive income due to tax rate change	—	—		—			244			(244		)	—
Cash dividends ($0.09 per share)	—	—		—			(3,604		)	—			(3,604		)
Balance at September 30, 2018	35,496,887	4,643,530		$	325,999		$	157,839		$	(6,608	)	$	477,230

See Notes to Unaudited Condensed Consolidated Financial Statements

4

Live Oak Bancshares, Inc.

Condensed Consolidated Statements of Cash Flows

For the nine months ended September 30, 2018 and 2017 (unaudited)

(Dollars in thousands)

	Nine Months Ended September 30,
	2018			2017
Cash flows from operating activities
Net income	$	40,958		$	28,769
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization	12,009			7,020
Net provision for loan and lease losses	6,236			5,481
Amortization of premium on securities, net of accretion	576			355
Amortization of discount on unguaranteed loans, net	5,282			1,263
Impairment expense on goodwill and other intangibles, net	2,680			—
Deferred tax (benefit) expense	(2,392		)	413
Originations of loans held for sale	(826,478		)	(884,741		)
Proceeds from sales of loans held for sale	966,076			648,300
Net gains on sale of loans held for sale	(69,483		)	(55,276		)
Net loss on sale of foreclosed assets	19			30
Net increase (decrease) in servicing assets	3,037			(1,398		)
Net loss on disposal of premises and equipment	37			213
Stock option based compensation expense	1,310			1,496
Restricted stock expense	5,743			4,210
Stock based compensation expense excess tax benefits	110			1,073
Business combination contingent consideration fair value adjustment	(260		)	350
Changes in assets and liabilities:
Other assets	(4,158		)	(17,661		)
Other liabilities	2,665			3,875
Net cash provided (used) by operating activities	143,967			(256,228		)
Cash flows from investing activities
Purchases of securities available-for-sale	(327,422		)	(13,009		)
Proceeds from sales, maturities, calls, and principal paydowns of securities available-for-sale	36,813			7,187
Proceeds from sale/collection of foreclosed assets	392			50
Business combination, net of cash acquired	—			(7,696		)
Sale of title insurance business, net of cash sold	(209		)	—
Maturities of certificates of deposit with other banks	2,250			4,000
Loan and lease originations and principal collections, net	(332,115		)	(273,501		)
Proceeds from sale of premises and equipment	865			—
Purchases of premises and equipment, net	(87,831		)	(71,420		)
Net cash used by investing activities	(707,257		)	(354,389		)

See Notes to Unaudited Condensed Consolidated Financial Statements

5

Live Oak Bancshares, Inc.

Condensed Consolidated Statements of Cash Flows (Continued)

For the nine months ended September 30, 2018 and 2017 (unaudited)

(Dollars in thousands)

	Nine Months Ended September 30,
	2018			2017
Cash flows from financing activities
Net increase in deposits	664,025			527,815
Proceeds from long term borrowings	18			16,900
Repayment of long term borrowings	(25,076		)	(25,971		)
Proceeds from short term borrowings	—			23,100
Repayment of short term borrowings	—			(15,000		)
Stock option exercises	1,587			602
Employee stock purchase program	342			445
Withholding cash issued in lieu of restricted stock	(708		)	(4,891		)
Sale of common stock, net of issuance costs	—			113,096
Shareholder dividend distributions	(3,604		)	(2,580		)
Net cash provided by financing activities	636,584			633,516
Net increase in cash and cash equivalents	73,294			22,899
Cash and cash equivalents, beginning	295,271			238,008
Cash and cash equivalents, ending	$	368,565		$	260,907
Supplemental disclosure of cash flow information
Interest paid	$	38,598		$	17,927
Income tax (refunds) payments, net	(383		)	7,094
Supplemental disclosures of noncash operating, investing, and financing activities
Unrealized holding (losses) gains on available-for-sale securities, net of taxes	$	(5,331	)	$	32
Transfers from loans and leases to foreclosed real estate and other repossessions	346			663
Net transfers from SBA receivable to foreclosed real estate	213			—
Transfer of loans held for sale to loans and leases held for investment	43,185			5,713
Transfer of loans and leases held for investment to loans held for sale	89,980			18,990
Transfers from short term borrowings to long term borrowings	—			8,100
Accrued premises and equipment additions	10,518			6
Loans to finance sale of other assets	3,642			—
Business combination:
Assets acquired (excluding goodwill)	—			5,766
Liabilities assumed	—			4,681
Purchase price	—			8,363
Goodwill recorded	—			7,278

See Notes to Unaudited Condensed Consolidated Financial Statements

6

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1. Basis of Presentation

Nature of Operations

Live Oak Bancshares, Inc. (the “Company” or “LOB”) is a bank holding company headquartered in Wilmington, North Carolina incorporated under the laws of North Carolina in December 2008. The Company conducts business operations primarily through its commercial bank subsidiary, Live Oak Banking Company (the “Bank”). The Bank was organized and incorporated under the laws of the State of North Carolina on February 25, 2008 and commenced operations on May 12, 2008. The Bank specializes in providing lending services to small businesses nationwide. The Bank identifies and grows lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A significant portion of the loans originated by the Bank are guaranteed by the Small Business Administration (“SBA”) under the 7(a) Loan Program and the U.S. Department of Agriculture ("USDA") Rural Energy for America Program ("REAP") and Business & Industry ("B&I") loan programs. On July 28, 2015 the Company completed its initial public offering with a secondary offering completed in August of 2017.

In 2010, the Bank formed Live Oak Number One, Inc., a wholly-owned subsidiary, to hold properties foreclosed on by the Bank.

In addition to the Bank, the Company owns Live Oak Grove, LLC, opened in September 2015 for the purpose of providing Company employees and business visitors an on-site restaurant location; Government Loan Solutions, Inc. (“GLS”), a management and technology consulting firm that specializes in the settlement, accounting, and securitization processes for government guaranteed loans, including loans originated under the SBA 7(a) loan program and USDA-guaranteed loans; and 504 Fund Advisors, LLC (“504FA”), formed to serve as the investment adviser to the 504 Fund, a closed-end mutual fund organized to invest in SBA section 504 loans.

In August 2016, the Company formed Live Oak Ventures, Inc. (formerly known as “Canapi, Inc.”) for the purpose of investing in businesses that align with the Company's strategic initiative to be a leader in financial technology.

In November 2016, the Company formed Live Oak Clean Energy Financing LLC for the purpose of providing financing to entities for renewable energy applications.

On February 1, 2017, the Company completed its acquisition of Reltco Inc. and National Assurance Title, Inc. (collectively referred to as "Reltco"), two nationwide title agencies under common control based in Tampa, Florida. Effective August 1, 2018, Reltco was sold. For more information regarding the sale, see subheading Sale of Title Insurance Business.

In June 2018, the Bank formed Live Oak Private Wealth, LLC for the purpose of providing high-net-worth individuals and families with strategic wealth and investment management services.

The Company earns revenue primarily from the sale of SBA and USDA-guaranteed loans and net interest income. Income from the sale of loans is comprised of net gains on the sale of loans, revenues on the servicing of sold loans and valuation of loan servicing rights. Offsetting these revenues are the cost of funding sources, provision for loan and lease losses, any costs related to foreclosed assets and other operating costs such as salaries and employee benefits, travel, professional services, occupancy, advertising and marketing, data processing, equipment and tax expense.

General

In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the nine months ended September 30, 2018 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2018. The consolidated balance sheet as of December 31, 2017 has been derived from the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities Exchange Commission on March 8, 2018 (SEC File No. 001-37497) (the "2017 Annual Report"). A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s 2017 Annual Report. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes in the Company's 2017 Annual Report.

The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.

7

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Amounts in all tables in the Notes to Unaudited Condensed Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated.

Business Segments

Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment.

Unconsolidated Joint Venture

On October 1, 2017, the Company started the digital banking joint venture between Live Oak Banking Company and First Data Corporation ("First Data"). The new company, named Apiture, combines First Data's and the Bank's digital banking platforms, products, services, and certain human resources used in the creation and delivery of technology solutions for financial institutions. The contributed assets of both the Company and First Data are considered businesses in accordance with relevant accounting standards. At closing, both the Bank and First Data received equal voting interests in Apiture in exchange for their respective contributions. As a term of the closing agreements, First Data is entitled to a preference in Apiture's cash earnings from the date of closing through December 31, 2017 and all of 2018, not to exceed $18.0 million and $18.9 million, respectively.

As a result of the above cash earnings preference, income (loss) is allocated utilizing the hypothetical liquidation at book value ("HLBV") method. Under the HLBV method, we allocate income or loss based on the change in each unitholders’ claim on the net assets of Apiture at period end, after adjusting for any distributions or contributions made during such period. As a result of the HLBV method there was no net income or loss attributed to the Company related to its ownership interest in Apiture during the three and nine months ended September 30, 2018.

As of September 30, 2018 and December 31, 2017 the Company had a $68.0 million equity method investment included in other assets on the consolidated balance sheet for this investment.

Derivative Financial Instruments

Interest Rate Futures Contracts

During the fourth quarter of 2016, the Company began using exchange-traded interest rate futures contracts to manage interest rate risk that may impact expected gains arising from future secondary market loan sales. Upon entering into a futures contract, the Company is required to pledge to the counterparty an amount of cash equal to a certain percentage of the contract amount, also known as an initial margin deposit. Subsequent payments, known as variation margin, are made or received by the Company each day to settle the daily fluctuations in the fair value of the underlying contract. Investments in these derivative contracts are subject to risks that can result in a loss of all or part of an investment. Credit risk is considered low because the counterparties are futures exchanges. The Company has not designated any derivative as a hedging instrument under applicable accounting guidance. Changes in fair value of the derivative contracts is recorded as a component of "net gains on sales of loans" on the consolidated statement of income. The fair value of the derivative contracts on the balance sheet date is zero due to the daily cash settlement of contracts.

Equity Warrant Assets

In connection with negotiated credit facilities and certain other services, the Company may obtain equity warrant assets giving the Company the right to acquire stock in private companies in certain verticals. These assets are held for prospective investment gains and are not used to hedge any economic risks. Further, the Company does not use other derivative instruments to hedge economic risks stemming from equity warrant assets.

Equity warrant assets in certain private client companies are recorded as derivatives when they contain net settlement terms and other qualifying criteria under Accounting Standards Codification 815. Equity warrant assets entitle the Company to purchase a specific number of shares of stock at a specific price within a specific time period, generally 10 years. Certain equity warrant assets contain contingent provisions, which adjust the underlying number of shares or purchase price upon the occurrence of certain future events to prevent dilution of the Company’s implied ownership represented by the warrants. Certain warrant agreements contain net share settlement provisions, which permit the receipt of, upon exercise, a share count equal to the intrinsic value of the warrant divided by the share price (otherwise known as a “cashless” exercise). These equity warrant assets are recorded at fair value and are classified as derivative assets, a component of other assets, on the consolidated balance sheet at the time they are obtained.

8

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The grant date fair values of equity warrant assets classified as derivatives received in connection with the issuance of a credit facility are deemed to be loan fees and recognized as an adjustment of loan yield through loan interest income. Similar to other loan fees, the yield adjustment related to grant date fair value of warrants is recognized over the life of that credit facility.

Any changes in fair value from the grant date fair value of equity warrant assets classified as derivatives will be recognized as increases or decreases to other assets on the consolidated balance sheet and as net gains or losses on derivative instruments, in other noninterest income, a component of consolidated net income. When a portfolio company is acquired, the Company may exercise these equity warrant assets for shares or cash.

The fair value of equity warrant assets classified as derivatives is reviewed quarterly using a Black-Scholes option pricing model.

For those equity warrant assets that do not contain net share settlement provisions, the Company considers these to be equity investments without readily determinable market values and records the asset at cost.

Sale of Title Insurance Business

On August 1, 2018, the Company financed the sale of its entire interest in Reltco, Inc. and National Assurance Title, Inc. for $3.0 million. The Company's divestiture was driven by expectations of future profitability under current market conditions impacting the mortgage industry. As a result of these expectations, the Company recorded a $3.0 million reserve against the amount financed on the date of the sale. In total, the transaction resulted in a net cost of $2.7 million which is recorded as “Impairment expense on goodwill and other intangibles, net” on the consolidated statements of income.

Revenue Recognition

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts with Customers” (Topic 606) and all subsequent ASUs that modified Topic 606. The implementation of the new standard did not have a material impact on the measurement or recognition of revenue and a cumulative effect adjustment to opening retained earnings was not necessary. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts were not adjusted and continue to be reported in accordance with the Company's historic accounting under Topic 605.

Topic 606 does not apply to revenue associated with financial instruments, including revenue from loans and lease financings or investment securities. In addition, certain noninterest income streams such as fees associated with servicing rights, financial guarantees, derivatives, title insurance, and equity and equity security investments are also not in scope of the new guidance. Therefore, the recognition of these revenue streams did not change upon adoption of Topic 606. Substantially all of the Company’s revenue is generated from contracts with customers. Noninterest revenue streams in-scope of Topic 606 are discussed below.

Other noninterest income

Other noninterest income consists of other recurring revenue streams from administration of trust assets held by the Company's trust department and from services provided by GLS to its clients for settlement, accounting, and valuation for government guaranteed loan sales and holdings. Trust account administration performance obligations are generally satisfied over time and fees are recognized monthly, based on the month-end market value of assets in fiduciary accounts and the applicable fee rate. Payment is generally received after month-end through a direct charge to customers' accounts. The Company does not earn performance-based incentives from trust account administration services. GLS provides services when requested by clients. Each requested service represents a specific performance obligation with a transaction price outlined by GLS' fee schedule. Revenue is recognized as the requested services are completed and payment is generally received the following month.

Contract Balances

A contract asset balance occurs when an entity performs a service for a customer before the customer pays consideration (resulting in a contract receivable) or before payment is due (resulting in a contract asset). A contract liability balance is an entity’s obligation to transfer a service to a customer for which the entity has already received payment (or payment is due) from the customer. The Company’s noninterest revenue streams are largely based on transactional activity, or standard month-end revenue accruals such as trust administration fees based on month-end market values. Consideration is often received immediately or shortly after the Company satisfies its performance obligation and revenue is recognized. The Company does not typically enter into long-term revenue contracts with customers, and therefore, does not experience significant contract balances. As of September 30, 2018 and December 31, 2017, the Company did not have any significant contract balances.

9

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Contract Acquisition Costs

In connection with the adoption of Topic 606, an entity is required to capitalize, and subsequently amortize into expense, certain incremental costs of obtaining a contract with a customer if these costs are expected to be recovered. The incremental costs of obtaining a contract are those costs that an entity incurs to obtain a contract with a customer that it would not have incurred if the contract had not been obtained (for example, sales commission). The Company utilizes the practical expedient which allows entities to immediately expense contract acquisition costs when the asset that would have resulted from capitalizing these costs would have been amortized in one year or less. Upon adoption of Topic 606, the Company did not capitalize any contract acquisition cost.

Reclassifications

Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications.

Note 2. Recent Accounting Pronouncements

In January 2016, the FASB issued ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01, among other things, (i) requires equity investments, with certain exceptions, to be measured at fair value with changes in fair value recognized in net income, (ii) simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment, (iii) eliminates the requirement for public business entities to disclose the methods and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet, (iv) requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, (v) requires an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments, (vi) requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statements and (viii) clarifies that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale. The Company adopted the standard in the first quarter of 2018 with no material impact on the consolidated financial statements. In accordance with (iv) above, the Company measured the fair value of the loan and lease portfolio using an exit price notion. See Note 10. Fair Value of Financial Instruments for additional information.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The FASB issued this ASU to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet by lessees for those leases classified as operating leases under current GAAP and disclosing key information about leasing arrangements. The amendments in this ASU are effective for the Company on January 1, 2019. The Company has created an implementation team that is currently evaluating the impact this standard will have on the consolidated financial statements upon adoption. Furthermore, the Company expects to adopt on a prospective basis.

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This new guidance replaces the incurred loss impairment methodology in current standards with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts and requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU 2016-13 will be effective for the Company on January 1, 2020. The Company is currently evaluating the potential impact of ASU 2016-13 on the consolidated financial statements. In that regard, a cross-functional working group has been formed, under the direction of the Company's Chief Financial Officer and Chief Credit Officer. The working group is comprised of individuals from various functional areas including credit, risk management, finance and information technology, among others. Implementation efforts continue with model development, ongoing system requirements evaluation and the identification of data and resource needs, among other things. The Company has also engaged a third-party vendor solution to assist in the application of ASU 2016-13. While the Company is currently unable to reasonably estimate the impact of adopting ASU 2016-13, the impact of adoption is expected to be significantly influenced by the composition, characteristics and quality of loan and securities portfolios as well as the prevailing economic conditions and forecasts as of the adoption date.

10

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805) - Clarifying the Definition of a Business” (“ASU 2017-01”).  ASU 2017-01 clarifies the definition and provides a more robust framework to use in determining when a set of assets and activities constitutes a business. ASU 2017-01 is intended to provide guidance when evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In February 2017, the FASB issued ASU No. 2017-05, “Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20) - Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets” (“ASU 2017-05”). ASU 2017-05 clarifies the scope of Subtopic 610-20 and adds guidance on nonfinancial asset derecognition as well as the accounting for partial sales of nonfinancial assets. The amendments conform the derecognition guidance on nonfinancial assets with the model for transactions in the new revenue standard. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In May 2017, the FASB issued ASU No. 2017-09, “Compensation - Stock Compensation (Topic 718) - Scope of Modification Accounting” (“ASU 2017-09”). ASU 2017-09 clarifies when changes to the terms or conditions of a share-based payment award should be accounted for as a modification. This guidance indicates modification accounting is required when the fair value, vesting conditions, or classification of the award changes. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In February 2018, the FASB issued ASU No. 2018-02, “Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (“ASU 2018-02”). ASU 2018-02 addresses the income tax accounting treatment of the stranded tax effects within other comprehensive income. The ASU allows for an entity to reclassify the stranded tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive income to retained earnings. ASU 2018-02 will be effective for the Company on January 1, 2019, with early adoption permitted. The Company early adopted ASU 2018-02 in the first quarter of 2018 and reclassified its stranded tax credit of $244 thousand within accumulated other comprehensive income to retained earnings at March 31, 2018.

In February 2018, the FASB issued ASU No. 2018-03, “Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2018-03”). ASU 2018-03 amendments clarify certain aspects of the guidance issued in ASU 2016-01. The amendments are effective for the Company for fiscal year 2018 with adoption as of July 1, 2018. The Company adopted the standard in the third quarter of 2018 with no material impact on the consolidated financial statements.

In March 2018, the FASB issued ASU No. 2018-05, “Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 118” (“ASU 2018-05”). ASU 2018-05 amends Accounting Standard Codification 740 to include recent SEC guidance pursuant to the issuance of SAB 118. These amendments address situations when a registrant does not have the necessary information available, prepared, or analyzed in reasonable detail to complete the accounting for certain income tax effects of the Tax Cuts and Jobs Act. The amendments were effective upon issuance and do not have a material effect on the Company's consolidated financial statements.

In June 2018, the FASB issued ASU No. 2018-07, “Compensation - Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018-07”). ASU 2018-07 amends Accounting Standard Codification 718 to largely align accounting for share-based payment awards issued to employees and nonemployees. Under the new guidance, existing employee guidance will generally apply to nonemployee share-based transactions, except for specific guidance on inputs into option pricing models and the attribution of cost. The amendments are effective for the Company on January 1, 2019 with early adoption permitted. The Company does not expect these amendments to have a material effect on its consolidated financial statements.

In July 2018, the FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases” (“ASU 2018-10”). ASU 2018-10 provides clarification on narrow aspects to Topic 842 and to correct unintended application of the guidance. The amendments are effective for the Company on January 1, 2019. The Company is currently assessing the effect the adoption of these amendments will have on the consolidated financial statements. See ASU 2016-02 for further discussion of implementation efforts.

11

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

In July 2018, the FASB issued ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements” (“ASU 2018-11”). ASU 2018-11 provides an additional transition method to adopt ASU 2016-02. The transition method allows an entity to apply ASU 2016-02 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. An entity that elects this transition method must provide required disclosures under Topic 840 for all periods that are in accordance with Topic 840. ASU 2018-11 also provides lessors with a practical expedient to not separate non-lease components from lease components by class of underlying asset. The amendments in this ASU are effective for the Company on January 1, 2019. The Company is currently assessing the effect the adoption of these amendments will have on the consolidated financial statements. See ASU 2016-02 for further discussion of implementation efforts.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes, modifies and adds certain fair value disclosure requirements on fair value measurements. The amendments are effective for the Company on January 1, 2020 with early adoption permitted. The Company does not expect these amendments to have a material effect on its consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendments are effective for the Company on January 1, 2020 with early adoption permitted. The Company is currently assessing the effect that the adoption of this standard will have on the consolidated financial statements.

Note 3. Earnings Per Share

Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Basic earnings per share:
Net income available to common shareholders	$	14,252	$	12,862	$	40,958	$	28,769
Weighted-average basic shares outstanding	40,119,561		37,366,041		40,025,265		35,485,371
Basic earnings per share	$	0.36	$	0.34	$	1.02	$	0.81
Diluted earnings per share:
Net income available to common shareholders, for diluted earnings per share	$	14,252	$	12,862	$	40,958	$	28,769
Total weighted-average basic shares outstanding	40,119,561		37,366,041		40,025,265		35,485,371
Add effect of dilutive stock options and restricted stock grants	1,568,869		1,278,636		1,561,722		1,244,683
Total weighted-average diluted shares outstanding	41,688,430		38,644,677		41,586,987		36,730,054
Diluted earnings per share	$	0.34	$	0.33	$	0.98	$	0.78
Anti-dilutive shares	—		243,199		—		250,698

12

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Note 4. Investment Securities

The carrying amount of investment securities and their approximate fair values are reflected in the following table:

	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
September 30, 2018
US treasury securities	$	4,965	$	—	$	31	$	4,934
US government agencies	33,598		—		523		33,075
Residential mortgage-backed securities	344,415		14		8,154		336,275
Total	$	382,978	$	14	$	8,708	$	374,284
December 31, 2017
US government agencies	$	22,778	$	3	$	157	$	22,624
Residential mortgage-backed securities	70,167		1		1,472		68,696
Mutual fund (1)	2,090		—		55		2,035
Total	$	95,035	$	4	$	1,684	$	93,355

(1) The following mutual fund was reclassified from investment securities available-for-sale to other assets in accordance with the adoption of ASU 2016-01.

There were no sales of securities during the three and nine months ended September 30, 2018 and 2017.

The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position.

	Less Than 12 Months				12 Months or More				Total
September 30, 2018	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
US treasury securities	$	4,934	$	31	$	—	$	—	$	4,934	$	31
US government agencies	26,603		486		6,472		37		33,075		523
Residential mortgage-backed securities	286,015		5,426		47,812		2,728		333,827		8,154
Total	$	317,552	$	5,943	$	54,284	$	2,765	$	371,836	$	8,708
	Less Than 12 Months				12 Months or More				Total
December 31, 2017	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
US government agencies	$	14,842	$	100	$	6,465	$	57	$	21,307	$	157
Residential mortgage-backed securities	23,481		439		40,648		1,033		64,129		1,472
Mutual fund	—		—		2,035		55		2,035		55
Total	$	38,323	$	539	$	49,148	$	1,145	$	87,471	$	1,684

At September 30, 2018, there were twenty-nine residential mortgage-backed securities and three US government agency securities in unrealized loss positions for greater than 12 months and one US treasury security, forty residential mortgage-backed securities and eight US government agency securities in unrealized loss positions for less than 12 months. Unrealized losses at December 31, 2017 were comprised of twenty-three residential mortgage-backed securities, three US government agencies and the 504 mutual fund in unrealized loss positions for greater than 12 months and five US government agency securities and eight residential mortgage-backed securities in unrealized loss positions for less than 12 months.

These unrealized losses are primarily the result of volatility in the market and are related to market interest rates. Since none of the unrealized losses relate to marketability of the securities or the issuer’s ability to honor redemption obligations and the Company has the intent and ability to hold the securities for a sufficient period of time to recover unrealized losses, none of the securities are deemed to be other than temporarily impaired.

All residential mortgage-backed securities in the Company’s portfolio at September 30, 2018 and December 31, 2017 were backed by U.S. government sponsored enterprises (“GSEs”).

13

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The following is a summary of investment securities by maturity:

	September 30, 2018
	Available-for-Sale
	Amortized cost		Fair value
US treasury securities
One to five years	$	4,965	$	4,934
Total	4,965		4,934
US government agencies
Within one year	6,510		6,472
One to five years	27,088		26,603
Total	33,598		33,075
Residential mortgage-backed securities
One to five years	3,806		3,617
Five to ten years	48,752		47,673
After 10 years	291,857		284,985
Total	344,415		336,275
Total	$	382,978	$	374,284

The table above reflects contractual maturities. Actual results will differ as the loans underlying the residential mortgage-backed securities may repay sooner than scheduled.

At September 30, 2018 and December 31, 2017, an investment security with a fair market value of $98 thousand and $100 thousand, respectively, was pledged to the Ohio State Treasurer to allow the Company's trust department to conduct business in the state of Ohio and investment securities with a fair market value of $2.5 million were pledged to the Company's trust department for uninsured trust assets held by the trust department.

14

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Note 5. Loans and Leases Held for Investment and Allowance for Loan and Lease Losses

Loan and Lease Portfolio Segments

The following describes the risk characteristics relevant to each of the portfolio segments. Each loan and lease category is assigned a risk grade during the origination and closing process based on criteria described later in this section.

Commercial and Industrial

Commercial and industrial loans (C&I) receive similar underwriting treatment as commercial real estate loans in that the repayment source is analyzed to determine its ability to meet cash flow coverage requirements as set forth by Bank policies. Repayment of the Bank’s C&I loans generally comes from the generation of cash flow as the result of the borrower’s business operations. This business cycle itself brings a certain level of risk to the portfolio. In some instances, these loans may carry a higher degree of risk due to a variety of reasons – illiquid collateral, specialized equipment, highly depreciable assets, uncollectable accounts receivable, revolving balances, or simply being unsecured. As a result of these characteristics, the SBA guarantee on these loans is an important factor in mitigating risk.

Construction and Development

Construction and development loans are for the purpose of acquisition and development of land to be improved through the construction of commercial buildings. Such loans are usually paid off through the conversion to permanent financing for the long-term benefit of the borrower’s ongoing operations. At the completion of the project, if the loan is converted to permanent financing or if scheduled loan amortization begins, it is then reclassified to the “Commercial Real Estate” segment. Underwriting of construction and development loans typically includes analysis of not only the borrower’s financial condition and ability to meet the required debt obligations, but also the general market conditions associated with the area and type of project being funded.

Commercial Real Estate

Commercial real estate loans are extensions of credit secured by owner occupied and non-owner occupied collateral. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Such repayment of commercial real estate loans is commonly derived from the successful ongoing operations of the business occupying the property. These typically include small businesses and professional practices.

Commercial Land

Commercial land loans are extensions of credit secured by farmland. Such loans are often for land improvements related to agricultural endeavors that may include construction of new specialized facilities. These loans are usually repaid through the conversion to permanent financing, or if scheduled loans amortization begins, for the long-term benefit of the borrower’s ongoing operations. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies.

Each of the loan types referenced in the sections above is further segmented into verticals in which the Bank chooses to operate. The Bank chooses to finance businesses operating in specific industries because of certain similarities. The similarities range from historical default and loss characteristics to business operations. However, there are differences that create the necessity to underwrite these loans according to varying criteria and guidelines. When underwriting a loan, the Bank considers numerous factors such as cash flow coverage, the credit scores of the guarantors, revenue growth, practice ownership experience and debt service capacity. Minimum guidelines have been set with regard to these various factors and deviations from those guidelines require compensating strengths when considering a proposed loan.

15

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Loans and leases consist of the following:

	September 30, 2018			December 31, 2017
Commercial & Industrial
Agriculture	$	4,980		$	3,274
Death Care Management	16,665			13,495
Healthcare	47,324			43,301
Independent Pharmacies	108,026			99,920
Registered Investment Advisors	91,334			93,770
Veterinary Industry	47,821			46,387
Other Industries	216,157			184,903
Total	532,307			485,050
Construction & Development
Agriculture	31,213			34,188
Death Care Management	9,366			6,119
Healthcare	71,429			49,770
Independent Pharmacies	2,314			1,496
Registered Investment Advisors	1,276			376
Veterinary Industry	19,522			13,184
Other Industries	78,807			58,120
Total	213,927			163,253
Commercial Real Estate
Agriculture	52,353			46,717
Death Care Management	69,514			67,381
Healthcare	167,365			126,631
Independent Pharmacies	18,872			19,028
Registered Investment Advisors	8,121			11,789
Veterinary Industry	122,537			113,932
Other Industries	233,856			134,172
Total	672,618			519,650
Commercial Land
Agriculture	220,326			178,897
Total	220,326			178,897
Total Loans and Leases1	1,639,178			1,346,850
Net Deferred Costs	7,336			8,545
Discount on SBA 7(a) and USDA Unguaranteed2	(15,177		)	(11,422		)
Loans and Leases, Net of Unearned	$	1,631,337		$	1,343,973

1 Total loans and leases include $192.4 million and $99.7 million of U.S. government guaranteed loans as of September 30, 2018 and December 31, 2017, respectively.

2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales.

16

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Credit Risk Profile

The Bank uses internal loan and lease reviews to assess the performance of individual loans and leases by industry segment. An independent review of the loan and lease portfolio is performed annually by an external firm. The goal of the Bank’s annual review of select borrowers' financial performance is to validate the adequacy of the risk grade assigned.

The Bank uses a grading system to rank the quality of each loan and lease. The grade is periodically evaluated and adjusted as performance dictates. Loan and lease grades 1 through 4 are passing grades and grade 5 is special mention. Collectively, grades 6 through 8 represent classified loans and leases in the Bank’s portfolio. The following guidelines govern the assignment of these risk grades:

Exceptional (1 Rated): These loans and leases are of the highest quality, with strong, well-documented sources of repayment. Debt service coverage (“DSC”) is over 2.00X based on historical results. Borrower has ownership experience and has demonstrated excellent revenue growth and/or profitability. Guarantors have credit scores above 750 and have strong personal liquidity.

Quality (2 Rated): These loans and leases are of good quality, with good, well-documented sources of repayment. DSC is over 1.74X based on historical results. Borrower has ownership experience and has demonstrated very good revenue growth and/or profitability. Guarantors have credit scores above 724 and have good personal liquidity.

Acceptable (3 rated): These loans and leases are of acceptable quality, with acceptable sources of repayment. DSC of over 1.24X based on historical or pro-forma results. Companies that do not meet these credit metrics must be evaluated to determine if they should be graded below this level.

Acceptable (4 rated): These loans and leases are considered very weak pass. These loans and leases are riskier than a 3-rated credit, but due to various mitigating factors are not considered a Special mention or worse. The mitigating factors must clearly be identified to offset further downgrade. Examples of loans and leases that may be put in this category include start-up loans and leases and loans and leases with less than 1:1 cash flow coverage with other sources of repayment.

Special mention (5 rated): These loans and leases are considered as emerging problems, with potentially unsatisfactory characteristics. These loans and leases require greater management attention. A loan or lease may be put into this category if the Bank is unable to obtain financial reporting from a company to fully evaluate its position.

Substandard (6 rated): Loans and leases graded Substandard are inadequately protected by current sound net worth, paying capacity of the borrower, or pledged collateral. They typically have unsatisfactory characteristics causing more than acceptable levels of risk, and have one or more well-defined weaknesses that could jeopardize the repayment of the debt.

Doubtful (7 rated): Loans and leases graded Doubtful have inherent weaknesses that make collection or liquidation in full questionable. Loans and leases graded Doubtful must be placed on non-accrual status.

Loss (8 rated): Loss rated loans and leases are considered uncollectible and of such little value that their continuance as an active Bank asset is not warranted. The asset should be charged off, even though partial recovery may be possible in the future.

17

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The following tables summarize the risk grades of each category:

	Risk Grades 1 - 4		Risk Grade 5		Risk Grades 6 - 8		Total
September 30, 2018
Commercial & Industrial
Agriculture	$	4,775	$	205	$	—	$	4,980
Death Care Management	16,464		195		6		16,665
Healthcare	37,035		3,179		7,110		47,324
Independent Pharmacies	92,735		4,545		10,746		108,026
Registered Investment Advisors	86,713		1,407		3,214		91,334
Veterinary Industry	44,374		1,171		2,276		47,821
Other Industries	198,875		15,860		1,422		216,157
Total	480,971		26,562		24,774		532,307
Construction & Development
Agriculture	31,213		—		—		31,213
Death Care Management	9,366		—		—		9,366
Healthcare	67,862		1,420		2,147		71,429
Independent Pharmacies	2,314		—		—		2,314
Registered Investment Advisors	1,276		—		—		1,276
Veterinary Industry	19,522		—		—		19,522
Other Industries	78,807		—		—		78,807
Total	210,360		1,420		2,147		213,927
Commercial Real Estate
Agriculture	51,786		567		—		52,353
Death Care Management	62,600		3,823		3,091		69,514
Healthcare	141,583		7,682		18,100		167,365
Independent Pharmacies	12,959		3,369		2,544		18,872
Registered Investment Advisors	7,993		128		—		8,121
Veterinary Industry	102,781		4,869		14,887		122,537
Other Industries	231,798		2,058		—		233,856
Total	611,500		22,496		38,622		672,618
Commercial Land
Agriculture	200,608		8,514		11,204		220,326
Total	200,608		8,514		11,204		220,326
Total1	$	1,503,439	$	58,992	$	76,747	$	1,639,178

18

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

	Risk Grades 1 - 4		Risk Grade 5		Risk Grades 6 - 8		Total
December 31, 2017
Commercial & Industrial
Agriculture	$	3,052	$	222	$	—	$	3,274
Death Care Management	13,371		117		7		13,495
Healthcare	36,530		2,246		4,525		43,301
Independent Pharmacies	86,152		5,541		8,227		99,920
Registered Investment Advisors	90,911		2,134		725		93,770
Veterinary Industry	42,313		1,704		2,370		46,387
Other Industries	184,540		363		—		184,903
Total	456,869		12,327		15,854		485,050
Construction & Development
Agriculture	31,738		2,450		—		34,188
Death Care Management	6,119		—		—		6,119
Healthcare	47,813		699		1,258		49,770
Independent Pharmacies	1,496		—		—		1,496
Registered Investment Advisors	376		—		—		376
Veterinary Industry	13,184		—		—		13,184
Other Industries	58,120		—		—		58,120
Total	158,846		3,149		1,258		163,253
Commercial Real Estate
Agriculture	46,717		—		—		46,717
Death Care Management	60,671		3,881		2,829		67,381
Healthcare	112,321		9,992		4,318		126,631
Independent Pharmacies	15,641		1,825		1,562		19,028
Registered Investment Advisors	11,649		140		—		11,789
Veterinary Industry	97,065		2,948		13,919		113,932
Other Industries	133,493		679		—		134,172
Total	477,557		19,465		22,628		519,650
Commercial Land
Agriculture	176,811		2,086		—		178,897
Total	176,811		2,086		—		178,897
Total1	$	1,270,083	$	37,027	$	39,740	$	1,346,850

1 Total loans and leases include $192.4 million of U.S. government guaranteed loans as of September 30, 2018, segregated by risk grade as follows: Risk Grades 1 – 4 = $126.4 million, Risk Grade 5 = $9.9 million, Risk Grades 6 – 8 = $56.1 million. As of December 31, 2017, total loans and leases include $99.7 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $65.0 million, Risk Grade 5 = $6.7 million, Risk Grades 6 – 8 = $28.0 million.

19

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Past Due Loans and Leases

Loans and leases are considered past due if the required principal and interest payments have not been received as of the date such payments were due. Loans and leases less than 30 days past due and accruing are included within current loans and leases shown below. The following tables show an age analysis of past due loans and leases as of the dates presented.

	Less Than 30 Days Past Due & Not Accruing		30-89 Days Past Due & Accruing		30-89 Days Past Due & Not Accruing		90 Days or More Past Due		Total Not Accruing & Past Due		Current		Total Loans and Leases		90 Days or More Past Due & Still Accruing
September 30, 2018
Commercial & Industrial
Agriculture	$	—	$	—	$	—	$	—	$	—	$	4,980	$	4,980	$	—
Death Care Management	—		74		—		—		74		16,591		16,665		—
Healthcare	44		2,874		687		2,680		6,285		41,039		47,324		—
Independent Pharmacies	—		—		3,869		6,573		10,442		97,584		108,026		—
Registered Investment Advisors	—		241		—		2,856		3,097		88,237		91,334		—
Veterinary Industry	162		—		569		796		1,527		46,294		47,821		—
Other Industries	—		1,123		—		651		1,774		214,383		216,157		—
Total	206		4,312		5,125		13,556		23,199		509,108		532,307		—
Construction & Development
Agriculture	—		—		—		—		—		31,213		31,213		—
Death Care Management	—		—		—		—		—		9,366		9,366		—
Healthcare	—		2,147		—		—		2,147		69,282		71,429		—
Independent Pharmacies	—		—		—		—		—		2,314		2,314		—
Registered Investment Advisors	—		—		—		—		—		1,276		1,276		—
Veterinary Industry	—		—		—		—		—		19,522		19,522		—
Other Industries	—		—		—		—		—		78,807		78,807		—
Total	—		2,147		—		—		2,147		211,780		213,927		—
Commercial Real Estate
Agriculture	—		—		—		—		—		52,353		52,353		—
Death Care Management	153		—		—		2,789		2,942		66,572		69,514		—
Healthcare	44		687		—		7,134		7,865		159,500		167,365		—
Independent Pharmacies	—		446		—		2,544		2,990		15,882		18,872		—
Registered Investment Advisors	—		—		—		—		—		8,121		8,121		—
Veterinary Industry	1,709		3,173		—		8,246		13,128		109,409		122,537		—
Other Industries	—		—		—		—		—		233,856		233,856		—
Total	1,906		4,306		—		20,713		26,925		645,693		672,618		—
Commercial Land
Agriculture	6,288		—		2,482		2,433		11,203		209,123		220,326		—
Total	6,288		—		2,482		2,433		11,203		209,123		220,326		—
Total1	$	8,400	$	10,765	$	7,607	$	36,702	$	63,474	$	1,575,704	$	1,639,178	$	—

20

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

	Less Than  30 Days Past Due & Not Accruing		30-89 Days Past Due & Accruing		30-89 Days Past Due & Not Accruing		90 Days or More Past Due		Total Not Accruing & Past Due		Current		Total Loans and Leases		90 Days or More Past Due & Still Accruing
December 31, 2017
Commercial & Industrial
Agriculture	$	—	$	—	$	—	$	—	$	—	$	3,274	$	3,274	$	—
Death Care Management	—		—		—		—		—		13,495		13,495		—
Healthcare	788		131		14		3,004		3,937		39,364		43,301		—
Independent Pharmacies	236		2,930		1,349		3,376		7,891		92,029		99,920		—
Registered Investment Advisors	—		321		—		—		321		93,449		93,770		—
Veterinary Industry	212		594		508		797		2,111		44,276		46,387		—
Other Industries	—		—		—		—		—		184,903		184,903		—
Total	1,236		3,976		1,871		7,177		14,260		470,790		485,050		—
Construction & Development
Agriculture	—		—		—		—		—		34,188		34,188		—
Death Care Management	—		—		—		—		—		6,119		6,119		—
Healthcare	—		—		—		—		—		49,770		49,770		—
Independent Pharmacies	—		—		—		—		—		1,496		1,496		—
Registered Investment Advisors	—		—		—		—		—		376		376		—
Veterinary Industry	—		—		—		—		—		13,184		13,184		—
Other Industries	—		—		—		—		—		58,120		58,120		—
Total	—		—		—		—		—		163,253		163,253		—
Commercial Real Estate
Agriculture	—		—		—		—		—		46,717		46,717		—
Death Care Management	—		—		168		1,391		1,559		65,822		67,381		—
Healthcare	40		54		1,916		1,550		3,560		123,071		126,631		—
Independent Pharmacies	—		—		—		1,562		1,562		17,466		19,028		—
Registered Investment Advisors	—		—		—		—		—		11,789		11,789		—
Veterinary Industry	1,804		3,226		—		4,765		9,795		104,137		113,932		—
Other Industries	—		—		—		—		—		134,172		134,172		—
Total	1,844		3,280		2,084		9,268		16,476		503,174		519,650		—
Commercial Land
Agriculture	—		—		—		—		—		178,897		178,897		—
Total	—		—		—		—		—		178,897		178,897		—
Total1	$	3,080	$	7,256	$	3,955	$	16,445	$	30,736	$	1,316,114	$	1,346,850	$	—

1 Total loans and leases include $192.4 million of U.S. government guaranteed loans as of September 30, 2018, of which $30.3 million is greater than 90 days past due, $12.3 million is 30-89 days past due and $149.8 million is included in current loans and leases as presented above. As of December 31, 2017, total loans and leases include $99.7 million of U.S. government guaranteed loans, of which $15.0 million is greater than 90 days past due, $7.4 million is 30-89 days past due and $77.3 million is included in current loans and leases as presented above.

21

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Nonaccrual Loans and Leases

Loans and leases that become 90 days delinquent, or in cases where there is evidence that the borrower’s ability to make the required payments is impaired, are placed in nonaccrual status and interest accrual is discontinued. If interest on nonaccrual loans and leases had been accrued in accordance with the original terms, interest income would have increased by approximately $800 thousand and $302 thousand for the three months ended September 30, 2018 and 2017, respectively, and for the nine months ended September 30, 2018 and 2017 interest income would have increased approximately $1.8 million and $831 thousand, respectively. All nonaccrual loans and leases are included in the held for investment portfolio.

Nonaccrual loans and leases as of September 30, 2018 and December 31, 2017 are as follows:

September 30, 2018	Loan and Lease Balance		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Healthcare	$	3,411	$	3,085	$	326
Independent Pharmacies	10,442		9,214		1,228
Registered Investment Advisors	2,856		2,536		320
Veterinary Industry	1,527		1,381		146
Other Industries	651		488		163
Total	18,887		16,704		2,183
Commercial Real Estate
Death Care Management	2,942		2,282		660
Healthcare	7,178		4,751		2,427
Independent Pharmacies	2,544		2,126		418
Veterinary Industry	9,955		8,452		1,503
Total	22,619		17,611		5,008
Commercial Land
Agriculture	11,203		5,497		5,706
Total	11,203		5,497		5,706
Total	$	52,709	$	39,812	$	12,897

December 31, 2017	Loan and Lease Balance		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Healthcare	$	3,806	$	3,235	$	571
Independent Pharmacies	4,961		3,906		1,055
Veterinary Industry	1,517		1,478		39
Total	10,284		8,619		1,665
Commercial Real Estate
Death Care Management	1,559		1,237		322
Healthcare	3,506		2,719		787
Independent Pharmacies	1,562		1,562		—
Veterinary Industry	6,569		5,733		836
Total	13,196		11,251		1,945
Total	$	23,480	$	19,870	$	3,610

22

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Allowance for Loan and Lease Loss Methodology

The methodology and the estimation process for calculating the Allowance for Loan and Lease Losses (“ALLL”) is described below:

Estimated credit losses should meet the criteria for accrual of a loss contingency, i.e., a provision to the ALLL, set forth in GAAP. The Company’s methodology for determining the ALLL is based on the requirements of GAAP, the Interagency Policy Statement on the Allowance for Loan and Lease Losses and other regulatory and accounting pronouncements. The ALLL is determined by the sum of three separate components: (i) the impaired loan and lease component, which addresses specific reserves for impaired loans and leases; (ii) the general reserve component, which addresses reserves for pools of homogeneous loans and leases; and (iii) an unallocated reserve component (if any) based on management’s judgment and experience. The loan and lease pools and impaired loans and leases are mutually exclusive; any loan or lease that is impaired is excluded from its homogenous pool for purposes of that pool’s reserve calculation, regardless of the level of impairment.

The ALLL policy for pooled loans and leases is governed in accordance with banking regulatory guidance for homogenous pools of non-impaired loans and leases that have similar risk characteristics. The Company follows a consistent and structured approach for assessing the need for reserves within each individual loan and lease pool.

Loans and leases are considered impaired when, based on current information and events, it is probable that the creditor will be unable to collect all interest and principal payments due according to the originally contracted, or reasonably modified, terms of the loan or lease agreement. The Company has determined that loans and leases that meet the criteria defined below must be reviewed quarterly to determine if they are impaired.

• All commercial loans and leases classified substandard or worse.

• Any other delinquent loan or lease that is in a nonaccrual status, or any loan or lease that is delinquent 90 days or more and still accruing interest.

• Any loan or lease which has been modified such that it meets the definition of a Troubled Debt Restructuring (TDR).

The Company’s policy for impaired loan and lease accounting subjects all loans and leases to impairment recognition; however, loan and lease relationships with unguaranteed credit exposure of less than $100,000 are generally not evaluated on an individual basis for impairment and instead are evaluated collectively using a methodology based on historical specific reserves on similar sized loans and leases. Any loan or lease not meeting the above criteria and determined to be impaired is subjected to an impairment analysis, which is a calculation of the probable loss on the loan or lease. This portion is the loan's or lease’s “impairment,” and is established as a specific reserve against the loan or lease, or charged against the ALLL.

Individual specific reserve amounts imply probability of loss and may not be carried in the reserve indefinitely. When the amount of the actual loss becomes reasonably quantifiable, the amount of the loss is charged off against the ALLL, whether or not all liquidation and recovery efforts have been completed. If the total amount of the individual specific reserve that will eventually be charged off cannot yet be sufficiently quantified but some portion of the impairment can be viewed as a confirmed loss, then the confirmed loss portion should be charged off against the ALLL and the individual specific reserve reduced by a corresponding amount.

For impaired loans or leases, the reserve amount is calculated on a loan or lease-specific basis. The Company utilizes two methods of analyzing impaired loans and leases not guaranteed by the SBA:

• The Fair Market Value of Collateral method utilizes the value at which the collateral could be sold considering the appraised value, appraisal discount rate, prior liens and selling costs. The amount of the reserve is the deficit of the estimated collateral value compared to the loan or lease balance.

• The Present Value of Future Cash Flows method takes into account the amount and timing of cash flows and the effective interest rate used to discount the cash flows.

23

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The following table details activity in the allowance for loan and lease losses by portfolio segment allowance for the periods presented:

Three months ended	Construction & Development			Commercial Real Estate			Commercial & Industrial			Commercial Land			Total
September 30, 2018
Beginning Balance	$	2,227		$	11,408		$	13,377		$	2,338		$	29,350
Charge offs	—			(397		)	(1,966		)	(106		)	(2,469		)
Recoveries	—			141			18			—			159
Provision	(555		)	(1,115		)	(148		)	1,575			(243		)
Ending Balance	$	1,672		$	10,037		$	11,281		$	3,807		$	26,797
September 30, 2017
Beginning Balance	$	1,603		$	7,494		$	8,351		$	2,112		$	19,560
Charge offs	—			(665		)	(343		)	—			(1,008		)
Recoveries	—			4			39			6			49
Provision	36			1,565			827			(2		)	2,426
Ending Balance	$	1,639		$	8,398		$	8,874		$	2,116		$	21,027

Nine months ended	Construction & Development			Commercial Real Estate			Commercial & Industrial			Commercial Land			Total
September 30, 2018
Beginning Balance	$	2,030		$	9,180		$	10,751		$	2,229		$	24,190
Charge offs	—			(816		)	(3,187		)	(106		)	(4,109		)
Recoveries	—			174			306			—			480
Provision	(358		)	1,499			3,411			1,684			6,236
Ending Balance	$	1,672		$	10,037		$	11,281		$	3,807		$	26,797
September 30, 2017
Beginning Balance	$	1,693		$	5,897		$	8,413		$	2,206		$	18,209
Charge offs	—			(952		)	(1,754		)	(35		)	(2,741		)
Recoveries	—			17			55			6			78
Provision	(54		)	3,436			2,160			(61		)	5,481
Ending Balance	$	1,639		$	8,398		$	8,874		$	2,116		$	21,027

The following tables detail the recorded allowance for loan and lease losses and the investment in loans and leases related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology:

September 30, 2018	Construction & Development		Commercial Real Estate		Commercial & Industrial		Commercial Land		Total
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	$	11	$	2,141	$	1,344	$	3,140	$	6,636
Loans and leases collectively evaluated for impairment2	1,661		7,896		9,937		667		20,161
Total allowance for loan and lease losses	$	1,672	$	10,037	$	11,281	$	3,807	$	26,797
Loans and leases receivable1:
Loans and leases individually evaluated for impairment	$	2,172	$	34,842	$	12,520	$	21,755	$	71,289
Loans and leases collectively evaluated for impairment2	211,755		637,776		519,787		198,571		1,567,889
Total loans and leases receivable	$	213,927	$	672,618	$	532,307	$	220,326	$	1,639,178

24

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

December 31, 2017	Construction & Development		Commercial Real Estate		Commercial & Industrial		Commercial Land		Total
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	$	157	$	1,502	$	1,126	$	—	$	2,785
Loans and leases collectively evaluated for impairment2	1,873		7,678		9,625		2,229		21,405
Total allowance for loan and lease losses	$	2,030	$	9,180	$	10,751	$	2,229	$	24,190
Loans and leases receivable1:
Loans and leases individually evaluated for impairment	$	1,237	$	17,105	$	8,672	$	—	$	27,014
Loans and leases collectively evaluated for impairment2	162,016		502,545		476,378		178,897		1,319,836
Total loans and leases receivable	$	163,253	$	519,650	$	485,050	$	178,897	$	1,346,850

1 Loans and leases receivable includes $192.4 million of U.S. government guaranteed loans as of September 30, 2018, of which $63.3 million are impaired. As of December 31, 2017, loans and leases receivable includes $99.7 million of U.S. government guaranteed loans, of which $28.1 million are considered impaired.

2 Included in loans and leases collectively evaluated for impairment are impaired loans and leases with individual unguaranteed exposure of less than $100 thousand. As of September 30, 2018, these balances totaled $17.3 million, of which $15.9 million are guaranteed by the U.S. government and $1.4 million are unguaranteed. As of December 31, 2017, these balances totaled $14.8 million, of which $13.2 million are guaranteed by the U.S. government and $1.6 million are unguaranteed.The allowance for loan and lease losses associated with these loans and leases totaled $397 thousand and $279 thousand as of September 30, 2018 and December 31, 2017, respectively.

25

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Loans and leases classified as impaired as of the dates presented are summarized in the following tables.

September 30, 2018	Recorded Investment		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Death Care Management	$	6	$	—	$	6
Healthcare	7,159		5,488		1,671
Independent Pharmacies	10,057		8,458		1,599
Registered Investment Advisors	3,217		2,536		681
Veterinary Industry	2,382		1,861		521
Other Industries	1,435		648		787
Total	24,256		18,991		5,265
Construction & Development
Healthcare	2,172		1,610		562
Total	2,172		1,610		562
Commercial Real Estate
Death Care Management	3,088		2,282		806
Healthcare	18,757		13,275		5,482
Independent Pharmacies	2,543		2,126		417
Veterinary Industry	15,977		11,815		4,162
Total	40,365		29,498		10,867
Commercial Land
Agriculture	21,755		13,199		8,556
Total	21,755		13,199		8,556
Total	$	88,548	$	63,298	$	25,250

December 31, 2017	Recorded Investment		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Death Care Management	$	7	$	—	$	7
Healthcare	4,551		3,235		1,316
Independent Pharmacies	8,571		6,356		2,215
Registered Investment Advisors	733		—		733
Veterinary Industry	2,762		2,001		761
Total	16,624		11,592		5,032
Construction & Development
Healthcare	1,237		944		293
Total	1,237		944		293
Commercial Real Estate
Death Care Management	2,831		1,237		1,594
Healthcare	4,315		2,967		1,348
Independent Pharmacies	1,562		1,562		—
Veterinary Industry	15,266		9,768		5,498
Total	23,974		15,534		8,440
Commercial Land
Agriculture	—		—		—
Total	—		—		—
Total	$	41,835	$	28,070	$	13,765

26

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The following table presents evaluated balances of loans and leases classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan and lease fees or costs.

	September 30, 2018
	Recorded Investment
	With a Recorded Allowance		With No Recorded Allowance		Total		Unpaid Principal Balance		Related Allowance Recorded
Commercial & Industrial
Death Care Management	$	—	$	6	$	6	$	6	$	—
Healthcare	7,093		66		7,159		7,402		416
Independent Pharmacies	9,758		299		10,057		11,680		415
Registered Investment Advisors	3,217		—		3,217		3,740		513
Veterinary Industry	2,259		123		2,382		2,657		129
Other Industries	979		456		1,435		1,998		213
Total	23,306		950		24,256		27,483		1,686
Construction & Development
Healthcare	2,172		—		2,172		2,147		11
Total	2,172		—		2,172		2,147		11
Commercial Real Estate
Death Care Management	2,786		302		3,088		3,226		16
Healthcare	18,523		234		18,757		18,751		1,174
Independent Pharmacies	2,543		—		2,543		2,835		14
Veterinary Industry	15,867		110		15,977		16,955		992
Total	39,719		646		40,365		41,767		2,196
Commercial Land
Agriculture	21,563		192		21,755		21,764		3,140
Total	21,563		192		21,755		21,764		3,140
Total Impaired Loans and Leases	$	86,760	$	1,788	$	88,548	$	93,161	$	7,033

27

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

	December 31, 2017
	Recorded Investment
	With a Recorded Allowance		With No Recorded Allowance		Total		Unpaid Principal Balance		Related Allowance Recorded
Commercial & Industrial
Death Care Management	$	—	$	7	$	7	$	7	$	—
Healthcare	3,521		1,030		4,551		5,643		165
Independent Pharmacies	8,154		417		8,571		9,078		521
Registered Investment Advisors	662		71		733		725		504
Veterinary Industry	2,505		257		2,762		3,113		182
Total	14,842		1,782		16,624		18,566		1,372
Construction & Development
Healthcare	1,237		—		1,237		1,258		157
Total	1,237		—		1,237		1,258		157
Commercial Real Estate
Death Care Management	2,221		610		2,831		2,964		260
Healthcare	3,717		598		4,315		4,332		192
Independent Pharmacies	1,562		—		1,562		1,933		8
Veterinary Industry	13,711		1,555		15,266		16,584		1,075
Total	21,211		2,763		23,974		25,813		1,535
Commercial Land
Agriculture	—		—		—		58		—
Total	—		—		—		58		—
Total Impaired Loans and Leases	$	37,290	$	4,545	$	41,835	$	45,695	$	3,064

28

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The following table presents the average recorded investment of impaired loans and leases for each period presented and interest income recognized during the period in which the loans and leases were considered impaired.

	Three months ended September 30, 2018				Three months ended September 30, 2017
	Average Balance		Interest Income Recognized		Average Balance		Interest Income Recognized
Commercial & Industrial
Death Care Management	$	6	$	—	$	42	$	1
Healthcare	7,152		28		7,076		11
Independent Pharmacies	10,325		4		4,266		26
Registered Investment Advisors	3,589		7		894		14
Veterinary Industry	2,423		16		2,511		11
Other Industries	1,822		17		—		—
Total	25,317		72		14,789		63
Construction & Development
Healthcare	2,162		12		602		2
Total	2,162		12		602		2
Commercial Real Estate
Death Care Management	3,098		24		2,512		13
Healthcare	18,765		150		3,079		11
Independent Pharmacies	2,739		—		1,985		—
Veterinary Industry	16,731		98		13,950		132
Total	41,333		272		21,526		156
Commercial Land
Agriculture	21,792		38		23		—
Total	21,792		38		23		—
Total	$	90,604	$	394	$	36,940	$	221

29

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

	Nine months ended September 30, 2018				Nine months ended September 30, 2017
	Average Balance		Interest Income Recognized		Average Balance		Interest Income Recognized
Commercial & Industrial
Death Care Management	$	7	$	—	$	313	$	3
Healthcare	7,232		59		4,996		25
Independent Pharmacies	10,180		31		7,998		52
Registered Investment Advisors	3,007		31		1,438		28
Veterinary Industry	2,488		54		4,329		24
Other Industries	1,875		22		—		—
Total	24,789		197		19,074		132
Construction & Development
Healthcare	2,162		63		120		2
Total	2,162		63		120		2
Commercial Real Estate
Death Care Management	3,115		88		2,030		30
Healthcare	17,535		230		2,940		24
Independent Pharmacies	2,763		1		149		—
Veterinary Industry	17,081		333		13,069		278
Total	40,494		652		18,188		332
Commercial Land
Agriculture	21,803		68		199		—
Total	21,803		68		199		—
Total	$	89,248	$	980	$	37,581	$	466

The following tables represent the types of TDRs that were made during the periods presented:

	Three months ended September 30, 2018					Three months ended September 30, 2017
	All Restructurings					All Restructurings
	Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment		Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment
Interest Only and Rate Concession
Commercial Land
Agriculture	4	$	10,276	$	10,276	—	$	—	$	—
Total Interest Only and Rate Concession	4	10,276		10,276		—	—		—
Extended Amortization
Commercial Land
Agriculture	1	8		8		—	—		—
Total Extended Amortization	1	8		8		—	—		—
Payment Deferral
Commercial & Industrial
Veterinary Industry	—	—		—		2	559		559
Total Payment Deferral	—	—		—		2	559		559
Total	5	$	10,284	$	10,284	2	$	559	$	559

30

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

	Nine months ended September 30, 2018					Nine months ended September 30, 2017
	All Restructurings					All Restructurings
	Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment		Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment
Interest Only
Construction and Development
Healthcare	1	$	612	$	612	—	$	—	$	—
Total Interest Only	1	612		612		—	—		—
Interest Only and Rate Concession
Commercial Land
Agriculture	4	10,276		10,276		—	—		—
Total Interest Only and Rate Concession	4	10,276		10,276		—	—		—
Extended Amortization
Commercial Land
Agriculture	1	8		8		—	—		—
Total Extended Amortization	1	8		8		—	—		—
Payment Deferral and Extended Amortization
Commercial & Industrial
Independent Pharmacies	—	—		—		1	262		262
Total Payment Deferral and Extended Amortization	—	—		—		1	262		262
Payment Deferral
Commercial & Industrial
Veterinary Industry	—	—		—		2	559		559
Total Payment Deferral	—	—		—		2	559		559
Total	6	$	10,896	$	10,896	3	$	821	$	821

Concessions made to improve a loan and lease’s performance have varying degrees of success. No TDRs that were modified within the twelve months ended September 30, 2018 and 2017 subsequently defaulted during the three and nine months ended September 30, 2018 and 2017.

31

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Note 6. Equipment Leasing

The Company purchases new equipment for the purpose of leasing such equipment to customers within its verticals. Equipment purchased to fulfill commitments to commercial renewable energy projects is rented out under operating leases while leases of equipment outside of the renewable energy vertical are generally direct financing leases. Accordingly, leased assets under operating leases are included in premises and equipment while leased assets under direct financing leases are included in loans and leases held for investment.

Direct Financing Leases

Interest income on direct financing leases is recognized when earned.  Unearned interest is recognized over the lease term on a basis which results in a constant rate of return on the unrecovered lease investment.  The term of each lease is generally 3-7 years which is consistent with the useful life of the equipment with no residual value.  The gross lease payments receivable and the net investment included in accounts receivable for such leases are as follows:

	As of
	September 30, 2018			December 31, 2017
Gross direct finance lease payments receivable	$	6,548		$	2,399
Less – unearned interest	(1,116		)	(373		)
Net investment in direct financing leases	$	5,432		$	2,026

Future minimum lease payments under finance leases are as follows:

As of September 30, 2018	Amount
2018	$	325
2019	1,384
2020	1,373
2021	1,287
2022	1,107
Thereafter	1,072
Total	$	6,548

Interest income of $100 thousand and $14 thousand was recognized in the three months ended September 30, 2018 and 2017, respectively. Interest income of $220 thousand and $21 thousand was recognized in the nine months ended September 30, 2018 and 2017, respectively.

Operating Leases

The term of each operating lease is generally 10 to 15 years. The Company retains ownership of the equipment and associated tax benefits such as investment tax credits and accelerated depreciation. At the end of the lease term, the lessee has the option to renew the lease for two additional terms or purchase the equipment at the then current fair market value.

Rental revenue from operating leases is recognized over a straight-line basis over the term of the lease. Rental equipment is recorded at cost and depreciated to an estimated residual value on a straight-line basis over the estimated useful life. The useful lives generally range from 20 to 25 years and residual values generally range from 20% to 40%, however, they are subject to periodic evaluation. Changes in useful lives or residual values will impact depreciation expense and any gain or loss from the sale of used equipment. The estimated useful lives and residual values of the Company's leasing equipment are based on industry disposal experience and the Company's expectations for future sale prices.

If the Company decides to sell or otherwise dispose of rental equipment, it is carried at the lower of cost or fair value less costs to sell or dispose.   Repair and maintenance costs that do not extend the lives of the rental equipment are charged to direct operating expenses at the time the costs are incurred.

32

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

As of September 30, 2018, the Company had a net investment of $144.9 million in assets included in premises and equipment that are subject to operating leases. Of the net investment, the gross balance of the assets was $153.0 million and accumulated depreciation was $8.1 million as of September 30, 2018. Depreciation expense recognized on these assets for the three and nine months ended September 30, 2018 was $2.2 million and $5.9 million, respectively. Depreciation expense recognized for the three and nine months ended September 30, 2017 was $840 thousand and $1.1 million, respectively.

A maturity analysis of future minimum lease payments under non-cancelable operating leases is as follows:

As of September 30, 2018	Amount
2018	$	1,765
2019	8,284
2020	8,341
2021	8,385
2022	8,417
Thereafter	53,939
Total	$	89,131

Note 7. Servicing Assets

Loans serviced for others are not included in the accompanying balance sheet. The unpaid principal balances of loans serviced for others requiring recognition of a servicing asset were $2.70 billion and $2.44 billion at September 30, 2018 and December 31, 2017, respectively. The unpaid principal balance for all loans serviced for others was $2.78 billion and $2.54 billion at September 30, 2018 and December 31, 2017, respectively.

The following summarizes the activity pertaining to servicing rights:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
Balance at beginning of period	$	52,689		$	53,675		$	52,298		$	51,994
Additions, net	5,558			3,527			14,634			9,412
Fair value changes:
Due to changes in valuation inputs or assumptions	(5,336		)	(789		)	(7,336		)	342
Decay due to increases in principal paydowns or runoff	(3,650		)	(3,021		)	(10,335		)	(8,356		)
Balance at end of period	$	49,261		$	53,392		$	49,261		$	53,392

The fair value of servicing rights was determined using a weighted average discount rate of 16.1% on September 30, 2018 and 12.6% on September 30, 2017. The fair value of servicing rights was determined using a weighted average prepayment speed of 11.1% on September 30, 2018 and 7.3% on September 30, 2017, depending on the stratification of the specific right. Changes to fair value are reported in loan servicing asset revaluation within the consolidated statements of income.

The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Changes in prepayment speed assumptions have the most significant impact on the fair value of servicing rights. Generally, as interest rates rise on variable rate loans, loan prepayments increase due to an increase in refinance activity, which results in a decrease in the fair value of servicing assets. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time, and those assumptions may not be appropriate if they are applied at a different time.

33

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Note 8. Borrowings

Total outstanding short and long term borrowings consisted of the following:

	September 30, 2018		December 31, 2017
Short term borrowings
On October 20, 2017, the Company entered into a revolving line of credit of $20 million with an unaffiliated commercial bank. The note is unsecured and accrues interest at LIBOR plus 1.750% for a term of 12 months. Payments are interest only with all principal and accrued interest due on October 19, 2018. On October 2, 2018, the Company renewed the revolving line of credit for an additional 12 months with a maturity date of October 18, 2019. The terms of this loan require the Company to maintain minimum capital and debt service coverage ratios. No advances have been made to this line of credit and there is $20 million of available credit remaining at September 30, 2018.	$	—	$	—
On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank. On April 18, 2017, the Company renewed and increased the revolving line of credit to $25 million. The note is unsecured and accrues interest at Prime minus 0.50% for a term of 24 months. Payments are interest only with all principal and accrued interest due on April 30, 2019. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. This line of credit was paid in full on August 25, 2017, and there is $25 million of available credit remaining at September 30, 2018.	—		—
Total short term borrowings	$	—	$	—

	September 30, 2018		December 31, 2017
Long term borrowings
On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus with a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments were interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments of $146 thousand began in October 2016 with all principal and accrued interest due on September 11, 2021. This note was repaid in full on January 31, 2018.	$	—	$	22,990
On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. One of the loans with an outstanding balance of $1.3 million was paid in full on August 17, 2018. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at September 30, 2018 is 6.00%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $1.5 million at September 30, 2018. Underlying loan carries a risk grade of 3 and is current with no delinquencies.	1,489		3,574
In October 2017, the Company entered into a capital lease of $19 thousand with an unaffiliated equipment lease company, secured by fitness equipment which is included in premises and equipment on the consolidated balance sheet. Payments are principal and interest due monthly starting December 15, 2017 over a term of 60 months. At the end of the lease term there is a $1.00 bargain purchase option.	17		—
Total long term borrowings	$	1,506	$	26,564

The Company may purchase federal funds through unsecured federal funds lines of credit with various correspondent banks, which totaled $72.5 million and $47.5 million as of September 30, 2018 and December 31, 2017, respectively. These lines are intended for short-term borrowings and are subject to restrictions limiting the frequency and terms of advances. These lines of credit are payable on demand and bear interest based upon the daily federal funds rate. The Company had no outstanding balances on the lines of credit as of September 30, 2018 and December 31, 2017.

34

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The Company has entered into a repurchase agreement with a third party for $5.0 million as of September 30, 2018 and December 31, 2017. At the time the Company enters into a transaction with the third party, the Company must transfer securities or other assets against the funds received. The terms of the agreement are set at market conditions at the time the Company enters into such transaction. The Company had no outstanding balance on the repurchase agreement as of September 30, 2018 and December 31, 2017.

On June 18, 2018, the Company entered into a borrowing agreement with the Federal Home Loan Bank of Atlanta. These borrowings must be secured with eligible collateral approved by the Federal Home Loan Bank of Atlanta. As of September 30, 2018, there was $854.2 million of potential borrowing capacity available under this agreement. There is no collateral pledged and no advances outstanding as of September 30, 2018.

The Company may borrow funds through the Federal Reserve Bank’s discount window. These borrowings are secured by a blanket floating lien on qualifying loans with a balance of $376.9 million and $348.5 million as of September 30, 2018 and December 31, 2017, respectively. At September 30, 2018 and December 31, 2017, the Company had approximately $210.1 million and $189.1 million, respectively, in borrowing capacity available under these arrangements with no outstanding balance as of September 30, 2018 and December 31, 2017.

Note 9. Income Taxes

The Company's effective tax rate is lower than the U.S. statutory rate primarily because of the anticipated effect of investment tax credits during 2018. The Company's effective tax rate in the future will depend on the actual investment tax credits earned as a part of its financing renewable energy applications.

Note 10. Fair Value of Financial Instruments

Fair Value Hierarchy

There are three levels of inputs in the fair value hierarchy that may be used to measure fair value. Financial instruments are considered Level 1 when valuation can be based on quoted prices in active markets for identical assets or liabilities. Level 2 financial instruments are valued using quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or models using inputs that are observable or can be corroborated by observable market data of substantially the full term of the assets or liabilities. Financial instruments are considered Level 3 when their values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable and when determination of the fair value requires significant management judgment or estimation.

Financial Instruments Measured at Fair Value

The following sections provide a description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the fair value hierarchy:

Investment securities: Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, discounted cash flow or at net asset value per share. Level 2 securities would include U.S. government agency securities, mortgage-backed securities, obligations of states and political subdivisions and certain corporate, asset backed mutual fund and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy.

Impaired loans: Impairment of a loan is based on the fair value of the collateral of the loan for collateral-dependent loans. Fair value of the loan’s collateral, when the loan is dependent on collateral, is determined by appraisals or independent valuation which is then adjusted for the cost related to liquidation of the collateral. For non-collateral dependent loans, impairment is determined by the present value of expected future cash flows. Impaired loans classified as Level 3 are based on management’s judgment and estimation.

35

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Servicing assets: Servicing rights do not trade in an active, open market with readily observable prices. While sales of servicing rights do occur, the precise terms and conditions typically are not readily available. Accordingly, the Company estimates the fair value of servicing rights using discounted cash flow models incorporating numerous assumptions from the perspective of a market participant including servicing income, servicing costs, market discount rates and prepayment speeds. Due to the nature of the valuation inputs, servicing rights are classified within Level 3 of the valuation hierarchy.

Foreclosed assets: Foreclosed real estate is adjusted to fair value less selling costs upon transfer of the loans to foreclosed real estate. Subsequently, foreclosed real estate is carried at the lower of carrying value or fair value less selling costs. Fair value is based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. Given the lack of observable market prices for identical properties and market discounts applied to appraised values, the Company generally classifies foreclosed assets as nonrecurring Level 3.

Mutual fund: The following mutual fund is registered with the Securities and Exchange Commission as a closed-end, non-diversified management investment company and operates as an interval fund. The fund primarily invests in the unguaranteed portion of SBA504 First Lien Loans secured by owner-occupied commercial real estate. This investment is valued using quoted prices in markets that are not active and is classified as Level 2 within the valuation hierarchy.

Equity warrant assets: Fair value measurements of equity warrant assets of private companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public companies that operate in similar industries as the companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. The Company classifies equity warrant assets within Level 3 of the valuation hierarchy.

Contingent consideration liability: Contingent consideration associated with the acquisition of Reltco will be adjusted to fair value quarterly until settled. The assumptions used to measure fair value are based on internal metrics that are unobservable and therefore the contingent consideration liability is classified within Level 3 of the valuation hierarchy.

Recurring Fair Value

The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis.

September 30, 2018	Total		Level 1		Level 2		Level 3
Investment securities available-for-sale
US treasury securities	$	4,934	$	—	$	4,934	$	—
US government agencies	33,075		—		33,075		—
Residential mortgage-backed securities	336,275		—		336,275		—
Servicing assets1	49,261		—		—		49,261
Mutual fund	2,068		—		2,068		—
Equity warrant assets	538		—		—		538
Total assets at fair value	$	426,151	$	—	$	376,352	$	49,799

36

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

December 31, 2017	Total		Level 1		Level 2		Level 3
Investment securities available-for-sale
US government agencies	$	22,624	$	—	$	22,624	$	—
Residential mortgage-backed securities	68,696		—		68,696		—
Mutual fund	2,035		—		2,035		—
Servicing assets1	52,298		—		—		52,298
Total assets at fair value	$	145,653	$	—	$	93,355	$	52,298
Contingent consideration liability2	$	1,900	$	—	$	—	$	1,900
Total liabilities at fair value	$	1,900	$	—	$	—	$	1,900

1 See Note 7 for a rollforward of recurring Level 3 fair values for servicing assets and various assumptions used in the fair value measurement.

2 Activity for the contingent consideration liability during the three months ended September 30, 2018 consisted of a $1.6 million write-off as a result of the disposition of Reltco during the quarter. During the nine months ended September 30, 2018, the Company recorded a $260 thousand negative fair value adjustment and $1.6 million write-off as a result of the disposition of Reltco. There was no activity for the contingent consideration liability during the three months ended September 30, 2017. During the nine months ended September 30, 2017, $4.3 million of contingent consideration was recorded upon the acquisition of Reltco as well as $350 thousand positive fair value adjustments.

Non-recurring Fair Value

The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis.

September 30, 2018	Total		Level 1		Level 2		Level 3
Impaired loans and leases	$	79,727	$	—	$	—	$	79,727
Foreclosed assets	1,429		—		—		1,429
Total assets at fair value	$	81,156	$	—	$	—	$	81,156

December 31, 2017	Total		Level 1		Level 2		Level 3
Impaired loans and leases	$	34,493	$	—	$	—	$	34,493
Foreclosed assets	1,281		—		—		1,281
Total assets at fair value	$	35,774	$	—	$	—	$	35,774

Level 3 Analysis

For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of September 30, 2018 and December 31, 2017 the significant unobservable inputs used in the fair value measurements were as follows:

September 30, 2018

Level 3 Assets with Significant Unobservable Inputs	Fair Value		Valuation Technique	Significant Unobservable Inputs	Range
Impaired loans and leases	$	79,727	Discounted appraisals Discounted expected cash flows	Appraisal adjustments (1) Interest rate & repayment term	10% to 48% Weighted average discount rate 6.16%
Foreclosed assets	$	1,429	Discounted appraisals	Appraisal adjustments (1)	9% to 37%
Equity warrant assets	$	538	Black-Scholes option pricing model	Volatility Risk-free interest rate Marketability discount Remaining life	20.00% 2.85% 20% 9-10 years

37

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

December 31, 2017

Level 3 Assets with Significant Unobservable Inputs	Fair Value		Valuation Technique	Significant Unobservable Inputs	Range
Impaired loans and leases	$	34,493	Discounted appraisals Discounted expected cash flows	Appraisal adjustments (1) Interest rate & repayment term	10% to 25% Weighted average discount rate 6.26%
Foreclosed assets	$	1,281	Discounted appraisals	Appraisal adjustments (1)	10% to 37%
Contingent consideration liability	$	1,900	Monte Carlo simulation	Volatility Risk-free rate of return Dividend yield Remaining life	25.00% 1.43% 0.51% 3.00 years

(1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments.

Estimated Fair Value of Other Financial Instruments

GAAP also requires disclosure of the fair value of financial instruments carried at book value on the consolidated balance sheet. The carrying amounts and estimated fair values of the Company’s financial instruments are as follows:

September 30, 2018	Carrying Amount		Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
Financial assets
Cash and due from banks	$	368,565	$	368,565	$	—	$	—	$	368,565
Certificates of deposit with other banks	750		748		—		—		748
Investment securities, available-for-sale	374,284		—		374,284		—		374,284
Loans held for sale(1)	646,475		—		—		649,054		649,054
Loans and leases, net of allowance for loan and lease losses(1)	1,604,540		—		—		1,594,589		1,594,589
Servicing assets	49,261		—		—		49,261		49,261
Accrued interest receivable	14,147		14,147		—		—		14,147
Financial liabilities
Deposits	2,924,288		—		2,871,159		—		2,871,159
Accrued interest payable	410		410		—		—		410
Long term borrowings	1,506		—		—		1,507		1,507

38

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

December 31, 2017	Carrying Amount		Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
Financial assets
Cash and due from banks	$	295,271	$	295,271	$	—	$	—	$	295,271
Certificates of deposit with other banks	3,000		2,993		—		—		2,993
Investment securities, available-for-sale	93,355		—		93,355		—		93,355
Loans held for sale (1)	680,454		—		—		706,972		706,972
Loans and leases, net of allowance for loan and lease losses(1)	1,319,783		—		—		1,319,615		1,319,615
Servicing assets	52,298		—		—		52,298		52,298
Accrued interest receivable	10,160		10,160		—		—		10,160
Financial liabilities
Deposits	2,260,263		—		2,232,370		—		2,232,370
Accrued interest payable	367		367		—		—		367
Long term borrowings	26,564		—		—		27,390		27,390

(1) In accordance with the adoption of ASU 2016-01, as of September 30, 2018, the fair value of loans and leases were measured using an exit price notion. As of December 31, 2017, the fair value of loans and leases were measured using an entry price notion.

Note 11. Commitments and Contingencies

Litigation

In the normal course of business the Company is involved in various legal proceedings. Management believes that the outcome of such proceedings will not materially affect the financial position, results of operations or cash flows of the Company.

Financial Instruments with Off-balance-sheet Risk

The Company is party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. These instruments involve, to varying degrees, credit risk in excess of the amount recognized in the balance sheet.

The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as for on-balance-sheet instruments. A summary of the Company’s commitments is as follows:

	September 30, 2018		December 31, 2017
Commitments to extend credit	$	1,432,771	$	1,701,137
Standby letters of credit	2,279		2,298
Solar purchase commitments	10,158		106,921
Airplane purchase agreement commitments	10,450		25,450
Total unfunded off-balance-sheet credit risk	$	1,455,658	$	1,835,806

39

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the party. Collateral held varies, but may include accounts receivable, inventory, property and equipment, residential real estate and income-producing commercial properties. In 2012, the Company began issuing commitment letters after approval of the loan by the Credit Department. Commitment letters generally expire ninety days after issuance.

Standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. Collateral held varies as specified above and is required in instances which the Company deems necessary.

Solar purchase commitments are commitments to purchase solar assets to fulfill leasing obligations.

As of September 30, 2018 and December 31, 2017, the Company had unfunded commitments to provide capital contributions for on-balance sheet investments in the amount of $3.0 million and $3.5 million, respectively.

Concentrations of Credit Risk

Although the Company is not subject to any geographic concentrations, a substantial amount of the Company’s loans, leases, and commitments to extend credit have been granted to customers in the agriculture, healthcare and veterinary verticals. The concentrations of credit by type of loan are set forth in Note 5. The distribution of commitments to extend credit approximates the distribution of loans outstanding. The Company does not have a significant number of credits to any single borrower or group of related borrowers whereby their retained unguaranteed exposure exceeds $7.5 million, except for ten relationships that have a retained unguaranteed exposure of $121.1 million of which $102.3 million of the unguaranteed exposure has been disbursed.

Additionally, the Company has future minimum lease payments due under non-cancelable operating leases totaling $89.1 million, of which $67.4 million is due from four relationships.

The Company from time-to-time may have cash and cash equivalents on deposit with financial institutions that exceed federally-insured limits.

Note 12. Stock Plans

On March 20, 2015, the Company adopted the 2015 Omnibus Stock Incentive Plan which replaced the previously existing Amended Incentive Stock Option Plan and Nonstatutory Stock Option Plan. Subsequently on May 24, 2016, the 2015 Omnibus Stock Incentive Plan was amended to authorize awards covering a maximum of 7,000,000 common voting shares and has an expiration date of March 20, 2025. On May 15, 2018, the Amended and Restated 2015 Omnibus Stock Incentive Plan was amended to authorize awards covering a maximum of 8,750,000 common voting shares. Options or restricted shares granted under the Amended and Restated 2015 Omnibus Stock Incentive Plan (the "Plan") expire no more than 10 years from the date of grant. Exercise prices under the Plan are set by the Board of Directors at the date of grant, but shall not be less than 100% of fair market value of the related stock at the date of the grant. Options or restricted shares vest over a minimum of three years from the date of the grant.

Stock Options

Compensation cost relating to share-based payment transactions are recognized in the financial statements with measurement based upon the fair value of the equity or liability instruments issued. For the three months ended September 30, 2018 and 2017, the Company recognized $470 thousand and $536 thousand in compensation expense for stock options, respectively. For the nine months ended September 30, 2018 and 2017, the Company recognized $1.2 million and $1.4 million in compensation expense for stock options, respectively.

40

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Stock option activity under the Plan during the nine month periods ended September 30, 2018 and 2017 is summarized below.

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at December 31, 2017	3,058,459	$	11.30
Exercised	171,333	9.26
Forfeited	174,845	13.69
Granted	—	—
Outstanding at September 30, 2018	2,712,281	$	11.27	6.28 years	$	47,005,905
Exercisable at September 30, 2018	813,730	$	10.67	6.11 years	$	14,587,733

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at December 31, 2016	3,478,208	$	11.51
Exercised	76,285	7.89
Forfeited	203,671	14.12
Granted	—	—
Outstanding at September 30, 2017	3,198,252	$	11.43	7.31 years	$	38,411,802
Exercisable at September 30, 2017	703,425	$	10.41	7.06 years	$	9,171,805

The following is a summary of non-vested stock option activity for the Company for the nine months ended September 30, 2018 and 2017.

	Shares		Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	2,364,999		$	4.65
Granted	—		—
Vested	(291,603	)	3.95
Forfeited	(174,845	)	5.98
Non-vested at September 30, 2018	1,898,551		4.63

	Shares		Weighted Average Grant Date Fair Value
Non-vested at December 31, 2016	3,016,100		$	4.78
Granted	—		—
Vested	(317,602	)	4.17
Forfeited	(203,671	)	6.03
Non-vested at September 30, 2017	2,494,827		4.75

The total intrinsic value of options exercised at September 30, 2018 and 2017 was $3.3 million and $1.1 million, respectively.

At September 30, 2018, unrecognized compensation costs relating to stock options amounted to $6.6 million which will be recognized over a weighted average period of 2.31 years.

41

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The weighted average fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts. There were no stock options granted during the three and nine months ended September 30, 2018 or 2017.

Restricted Stock

Restricted stock awards are authorized in the form of restricted stock awards or units ("RSU"s) and restricted stock awards or units with a market price condition ("Market RSU"s).

RSUs have a restriction based on the passage of time and may also have a restriction based on a non-market-related performance criteria. The fair value of the RSUs is based on the closing price on the date of the grant.

Market RSUs also have a restriction based on the passage of time and non-market-related performance criteria, but also have a restriction based on market price criteria related to the Company’s share price closing at or above a specified price ranging from $34.00 to $55.00 per share for at least twenty (20) consecutive trading days at any time prior to expiration date. The amount of Market RSUs earned will not exceed 100% of the Market RSUs awarded. The fair value of the Market RSUs and the implied service period is calculated using the Monte Carlo simulation method.

RSU stock activity under the Plan during the first nine months of 2018 is summarized below.

	Shares	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	181,814	$	20.03
Granted	230,599	28.72
Vested	83,829	23.68
Forfeited	38,793	22.96
Non-vested at September 30, 2018	289,791	25.50

For the three months ended September 30, 2018 and 2017, the Company recognized $401 thousand and $191 thousand in compensation expense for RSUs, respectively. For the nine months ended September 30, 2018 and 2017, the Company recognized $2.2 million and $517 thousand in compensation expense for RSUs, respectively.

At September 30, 2018, unrecognized compensation costs relating to RSUs amounted to $6.6 million which will be recognized over a weighted average period of 5.19 years.

Market RSU stock activity under the Plan during the first nine months of 2018 is summarized below.

	Shares	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	2,532,808	$	8.78
Granted	485,000	15.73
Vested	—	—
Forfeited	223,128	9.08
Non-vested at September 30, 2018	2,794,680	9.96

The compensation expense for Market RSUs is measured based on their grant date fair value as calculated using the Monte Carlo simulation and is recognized on a straight-line basis over the average vesting period. The Monte Carlo simulation used 100,000 simulation paths to assess the expected date of achieving the market price criteria.

Related to the 75,000 Market RSUs granted on May 14, 2018, the share price simulation was based on the Cox, Ross & Rubinstein option pricing methodology for a period of 7.0 years. The implied term of the restricted stock was 3.3 years. The Monte Carlo Simulation used various assumptions that included a risk free rate of return of 2.96%, expected volatility of 27.00% and a dividend yield of 0.42%.

42

Live Oak Bancshares, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Related to the 410,000 Market RSUs granted on August 10, 2018, the share price simulation was based on the Cox, Ross & Rubinstein option pricing methodology for a period of 7.0 years. The implied term of the restricted stock ranges from 1.6 years to 3.5 years. The Monte Carlo Simulation used various assumptions that included a risk free rate of return of 2.78%, expected volatility of 28.10% and a dividend yield of 0.40%.

For the three months ended September 30, 2018 and 2017, the Company recognized $1.6 million and $1.3 million in compensation expense for Market RSUs, respectively. For the nine months ended September 30, 2018 and 2017, the Company recognized $3.5 million and $3.7 million in compensation expense for Market RSUs, respectively.

At September 30, 2018, unrecognized compensation costs relating to Market RSUs amounted to $18.4 million which will be recognized over a weighted average period of 2.66 years.

Employee Stock Purchase Plan

The Company adopted an Employee Stock Purchase Plan on October 8, 2014. On May 24, 2016, the plan was amended and the Amended and Restated Employee Stock Purchase Plan (the "ESPP") became effective within the meaning of Section 423 of the Internal Revenue Code of 1986, as amended. Under the ESPP, eligible employees are able to purchase available shares with post-tax dollars as of the grant date. In order for employees to be eligible to participate in the ESPP they must be employed or on an authorized leave of absence from the Company or any subsidiary immediately prior to the grant date. ESPP stock purchases cannot exceed $25 thousand in fair market value per employee per calendar year. Options to purchase shares under the ESPP are granted at a 15% discount to fair market value. For the three months ended September 30, 2018 and 2017, the Company recognized $31 thousand and $36 thousand, respectively. For the nine months ended September 30, 2018 and 2017 the Company recognized $60 thousand and $79 thousand expense, respectively.

43

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following presents management’s discussion and analysis of the financial condition and results of operations of Live Oak Bancshares, Inc. (the “Company” or “LOB”). This discussion should be read in conjunction with the financial statements and related notes included elsewhere in this quarterly report on Form 10-Q and with the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (the "2017 Annual Report"). Results of operations for the periods included in this quarterly report on Form 10-Q are not necessarily indicative of results to be obtained during any future period.

Important Note Regarding Forward-Looking Statements

This quarterly report on Form 10-Q contains statements that management believes are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. These statements generally relate to the Company’s financial condition, results of operations, plans, objectives, future performance or business. They usually can be identified by the use of forward-looking terminology, such as “believes,” “expects,” or “are expected to,” “plans,” “projects,” “goals,” “estimates,” “will,” “may,” “should,” “could,” “would,” “continues,” “intends to,” “outlook” or “anticipates,” or variations of these and similar words, or by discussions of strategies that involve risks and uncertainties. You should not place undue reliance on these statements, as they are subject to risks and uncertainties, including but not limited to, those described in this quarterly report on Form 10-Q. When considering these forward-looking statements, you should keep in mind these risks and uncertainties, as well as any cautionary statements management may make. Moreover, you should treat these statements as speaking only as of the date they are made and based only on information actually known to the Company at the time. Management undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements contained in this quarterly report on Form 10-Q are based on current expectations, estimates and projections about the Company’s business, management’s beliefs and assumptions made by management. These statements are not guarantees of the Company’s future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements. These risks, uncertainties and assumptions include, without limitation:

• deterioration in the financial condition of borrowers resulting in significant increases in the Company’s loan and lease losses and provisions for those losses and other adverse impacts to results of operations and financial condition;

• changes in Small Business Administration ("SBA") rules, regulations and loan products, including specifically the Section 7(a) program, changes in SBA standard operating procedures or changes to the status of Live Oak Banking Company (the "Bank") as an SBA Preferred Lender;

• changes in rules, regulations or procedures for other government loan programs, including those of the United States Department of Agriculture;

• changes in interest rates that affect the level and composition of deposits, loan demand and the values of loan collateral, securities, and interest sensitive assets and liabilities;

• the failure of assumptions underlying the establishment of reserves for possible loan and lease losses;

• changes in loan underwriting, credit review or loss reserve policies associated with economic conditions, examination conclusions, or regulatory developments;

• a reduction in or the termination of the Company’s ability to use the technology-based platform that is critical to the success of the Company’s business model, including a failure in or a breach of the Company’s operational or security systems or those of its third party service providers;

• changes in financial market conditions, either internationally, nationally or locally in areas in which the Company conducts operations, including reductions in rates of business formation and growth, demand for the Company’s products and services, commercial and residential real estate development and prices, premiums paid in the secondary market for the sale of loans, and valuation of servicing rights;

• changes in accounting principles, policies, and guidelines applicable to bank holding companies and banking;

• fluctuations in markets for equity, fixed-income, commercial paper and other securities, which could affect availability, market liquidity levels, and pricing;

• the effects of competition from other commercial banks, non-bank lenders, consumer finance companies, credit unions, securities brokerage firms, insurance companies, money market and mutual funds, and other financial institutions operating in the Company’s market area and elsewhere, including institutions operating regionally, nationally and internationally, together with such competitors offering banking products and services by mail, telephone and the Internet;

• the Company's ability to attract and retain key personnel;

44

• changes in governmental monetary and fiscal policies as well as other legislative and regulatory changes, including with respect to SBA lending programs and investment tax credits;

• changes in political and economic conditions;

• the impact of heightened regulatory scrutiny of financial products and services, primarily led by the Consumer Financial Protection Bureau;

• the Company's ability to comply with any requirements imposed on it by regulators, and the potential negative consequences that may result;

• operational, compliance and other factors, including conditions in local areas in which the Company conducts business such as inclement weather or a reduction in the availability of services or products for which loan proceeds will be used, that could prevent or delay closing and funding loans before they can be sold in the secondary market;

• the effect of any mergers, acquisitions or other transactions, to which the Company or the Bank may from time to time be a party, including management’s ability to successfully integrate any businesses acquired;

• other risk factors listed from time to time in reports that the Company files with the SEC, including in the Company’s 2017 Annual Report; and

• the success at managing the risks involved in the foregoing.

Except as otherwise disclosed, forward-looking statements do not reflect: (i) the effect of any acquisitions, divestitures or similar transactions that have not been previously disclosed; (ii) any changes in laws, regulations or regulatory interpretations; or (iii) any change in current dividend or repurchase strategies, in each case after the date as of which such statements are made. All forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update any statement, to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

Amounts in all tables in Management’s Discussion and Analysis of Financial Condition and Results of Operations have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated.

Nature of Operations

LOB is a bank holding company headquartered in Wilmington, North Carolina incorporated under the laws of North Carolina in December 2008. The Company conducts business operations primarily through its commercial bank subsidiary, Live Oak Banking Company (the “Bank”). The Bank was incorporated in February 2008 as a North Carolina-chartered commercial bank. The Bank specializes in providing lending services to small businesses nationwide. The Bank identifies and grows within selected industry sectors, or verticals, by leveraging expertise within those industries, and more broadly to select borrowers outside of those industries. A significant portion of the loans originated by the Bank are guaranteed by the SBA under its 7(a) program. In 2010, the Bank formed Live Oak Number One, Inc., a wholly-owned subsidiary, to hold properties foreclosed on by the Bank.

Effective July 29, 2016, the Company elected to become a “financial holding company” within the meaning of the Bank Holding Company Act. A financial holding company, and the nonbank companies under its control, are permitted to engage in activities considered financial in nature or incidental to financial activities. For the Company to become and remain eligible for financial holding company status, it and the Bank must meet certain criteria, including capital, management and Community Reinvestment Act (“CRA”) requirements. The failure to meet such criteria could, depending on which requirements were not met, result in the Company facing restrictions on new financial activities or acquisitions or being required to discontinue existing activities that are not otherwise permissible for bank holding companies.

45

In June 2018, the Bank formed Live Oak Private Wealth, LLC for the purpose of providing high-net-worth individuals and families with strategic wealth and investment management services. In 2017, the Bank entered into a joint venture, Apiture LLC (“Apiture”), with First Data Corporation for the purpose of creating next generation technology for financial institutions. In addition to the Bank, the Company owns Live Oak Clean Energy Financing LLC, formed in November 2016, for the purpose of providing financing to entities for renewable energy applications; Live Oak Ventures, Inc. (formerly known as “Canapi, Inc.”), formed in August 2016, for the purpose of investing in businesses that align with the Company's strategic initiative to be a leader in financial technology; Live Oak Grove, LLC, opened in September 2015 for the purpose of providing Company employees and business visitors an on-site restaurant location; Government Loan Solutions, Inc. (“GLS”), a management and technology consulting firm that specializes in the settlement, accounting, and securitization processes for government guaranteed loans, including loans originated under the SBA 7(a) loan program and U.S. Department of Agriculture ("USDA")-guaranteed loans; and 504 Fund Advisors, LLC (“504FA”), which was formed to serve as the investment advisor to The 504 Fund, a closed-end mutual fund organized to invest in SBA section 504 loans. In addition, the Company owned Reltco Inc. and National Assurance Title, Inc. (collectively referred to as “Reltco”) until the Company sold Reltco on August 1, 2018. See Note 1 under the subheading Sale of Title Insurance Business for more information.

The Company generates revenue primarily from the sale of SBA-guaranteed loans and USDA guaranteed Rural Energy for America Program ("REAP") and Business & Industry ("B&I") loans and net interest income. Income from the sale of loans is comprised of loan servicing revenue and revaluation of related servicing assets and net gains on sales of loans. Offsetting these revenues are the cost of funding sources, provision for loan and lease losses, any costs related to foreclosed assets and other operating costs such as salaries and employee benefits, travel, professional services, occupancy, advertising and marketing, data processing, equipment and tax expense.

On July 23, 2015 the Company closed on its initial public offering with a secondary offering completed in August of 2017.

Business Outlook

Below is a discussion of management’s current expectations regarding company performance over the near-term based on market conditions, the regulatory environment and business strategies as of the time the Company filed this Report. Actual outcomes and results may differ materially from what is expressed or forecasted in these forward-looking statements. See “Important Note Regarding Forward-Looking Statements” in this Report for more information on forward-looking statements.

For the full year of 2018, the Company expects to originate approximately $1.70 billion to $1.80 billion in loans and leases. During the fourth quarter of 2018, the Company expects to retain more loans on the consolidated balance sheet by selling less into the secondary market, compared to historical trends.

Results of Operations

Performance Summary

Three months ended September 30, 2018 compared with three months ended September 30, 2017

For the three months ended September 30, 2018, the Company reported net income of $14.3 million, or $0.34 per diluted share, as compared to $12.9 million, or $0.33 per diluted share, for the three months ended September 30, 2017. This increase in net income is primarily due to the following items:

• Increased net interest income of $6.7 million, or 31.9%, predominately driven by significant growth in the combined held for sale and held for investment loan and lease portfolios along with higher investment security holdings;

• A decline in the provision for loan and lease losses of $2.7 million, or 110.0%, primarily as a result of updated loss factors consistent with our methodology for estimating the allowance for loan and lease losses;

• Increased net gains on sales of loans of $3.9 million, or 21.3%, as a result of higher loan sale volumes partially offset by lower average premiums;

• Increased loan servicing revenue of $1.0 million, or 15.7%, attributable to a higher serviced loan portfolio; and

• Increased lease income of $1.5 million for lease activities that began during the second quarter of 2017.

Partially offsetting the above factors was a decline in title insurance income of $1.5 million combined with increases in various cost factors as follows: $5.7 million in the loan servicing asset revaluation loss, $1.5 million in salaries and employee benefits, $1.7 million in data processing expense, $1.4 million in equipment expense, $2.7 million one-time net impairment expense associated with the sale of the title insurance business and a lower income tax benefit of $1.9 million.

46

Nine months endedSeptember 30, 2018 compared with nine months ended September 30, 2017

For the nine months ended September 30, 2018, the Company reported net income of $41.0 million, or $0.98 per diluted share, as compared to $28.8 million, or $0.78 per diluted share, for the nine months ended September 30, 2017. This increase in net income is primarily attributable to the following items:

• Increased net interest income of $24.2 million, or 43.9%, predominately driven by significant growth in the loans and leases held for sale and held for investment portfolios along with higher investment security holdings;

• Increased loan servicing revenue of $2.8 million, or 15.0%, as a result of continued growth in the servicing portfolio due to ongoing loan sales;

• Increased net gains on sales of loans of $14.2 million, or 25.7%, due to a higher year-to-date sale volume partially offset by a decrease in the average net gain per loan sold; and

• Increased lease income of $5.0 million for operating lease activities that began during the second quarter of 2017.

Partially offsetting the above factors was a decline in title insurance income of $3.0 million combined with increases in various cost factors as follows: $11.3 million in the loan servicing asset revaluation loss, $7.2 million in salaries and employee benefits, $1.3 million in occupancy expense, $3.9 million in data processing expense, $5.1 million in equipment expense, $2.7 million one-time net impairment expense associated with the sale of the title insurance business and a lower income tax benefit of $1.5 million.

Net Interest Income and Margin

Net interest income represents the difference between the income that the Company earns on interest-earning assets and the cost it incurs on interest-bearing liabilities. The Company’s net interest income depends upon the volume of interest-earning assets and interest-bearing liabilities and the interest rates that the Company earns or pays on them. Net interest income is affected by changes in the amount and mix of interest-earning assets and interest-bearing liabilities, referred to as “volume changes.” It is also affected by changes in yields earned on interest-earning assets and rates paid on interest-bearing deposits and other borrowed funds, referred to as “rate changes.” Without a branch network, the Bank generates deposits over the Internet and in the community in which it is headquartered. Due to the nature of a branchless bank and the relatively low overhead required for deposit gathering, the rates that the Bank offers are generally above the industry average.

Three months ended September 30, 2018 compared with three months ended September 30, 2017

For the three months ended September 30, 2018, net interest income increased $6.7 million, or 31.9%, to $27.7 million compared to $21.0 million for the three months ended September 30, 2017. This increase was principally due to the significant growth in average interest earning assets, predominately loans, leases and investment securities, and to a lesser extent by higher yields on these assets which outpaced the relative growth and change in the cost of interest bearing liabilities, primarily related to deposits. Average interest earning assets increased by $909.5 million, or 42.6%, to $3.04 billion for the three months ended September 30, 2018, compared to $2.13 billion for the three months ended September 30, 2017, while the yield on average interest earning assets increased twenty-two basis points to 5.46%. The cost of funds on interest bearing liabilities for the three months ended September 30, 2018 increased fifty basis points to 1.93%, and the average balance of interest bearing liabilities increased by $925.4 million, or 46.6%, over the same period in 2017. As indicated in the rate/volume table below, the increase in interest earning assets and corresponding yields outpaced the higher volume of interest bearing liabilities along with an increasing cost of funds, resulting in increased interest income of $13.7 million and increased interest expense of $7.0 million for the three months ended September 30, 2018 compared to the three months ended September 30, 2017. For the three months ended September 30, 2017 compared to the three months ended September 30, 2018, net interest margin declined from 3.91% to 3.61%, respectively, principally due to the narrowing of the interest rate spread during the quarter. This compression of the spread was largely the result of strategic liquidity initiatives which were accomplished during the first quarter of 2018 which led to much higher levels of investment securities and cash balances held with other banks which carry much lower yields.

47

Nine months endedSeptember 30, 2018 compared with nine months ended September 30, 2017

For the nine months ended September 30, 2018, net interest income increased $24.2 million, or 43.9%, to $79.2 million compared to $55.1 million for the nine months ended September 30, 2017. This increase was principally due to the significant growth in average interest earning assets and to a lesser extent higher yields on these assets outpacing the growth and change in the cost of interest bearing liabilities. Average interest earning assets increased by $1.05 billion, or 55.0%, to $2.95 billion for the nine months ended September 30, 2018 compared to $1.90 billion for the nine months ended September 30, 2017, while the yield on average interest earning assets increased by twenty-two basis points to 5.34%. The cost of funds on interest bearing liabilities for the nine months ended September 30, 2018 increased by fifty basis points to 1.84%, and the average balance of interest bearing liabilities increased by $1.03 billion, or 58.1%, during the same period. As indicated in the rate/volume table below, the increase in interest bearing liabilities and corresponding cost of funds was outpaced by the positive effects of the increased volume of interest earning assets along with higher yields, resulting in increased interest income of $45.0 million and increased interest expense of $20.8 million for the nine months ended September 30, 2018. For the nine months ended September 30, 2017 compared to the nine months ended September 30, 2018, net interest margin declined from 3.87% to 3.59% due to the aforementioned effects.

48

Average Balances and Yields. The following table presents information regarding average balances for assets and liabilities, the total dollar amounts of interest income and dividends from average interest-earning assets, the total dollar amount of interest expense on average interest-bearing liabilities, and the resulting average yields and costs. The yields and costs for the periods indicated are derived by dividing the income or expense by the average balances for assets or liabilities, respectively, for the periods presented and annualizing that result. Loan fees are included in interest income on loans.

	Three months ended September 30,
	2018							2017
	Average Balance			Interest		Average Yield/Rate		Average Balance			Interest		Average Yield/Rate
Interest earning assets:
Interest earning balances in other banks	$	349,739		$	1,638	1.86	%	$	292,066		$	870	1.18	%
Investment securities	388,520			2,528		2.58		73,312			325		1.76
Loans held for sale	693,517			11,270		6.45		653,342			9,922		6.03
Loans and leases held for investment (1)	1,612,699			26,454		6.51		1,116,209			17,055		6.06
Total interest earning assets	3,044,475			41,890		5.46		2,134,929			28,172		5.24
Less: allowance for loan and lease losses	(29,266		)					(19,544		)
Non-interest earning assets	434,963							242,014
Total assets	$	3,450,172						$	2,357,399
Interest bearing liabilities:
Interest bearing checking	$	31,950		$	87	1.08	%	$	35,127		$	51	0.58	%
Savings	943,958			4,026		1.69		196,220			682		1.38
Money market accounts	120,702			314		1.03		453,985			1,303		1.14
Certificates of deposit	1,810,040			9,738		2.13		1,257,072			4,722		1.49
Total deposits	2,906,650			14,165		1.93		1,942,404			6,758		1.38
Other borrowings	3,365			1		0.12		42,219			389		3.66
Total interest bearing liabilities	2,910,015			14,166		1.93		1,984,623			7,147		1.43
Non-interest bearing deposits	46,272							43,652
Non-interest bearing liabilities	21,804							22,650
Shareholders' equity	472,081							306,474
Total liabilities and shareholders' equity	$	3,450,172						$	2,357,399
Net interest income and interest rate spread				$	27,724	3.53	%				$	21,025	3.81	%
Net interest margin						3.61							3.91
Ratio of average interest-earning assets to average interest-bearing liabilities						104.62	%						107.57	%

(1) Average loan and lease balances include non-accruing loans.

49

	Nine months ended September 30,
	2018							2017
	Average Balance			Interest		Average Yield/Rate		Average Balance			Interest		Average Yield/Rate
Interest earning assets:
Interest earning balances in other banks	$	403,024		$	5,032	1.67	%	$	229,074		$	1,682	0.98	%
Investment securities	315,120			6,175		2.62		71,319			964		1.81
Loans held for sale	722,308			34,423		6.37		561,408			24,679		5.88
Loans and leases held for investment(1)	1,508,833			72,259		6.40		1,041,265			45,611		5.86
Total interest earning assets	2,949,285			117,889		5.34		1,903,066			72,936		5.12
Less: allowance for loan and lease losses	(27,157		)					(18,652		)
Non-interest earning assets	422,295							206,653
Total assets	$	3,344,423						$	2,091,067
Interest bearing liabilities:
Interest bearing checking	$	37,448		$	290	1.04	%	$	39,973		$	173	0.58	%
Savings	922,028			11,206		1.62		67,395			693		1.37
Money market accounts	147,002			1,297		1.18		469,505			3,365		0.96
Certificates of deposit	1,697,620			25,717		2.03		1,163,081			12,662		1.46
Total deposits	2,804,098			38,510		1.84		1,739,954			16,893		1.30
Other borrowings	5,998			131		2.92		37,736			985		3.49
Total interest bearing liabilities	2,810,096			38,641		1.84		1,777,690			17,878		1.34
Non-interest bearing deposits	52,225							35,073
Non-interest bearing liabilities	20,691							22,288
Shareholders’ equity	461,411							256,016
Total liabilities and shareholders’ equity	$	3,344,423						$	2,091,067
Net interest income and interest rate spread				$	79,248	3.50	%				$	55,058	3.78	%
Net interest margin						3.59							3.87
Ratio of average interest-earning assets to average interest-bearing liabilities						104.95	%						107.05	%

(1) Average loan and lease balances include non-accruing loans.

50

Rate/Volume Analysis. The following table sets forth the effects of changing rates and volumes on net interest income. The rate column shows the effects attributable to changes in rate (changes in rate multiplied by prior volume). The volume column shows the effects attributable to changes in volume (changes in volume multiplied by prior rate). The total column represents the sum of the prior columns. For purposes of this table, increases or decreases attributable to changes in both rate and volume that cannot be segregated have been allocated proportionally based on the changes due to rate and the changes due to volume.

	Three months ended September 30,									Nine months ended September 30,
	2018 vs. 2017									2018 vs. 2017
	Increase (Decrease) Due to									Increase (Decrease) Due to
	Rate			Volume			Total			Rate			Volume			Total
Interest income:
Interest earning balances in other banks	$	547		$	221		$	768		$	1,625		$	1,725		$	3,350
Investment securities	479			1,724			2,203			1,175			4,036			5,211
Loans held for sale	717			631			1,348			2,373			7,371			9,744
Loans and leases held for investment	1,534			7,865			9,399			5,211			21,437			26,648
Total interest income	3,277			10,441			13,718			10,384			34,569			44,953
Interest expense:
Interest bearing checking	43			(7		)	36			132			(15		)	117
Savings	450			2,894			3,344			926			9,587			10,513
Money market accounts	(77		)	(912		)	(989		)	510			(2,578		)	(2,068		)
Certificates of deposit	2,490			2,526			5,016			6,097			6,958			13,055
Other borrowings	(202		)	(186		)	(388		)	(96		)	(758		)	(854		)
Total interest expense	2,704			4,315			7,019			7,569			13,194			20,763
Net interest income	$	573		$	6,126		$	6,699		$	2,815		$	21,375		$	24,190

Provision for Loan and Lease Losses

The provision for loan and lease losses represents the amount necessary to be charged against the current period’s earnings to maintain the allowance for loan and lease losses at a level that is appropriate in relation to the estimated losses inherent in the loan and lease portfolio. A number of factors are considered in determining the required level of loan and lease loss reserves and the provision required to achieve the appropriate reserve level, including loan and lease growth, credit risk rating trends, nonperforming loan and lease levels, delinquencies, loan and lease portfolio concentrations and economic and market trends.

Losses inherent in loan relationships are mitigated if a portion of the loan is guaranteed by the SBA or USDA. A typical SBA 7(a) loan carries a 75% guarantee while USDA guarantees range from 60% to 80% depending on loan size, which serve to reduce the risk profile of these loans. The Company believes that its focus on compliance with regulations and guidance from the SBA and USDA are key factors to managing this risk.

For the third quarter of 2018 there was a negative provision for loan and lease losses of $243 thousand compared to provision expenses of $2.4 million for the same period in 2017, a decrease of $2.7 million, or 110.0%. For the nine months ended September 30, 2018 the provision was $6.2 million compared to $5.5 million for the same period in 2017, an increase of $755 thousand, or 13.8%. The decrease in the provision for loan and lease losses compared to the prior year quarter along with the reduced level of increase in year to year periods was primarily attributable to updated loss factors in the third quarter 2018 consistent with our methodology for estimating the allowance for loan and lease losses. Specifically, during the third quarter of 2018, the family entertainment portfolio passed the Company's allowance policy criteria for new verticals to transition to mature status thereby moving from using industry loss rates to actual incurred loss rates. This transition to actual loss rates reduced the provision by $2.9 million in the third quarter of 2018. Also contributing to lower provision costs was a strategic transfer of $29.9 million in unguaranteed renewable energy loans from held for investment to held for sale in the third quarter of 2018. This change in intent to designate loans for sale that were previously held for investment decreased the provision by $434 thousand.

Loans and leases held for investment were $1.63 billion as of September 30, 2018, increasing by $461.5 million, or 39.4%, compared to September 30, 2017. This growth was fueled by strong loan origination volumes and ongoing disbursements for loans in the construction portfolio over the past year.

51

Net charge-offs were $2.3 million, or 0.57% of average quarterly loans and leases held for investment on an annualized basis, for the three months ended September 30, 2018, compared to net charge-offs of $959 thousand, or 0.34%, for the three months ended September 30, 2017. Net charge-offs for the first nine months of 2018 and 2017 totaled $3.6 million and $2.7 million, respectively. Year to date net charge-offs as a percentage of year to date average loans and leases held for investment were 0.24% and 0.26% at September 30, 2018 and 2017, respectively. Net charge-offs are a key element of historical experience in the Company's estimation of the allowance for loan and lease losses.

In addition, at September 30, 2018, nonperforming loans and leases not guaranteed by the SBA totaled $12.9 million, which was 0.79% of the held-for-investment loan and lease portfolio compared to $3.3 million, or 0.28% of loans and leases held for investment at September 30, 2017.

Noninterest Income

Noninterest income is principally comprised of net gains from the sale of SBA and USDA-guaranteed loans along with loan servicing revenue and revaluation. Revenue from the sale of loans depends upon the volume, maturity structure and rates of underlying loans as well as the pricing and availability of funds in the secondary markets prevailing in the period between completed loan funding and closing of sale. In addition, the loan servicing revaluation is significantly impacted by changes in market rates and other underlying assumptions such as prepayment speeds and default rates. Noninterest income also commonly includes lease income, construction supervision fee income and title insurance income. Other less common elements of noninterest income include nonrecurring gains and losses on investments.

The following table shows the components of noninterest income and the dollar and percentage changes for the periods presented.

	Three Months Ended September 30,						Increase (Decrease)
	2018			2017			Amount			Percent
Noninterest income
Loan servicing revenue	$	7,506		$	6,490		$	1,016		15.65	%
Loan servicing asset revaluation	(9,380		)	(3,691		)	(5,689		)	(154.13	)
Net gains on sales of loans	22,004			18,148			3,856			21.25
Lease income	2,194			682			1,512			221.70
Construction supervision fee income	578			362			216			59.67
Title insurance income	479			1,968			(1,489		)	(75.66	)
Other noninterest income	950			1,101			(151		)	(13.71	)
Total noninterest income	$	24,331		$	25,060		$	(729	)	(2.91	)%

	Nine Months Ended September 30,						Increase (Decrease)
	2018			2017			Amount			Percent
Noninterest income
Loan servicing revenue	$	21,369		$	18,587		$	2,782		14.97	%
Loan servicing asset revaluation	(18,138		)	(6,864		)	(11,274		)	(164.25	)
Net gains on sales of loans	69,483			55,276			14,207			25.70
Lease income	5,722			691			5,031			728.08
Construction supervision fee income	1,954			1,077			877			81.43
Title insurance income	2,775			5,803			(3,028		)	(52.18	)
Other noninterest income	2,535			2,910			(375		)	(12.89	)
Total noninterest income	$	85,700		$	77,480		$	8,220		10.61	%

For the three months ended September 30, 2018, noninterest income decreased by $729 thousand, or 2.9%, compared to the three months ended September 30, 2017. The decrease from the prior year is primarily the result of $9.4 million in the loan servicing asset revaluation loss in the third quarter of 2018 compared to $3.7 million in the third quarter of 2017. The higher negative revaluation results from the current rising rate environment and flattening yield curve which has led to increased prepayment speeds and fewer active loan purchasers relative to the growing pool of loans available for sale.

52

Also impacting the overall decrease in noninterest income was a decline in title insurance income of $1.5 million. The title insurance business was sold on August 1, 2018. Partially offsetting the overall decrease in noninterest income was growth in loan servicing revenue of $1.0 million, net gains on sale of loans of $3.9 million, and operating lease income of $1.5 million.

For the nine months ended September 30, 2018, noninterest income increased by $8.2 million, or 10.6%, compared to the nine months ended September 30, 2017. The higher noninterest income total was primarily the result of higher year-to-date levels in the serviced loan portfolio and the volume of loans sold in the secondary market which generated $2.8 million of increased servicing revenue and $14.2 million of increased net gains on sale of loans. Also contributing to increased levels of noninterest income was $5.0 million of operating lease income. Partly offsetting the overall increase in noninterest income was a higher negative loan servicing revaluation adjustment of $11.3 million and a decline in title insurance income of $3.0 million.

The following table reflects loan and lease production, sales of guaranteed loans and the aggregate balance in guaranteed loans sold. These components are key drivers of the Company's noninterest income.

	Three months ended September 30,				Three months ended June 30,				Three months ended March 31,
	2018		2017		2018		2017		2018		2017
Amount of loans and leases originated	$	377,337	$	395,682	$	491,797	$	586,471	$	397,559	$	468,663
Guaranteed portions of loans sold	298,073		163,843		295,216		203,714		247,243		208,715
Outstanding balance of guaranteed loans sold (1)	3,102,820		2,584,163		2,951,379		2,521,506		2,812,108		2,410,791

	Nine months ended September 30,				For years ended December 31,
	2018		2017		2017		2016		2015		2014
Amount of loans and leases originated	$	1,266,693	$	1,450,816	$	1,934,238	$	1,537,010	$	1,158,640	$	848,090
Guaranteed portions of loans sold	840,532		576,272		787,926		761,933		640,886		433,912
Outstanding balance of guaranteed loans sold (1)	3,102,820		2,584,163		2,680,641		2,278,618		1,779,989		1,302,828

(1) This represents the outstanding principal balance of guaranteed loans serviced, as of the last day of the applicable period, which have been sold into the secondary market.

Changes in various components of noninterest income are discussed in more detail below.

Loan Servicing Revenue: While portions of the loans that the Bank originates are sold and generate gain on sale revenue, servicing rights for all loans that the Bank originates, including loans sold, are retained by the Bank. In exchange for continuing to service loans that are sold, the Bank receives fee income represented in loan servicing revenue equivalent to one percent of the outstanding balance of SBA loans sold and 0.40% of the outstanding balance of USDA loans sold. In addition, the cost of servicing sold loans is approximately 0.40% of the balance of the loans sold, which is included in the loan servicing revaluation computations. Unrecognized servicing revenue is reflected in a servicing asset recorded on the consolidated balance sheet. Revenues associated with the servicing of loans are recognized over the expected life of the loan through the consolidated income statement, and the servicing asset is reduced as this revenue is recognized. For three and nine months ended September 30, 2018, loan servicing revenue increased $1.0 million, or 15.7%, and $2.8 million, or 15.0%, respectively, as compared to the three and nine months ended September 30, 2017, as a result of an increase in the average outstanding balance of guaranteed loans sold. At September 30, 2018, the outstanding balance of government guaranteed loans sold in the secondary market was $3.10 billion compared to $2.58 billion at September 30, 2017.

Loan Servicing Revaluation: The Company revalues its serviced loan portfolio at least quarterly. The revaluation considers the amortization of the portfolio, current market conditions for loan sale premiums, and current prepayment speeds. For the three months ended September 30, 2018, there was a net negative loan servicing revaluation adjustment of $9.4 million compared to a net negative adjustment of $3.7 million for the three months ended September 30, 2017. For the nine months ended September 30, 2018, there was a net negative loan servicing revaluation adjustment of $18.1 million compared to a net negative adjustment of $6.9 million for the nine months ended September 30, 2017. The higher negative loan servicing revaluation amount for the third quarter of 2018 as compared to the third quarter of 2017 was primarily a result of the current rising rate environment and flattening yield curve which has led to increased prepayment speeds and fewer active loan purchasers relative to the growing pool of loans available for sale.

53

Net Gains on Sale of Loans: For the three and nine months ended September 30, 2018, net gains on sales of loans increased $3.9 million, or 21.2%, and $14.2 million, or 25.7%, respectively, compared to the three and nine months ended September 30, 2017. For the three months ended September 30, 2018, the volume of guaranteed loans sold increased $134.2 million, or 81.9%, to $298.1 million from $163.8 million for the three months ended September 30, 2017. For the nine months ended September 30, 2018, the volume of guaranteed loans sold increased $264.3 million, or 45.9%, to $840.5 million from $576.3 million for the nine months ended September 30, 2017. The volume-driven increases in the year-to-date net gain on loan sale comparisons were partially offset by lower average premiums paid in the secondary market primarily due to changes driving the higher negative loan servicing valuation discussed above. The average net gain on sale of loans for the three and nine months ended September 30, 2018 was lower at $72 thousand and $84 thousand of revenue for each $1 million in loans sold, respectively, compared to $111 thousand and $97 thousand for the three and nine months ended September 30, 2017, respectively.

Noninterest Expense

Noninterest expense comprises all operating costs of the Company, such as employee related costs, travel, professional services, advertising and marketing expenses, exclusive of interest and income tax expense.

The following table shows the components of noninterest expense and the related dollar and percentage changes for the periods presented.

	Three Months Ended September 30,				Increase (Decrease)
	2018		2017		Amount			Percent
Noninterest expense
Salaries and employee benefits	$	20,553	$	19,037	$	1,516		7.96	%
Non-staff expenses:
Travel expense	2,003		2,289		(286		)	(12.49	)
Professional services expense	1,228		1,068		160			14.98
Advertising and marketing expense	1,462		1,516		(54		)	(3.56	)
Occupancy expense	1,588		1,473		115			7.81
Data processing expense	3,661		1,982		1,679			84.71
Equipment expense	3,649		2,228		1,421			63.78
Other loan origination and maintenance expense	1,742		1,601		141			8.81
FDIC insurance	1,105		858		247			28.79
Title insurance closing services expense	114		687		(573		)	(83.41	)
Impairment expense on goodwill and other intangibles, net	2,680		—		2,680			100.00
Other expense	1,459		3,117		(1,658		)	(53.19	)
Total non-staff expenses	20,691		16,819		3,872			23.02
Total noninterest expense	$	41,244	$	35,856	$	5,388		15.03	%

54

	Nine Months Ended September 30,				Increase (Decrease)
	2018		2017		Amount			Percent
Noninterest expense
Salaries and employee benefits	$	62,908	$	55,687	$	7,221		12.97	%
Non-staff expenses:
Travel expense	5,887		6,035		(148		)	(2.45	)
Professional services expense	3,645		4,228		(583		)	(13.79	)
Advertising and marketing expense	4,992		4,977		15			0.30
Occupancy expense	5,327		4,018		1,309			32.58
Data processing expense	9,404		5,536		3,868			69.87
Equipment expense	10,094		5,005		5,089			101.68
Other loan origination and maintenance expense	4,485		3,587		898			25.03
FDIC insurance	2,687		2,308		379			16.42
Title insurance closing services expense	912		1,877		(965		)	(51.41	)
Impairment expense on goodwill and other intangibles, net	2,680		—		2,680			100.00
Other expense	7,125		8,883		(1,758		)	(19.79	)
Total non-staff expenses	57,238		46,454		10,784			23.21
Total noninterest expense	$	120,146	$	102,141	$	18,005		17.63	%

Total noninterest expense for the three and nine months ended September 30, 2018 increased $5.4 million, or 15.0%, and $18.0 million, or 17.6%, respectively, compared to the same periods in 2017. The increase in noninterest expense was principally comprised of increased personnel, occupancy, data processing and equipment expense driven by the significant growth of the Company's core business. Also contributing significantly to the increase in noninterest expense was a one-time $2.7 million net impairment expense associated with the sale of the title insurance business. Changes in various components of noninterest expense are discussed below.

Salaries and employee benefits: Total personnel expense for the three and nine months ended September 30, 2018 increased by $1.5 million, or 8.0%, and $7.2 million, or 13.0%, respectively, compared to the same periods in 2017. The primary drivers for this increase was the continued investment in human capital to support the growing loan and lease production from new and existing verticals partially offset by transferring the recognition of costs associated with software development to data processing expense with the formation of Apiture. Total full-time equivalent employees decreased from 530 at September 30, 2017 to 504 at September 30, 2018. Another limiting factor was the sale of the title insurance business on August 1, 2018 which reduced the full-time equivalent count by 33 for the last two months of the quarter. Salaries and employee benefits expense included $2.5 million and $2.0 million of stock-based compensation in the three months ended September 30, 2018 and 2017, respectively, and $7.1 million and $6.2 million for the nine months ended September 30, 2018 and 2017, respectively. Expenses related to the employee stock purchase program, stock grants, stock option compensation and restricted stock expense are all considered stock-based compensation.

Of the total stock-based compensation included in salaries and employee benefits, $360 thousand for the third quarter and $1.1 million for the first nine months of 2018 and $286 thousand for the third quarter and $1.0 million for the first nine months of 2017, respectively, were related to restricted stock unit ("RSU") awards for key employee retention with an effective grant date of May 24, 2016.

Occupancy expense: For the three and nine months ended September 30, 2018, total occupancy expense increased $115 thousand, or 7.8%, and $1.3 million, or 32.6%, respectively, compared to the same periods in 2017. This increase was driven by continued investment in facilities and infrastructure to support the Company's growth initiatives.

Data processing expense: For the three and nine months ended September 30, 2018, total data processing expense increased $1.7 million, or 84.7%, and $3.9 million, or 69.9%, respectively, compared to the same periods in 2017. Largely influencing this increase was the contribution of software development resources to Apiture which transferred the recognition of costs associated with the Company’s technology development from salaries and employee benefits to data processing.

Equipment expense: For the three and nine months ended September 30, 2018, the total costs associated with equipment increased $1.4 million, or 63.8%, and $5.1 million, or 101.7%, respectively, compared to the same periods in 2017. A major factor behind this increase was the depreciation of solar panels arising from operating lease activities that began during the second quarter of 2017.

55

Impairment expense on goodwill and other intangible assets, net: This $2.7 million in expense is related to the seller financed exit of the title insurance business in the third quarter of 2018. See Note 1 under the subheading Sale of Title Insurance for more information.

Income Tax Benefit

The effective tax rates for the three and nine months ended September 30, 2018 was (28.9)% and (6.2)%, respectively, compared to the effective rates of (64.8)% and (15.5)% for the three and nine months ended September 30, 2017, respectively. The negative tax rates principally reflect the anticipated generation of investment tax credits by the solar panel leasing activity under the Company’s strategic initiatives in the renewable energy sector. Additionally, the tax rate for the three months ended September 30, 2018 was reduced due to an updated income forecast for the year that in turn impacted the expected effective tax rate. The actual effective tax rate for 2018 may differ from the estimated annualized amount because the actual amount will be dependent upon the nature and amount of future income and expenses as well as investments generating investment tax credits and transactions with discrete tax effects.

Discussion and Analysis of Financial Condition

September 30, 2018 vs. December 31, 2017

Total assets at September 30, 2018 were $3.44 billion, an increase of $686.3 million, or 24.9%, compared to total assets of $2.76 billion at December 31, 2017. The growth in total assets was principally driven by the following:

• Increased cash and due from banks largely due to the significant growth from deposit gathering campaigns that generated $664.0 million in new deposits and were designed to strengthen the liquidity profile;

• Increased investment securities available-for-sale of $280.9 million which was driven by the Company's strategic plan to enhance contingency funding sources;

• Growth in loans and leases held for investment of $287.4 million due to newly originated loans and leases; and

• Increased premises and equipment of $85.1 million related primarily to expansion of facilities and infrastructure to accommodate Company growth and the addition of solar panels to meet leasing commitments.

Cash and cash equivalents were $368.6 million at September 30, 2018, an increase of $73.3 million, or 24.8%, compared to $295.3 million at December 31, 2017. This increase primarily reflected the results of successful deposit gathering campaigns and the sale of loans.

Total investment securities increased $280.9 million during the first nine months of 2018, from $93.4 million at December 31, 2017, to $374.3 million at September 30, 2018, an increase of 300.9%. The Company increased its investment securities position during the first and second quarter of 2018 as part of the aforementioned strategic liquidity initiative employed to enhance contingent funding sources. At September 30, 2018, the investment portfolio is comprised of U.S. treasury, U.S. government agency and residential mortgage-backed securities.

Loans held for sale decreased $34.0 million, or 5.0%, during the first nine months of 2018, from $680.5 million at December 31, 2017, to $646.5 million at September 30, 2018. This decrease reflected the impact of a higher volume of loan sales combined with a slowdown in origination activity during the same period. Lower origination volume was primarily the result of increased lending competition in existing verticals.

Loans and leases held for investment increased $287.4 million, or 21.4%, during the first nine months of 2018, from $1.34 billion at December 31, 2017, to $1.63 billion at September 30, 2018. The increase was primarily the result of continued growth in loan and lease origination activities during the first three quarters of 2018, partially offset by an increase in prepayments.

Premises and equipment, net, increased $85.1 million, or 47.6%, during the first nine months of 2018 which was primarily driven by construction of new facilities and infrastructure to accommodate Company growth and the addition of solar panels to meet leasing commitments.

Servicing assets decreased $3.0 million, or 5.8%, during the first nine months of 2018 due to the higher negative loan servicing revaluation amount in the third quarter of 2018 discussed more fully in the preceding Noninterest Income section under the subheading Loan Servicing Revaluation. This decrease was partially offset by additions to the servicing asset from loan sales.

Total deposits were $2.92 billion at September 30, 2018, an increase of $664.0 million, or 29.4%, from $2.26 billion at December 31, 2017. The increase in deposits was driven by the combined success of deposit gathering campaigns to support the growth in loan and lease originations and strategic liquidity initiatives.

56

Long term borrowings decreased $25.1 million, or 94.3%, during the first nine months of 2018, from $26.6 million at December 31, 2017 to $1.5 million at September 30, 2018. The decrease was primarily the result of significant debt reductions during the first quarter of 2018, largely funded by capital raised in the third quarter of 2017.

Other liabilities increased $7.0 million, or 20.2%, during the first nine months of 2018, from $34.7 million at December 31, 2017 to $41.7 million at September 30, 2018. The increase is principally related to premises and equipment accruals.

Shareholders’ equity at September 30, 2018 was $477.2 million as compared to $436.9 million at December 31, 2017. The book value per share was $11.89 at September 30, 2018 compared to $10.95 at December 31, 2017. Average equity to average assets was 13.8% for the nine months ended September 30, 2018 compared to 13.5% for the full year ended December 31, 2017. The increase in shareholders’ equity was principally the result of net income to common shareholders for the nine months ended September 30, 2018 of $41.0 million combined with stock-based compensation expense of $7.1 million, partially offset by other comprehensive losses of $5.3 million and $3.6 million in dividends.

Asset Quality

Management considers asset quality to be of primary importance. A formal loan review function, independent of loan origination, is used to identify and monitor problem loans. This function reports directly to the Audit & Risk Committee of the Board of Directors.

Nonperforming Assets

The Bank places loans on nonaccrual status when they become 90 days past due as to principal or interest payments, or prior to that if management has determined based upon current information available to them that the timely collection of principal or interest is not probable. When a loan is placed on nonaccrual status, any interest previously accrued as income but not actually collected is reversed and recorded as a reduction of loan interest and fee income. Typically, collections of interest and principal received on a nonaccrual loan are applied to the outstanding principal as determined at the time of collection of the loan.

Troubled debt restructurings occur when, because of economic or legal reasons pertaining to the debtor’s financial difficulties, debtors are granted concessions that would not otherwise be considered. Such concessions would include, but are not limited to, the transfer of assets or the issuance of equity interests by the debtor to satisfy all or part of the debt, modification of the terms of debt or the substitution or addition of debtor(s).

The following table provides information with respect to nonperforming assets and troubled debt restructurings at the dates indicated.

	September 30, 2018			December 31, 2017
Nonperforming assets:
Total nonperforming loans (all on nonaccrual)	$	52,709		$	23,480
Total accruing loans past due 90 days or more	—			—
Foreclosed assets	1,429			1,281
Total troubled debt restructurings	20,095			10,223
Less nonaccrual troubled debt restructurings	(6,292		)	(8,129		)
Total performing troubled debt restructurings	13,803			2,094
Total nonperforming assets and troubled debt restructurings	$	67,941		$	26,855
Total nonperforming loans to total loans and leases held for investment	3.23		%	1.75		%
Total nonperforming loans to total assets	1.53		%	0.85		%
Total nonperforming assets and troubled debt restructurings to total assets	1.97		%	0.97		%

57

	September 30, 2018			December 31, 2017
Nonperforming assets guaranteed by U.S. government:
Total nonperforming loans guaranteed by the SBA (all on nonaccrual)	$	39,812		$	19,870
Total accruing loans past due 90 days or more guaranteed by the SBA	—			—
Foreclosed assets guaranteed by the SBA	1,271			1,191
Total troubled debt restructurings guaranteed by the SBA	14,841			7,178
Less nonaccrual troubled debt restructurings guaranteed by the SBA	(5,707		)	(7,099		)
Total performing troubled debt restructurings guaranteed by SBA	9,134			79
Total nonperforming assets and troubled debt restructurings guaranteed by the SBA	$	50,217		$	21,140
Total nonperforming loans not guaranteed by the SBA to total held for investment loans and leases	0.79		%	0.27		%
Total nonperforming loans not guaranteed by the SBA to total assets	0.37		%	0.13		%
Total nonperforming assets and troubled debt restructurings not guaranteed by the SBA to total assets	0.51		%	0.21		%

Total nonperforming assets and troubled debt restructurings at September 30, 2018 were $67.9 million, which represented a $41.1 million, or 153.0%, increase from December 31, 2017. Total nonperforming assets at September 30, 2018 were comprised of $52.7 million in nonaccrual loans and $1.4 million in foreclosed assets. Of the $67.9 million of nonperforming assets and troubled debt restructurings ("TDRs"), $50.2 million carried an SBA guarantee, leaving an unguaranteed exposure of $17.7 million in total nonperforming assets and TDRs at September 30, 2018. This represents an increase of $12.0 million, or 210.1%, from an unguaranteed exposure of $5.7 million at December 31, 2017. Almost all of this increase in nonperforming assets and TDRs arose from our mature verticals. See the below discussion related to the change in potential problem and impaired loans for management’s overall observations in regard to growth in this area.

As a percentage of the Bank’s total capital, nonperforming loans represented 14.0% at September 30, 2018, compared to 7.8% at December 31, 2017. Adjusting the ratio to include only the unguaranteed portion of nonperforming loans to reflect management’s belief that the greater magnitude of risk resides in this portion, the ratios at September 30, 2018 and December 31, 2017 were 3.4% and 1.2%, respectively.

As of September 30, 2018 and December 31, 2017, potential problem and impaired loans and leases totaled $135.7 million and $76.8 million, respectively. Risk Grades 5 through 8 represent the spectrum of criticized and impaired loans and leases. At September 30, 2018, the portion of criticized loans and leases guaranteed by the SBA or USDA totaled $66.0 million resulting in unguaranteed exposure risk of $69.7 million, or 4.9% of total held for investment unguaranteed exposure. This compares to the December 31, 2017 portion of criticized loans and leases guaranteed by the SBA or USDA which totaled $34.7 million resulting in unguaranteed exposure risk of $42.1 million, or 3.4% of total held for investment unguaranteed exposure. As of September 30, 2018 loans and leases in Healthcare, Veterinary, Independent Pharmacy and Agriculture industry verticals comprise the largest portion of the total potential problem and impaired loans at 29.2%, 17.1%, 15.6% and 15.1%, respectively. As of December 31, 2017 loans in the Healthcare and Veterinary industries comprised the largest portion of the total potential problem and impaired loans and leases at 30.0% and 27.3%, respectively. No systemic issues were identified in the first nine months of 2018 increase in potential problem and impaired loans and leases which were comprised of a relatively small number of borrowers largely concentrated in our more mature verticals. Furthermore, the Company believes that its underwriting and credit quality standards have improved as the business has matured.

The Bank does not classify loans and leases that experience insignificant payment delays and payment shortfalls as impaired. The Bank considers an “insignificant period of time” from payment delays to be a period of 90 days or less. The Bank would consider a modification for a customer experiencing what is expected to be a short-term event that has temporarily impacted cash flow. This could be due, among other reasons, to illness, weather, impact from a one-time expense, slower than expected start-up, construction issues or other short-term issues. In all cases, credit will review the request to determine if the customer is stressed and how the event has impacted the ability of the customer to repay the loan or lease long term. To date, the only types of short term modifications the Bank has given are payment deferral and interest only extensions. The Bank does not typically alter the rate or lengthen the amortization of the note due to insignificant payment delays. Short term modifications are not classified as TDRs, because they do not meet the definition set by the applicable accounting standards and the Federal Deposit Insurance Corporation.

58

Management endeavors to be proactive in its approach to identify and resolve problem loans and leases and is focused on working with the borrowers and guarantors of these loans and leases to provide loan and lease modifications when warranted. Management implements a proactive approach to identifying and classifying loans and leases as criticized, Risk Grade 5. For example, at September 30, 2018 and December 31, 2017, Risk Grade 5 loans and leases totaled $59.0 million and $37.0 million, respectively. The increase in Risk Grade 5 loans during the first nine months of 2018 was principally confined to three verticals; Government Contracting ($9.4 million or 42.7% of increase), Wine and Craft Beverage ($7.0 million or 31.7% of increase) and Agriculture ($4.5 million or 20.6% of increase). The majority of the Government Contracting loans downgraded to Risk Grade 5 in the first half of 2018 are asset-based, collateral intensive loans.  During the second quarter of 2018, management enhanced the risk grading methodology for these types of loans.  The enhanced methodology includes more robust collateral centric loss given default measures.   As these loans come up for renewal and reapproval, additional servicing controls can be enhanced and appropriately measured, which is expected to improve the overall risk grades for some of these loans.  This continues to be an ongoing process over the next several quarters. The first nine months of 2018 increase in Risk Grade 5 loans related to Wine and Craft Beverage was due to the ongoing maturity of larger existing verticals while the increase in Agriculture was related principally to issues with a single integrator impacting one relationship. This relationship was also a primary driver in the increase of TDRs for the three months ended September 30, 2018. At September 30, 2018, approximately 97.7% of loans classified as Risk Grade 5 are performing with no current payments past due more than 30 days. While the level of nonperforming assets fluctuates in response to changing economic and market conditions, the relative size and composition of the loan and lease portfolio, and management’s degree of success in resolving problem assets, management believes that a proactive approach to early identification and intervention is critical to successfully managing a small business loan portfolio.

Allowance for Loan and Lease Losses

The allowance for loan and lease losses (“ALLL”), a material estimate which could change significantly in the near-term in the event of rapidly deteriorating credit quality, is established through a provision for loan and lease losses charged to earnings to account for losses that are inherent in the loan and lease portfolio and estimated to occur, and is maintained at a level that management considers appropriate to absorb potential losses in the portfolio. Loan and lease losses are charged against the ALLL when management believes that the collectability of the principal loan and lease balance is unlikely. Subsequent recoveries, if any, are credited to the ALLL when received.

Judgment in determining the adequacy of the ALLL is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available and as situations and information change.

The ALLL is evaluated on a quarterly basis by management and takes into consideration such factors as changes in the nature and volume of the loan and lease portfolio, overall portfolio quality, review of specific problem loans and leases and current economic conditions and trends that may affect the borrower’s ability to repay.

Estimated credit losses should meet the criteria for accrual of a loss contingency, i.e., a provision to the ALLL, set forth in accounting principles generally accepted in the United States of America (“GAAP”). Methodology for determining the ALLL is generally based on GAAP, the Interagency Policy Statement on the Allowance for Loan and Lease Losses and other regulatory and accounting pronouncements. The ALLL is determined by the sum of three separate components: (i) the impaired loan or lease component, which addresses specific reserves for impaired loans or leases; (ii) the general reserve component, which addresses reserves for pools of homogeneous loans and leases; and (iii) an unallocated reserve component (if any) based on management’s judgment and experience. The loan and lease pools and impaired loans and leases are mutually exclusive; any loan or lease that is impaired should be excluded from its homogeneous pool for purposes of that pool’s reserve calculation, regardless of the level of impairment.

The ALLL of $24.2 million at December 31, 2017 increased by $2.6 million, or 10.8%, to $26.8 million at September 30, 2018. The ALLL, as a percentage of loans and leases held for investment, amounted to 1.6% at September 30, 2018 and 1.8% at December 31, 2017. The increase in the allowance for loan and lease losses was largely attributable to continued growth in the loan and lease portfolio which was largely offset by the effects of updated loss factors in the third quarter 2018, as addressed more fully in the Provision for Loan and Lease Losses section of Results of Operations. General reserves as a percentage of non-impaired loans amounted to 1.29% at September 30, 2018 and 1.62% December 31, 2017. See the aforementioned Provision for Loan and Lease Losses section for a discussion of the Company's charge-off experience.

59

Actual past due held for investment loans and leases have increased by $27.4 million since December 31, 2017. Of this increase, $20.3 million, or 73.9%, is 90 days or more past due with $5.0 million of that amount being comprised of unguaranteed loans and leases. At September 30, 2018 and December 31, 2017, total held for investment unguaranteed loans and leases past due as a percentage of total held for investment unguaranteed loans and leases was 0.86% and 0.43%, respectively. The growth in past dues during the first nine months of 2018 is reflected in the earlier discussed increase in classified loans during the same period. Management continues to actively monitor and work to improve asset quality. Management believes the ALLL of $26.8 million at September 30, 2018 is appropriate in light of the risk inherent in the loan and lease portfolio. Management’s judgments are based on numerous assumptions about current events that it believes to be reasonable, but which may or may not be valid. Thus, there can be no assurance that loan and lease losses in future periods will not exceed the current ALLL or that future increases in the ALLL will not be required. No assurance can be given that management’s ongoing evaluation of the loan and lease portfolio in light of changing economic conditions and other relevant circumstances will not require significant future additions to the ALLL, thus adversely affecting the Company’s operating results. Additional information on the ALLL is presented in Note 5 - Loans and Leases Held for Investment and Allowance for Loan and Lease Losses of the Notes to the Unaudited Condensed Consolidated Financial Statements in this report.

Liquidity Management

Liquidity management refers to the ability to meet day-to-day cash flow requirements based primarily on activity in loan and deposit accounts of the Company’s customers. Liquidity is immediately available from four major sources: (a) cash on hand and on deposit at other banks; (b) the outstanding balance of federal funds sold; (c) the market value of unpledged investment securities; and (d) availability under lines of credit. At September 30, 2018, the total amount of these four items was $1.07 billion, or 31.2% of total assets, an increase of $399.5 million from $674.2 million, or 24.4% of total assets, at December 31, 2017.

Loans and other assets are funded by loan sales, wholesale deposits and core deposits. To date, an increasing retail deposit base and an increased long term wholesale deposit base have been adequate to meet loan obligations, while maintaining the desired level of immediate liquidity. Additionally, the investment securities portfolio is available for both immediate and secondary liquidity purposes.

At September 30, 2018, none of the investment securities portfolio was pledged to secure public deposits or pledged to retail repurchase agreements, while $98 thousand was pledged for trust activities in the State of Ohio and $2.5 million was pledged for uninsured trust assets, leaving $371.7 million available as lendable collateral.

Contractual Obligations

The following table presents the Company’s significant fixed and determinable contractual obligations by payment date as of September 30, 2018. The payment amounts represent those amounts contractually due to the recipient. The table excludes liabilities recorded where management cannot reasonably estimate the timing of any payments that may be required in connection with these liabilities.

	Payments Due by Period
	Total		Less than One Year		One to Three Years		Three to Five Years		More Than Five Years
Contractual Obligations
Deposits without stated maturity	$	1,107,959	$	1,107,959	$	—	$	—	$	—
Time deposits	1,816,329		1,154,837		514,305		71,041		76,146
Long term borrowings	1,506		4		1,497		5		—
Operating lease obligations1	2,603		1,219		836		431		117
Total	$	2,928,397	$	2,264,019	$	516,638	$	71,477	$	76,263

1 The following obligations only include base rent and does not include any additional payments such as taxes, insurance, maintenance and repairs or common area maintenance.

As of September 30, 2018 and December 31, 2017, the Company had unfunded commitments to provide capital contributions for on-balance sheet investments in the amount of $3.0 million and $3.5 million, respectively.

60

Asset/Liability Management and Interest Rate Sensitivity

One of the primary objectives of asset/liability management is to maximize the net interest margin while minimizing the earnings risk associated with changes in interest rates. One method used to manage interest rate sensitivity is to measure, over various time periods, the interest rate sensitivity positions, or gaps. This method, however, addresses only the magnitude of asset and liability repricing timing differences as of the report date and does not address earnings, market value nor growth. Therefore, management uses an earnings simulation model to prepare, on a regular basis, earnings projections based on a range of interest rate scenarios to more accurately measure interest rate risk.

The balance sheet is asset-sensitive with a total cumulative gap position of 2.6% at September 30, 2018. This is relatively unchanged in asset sensitivity from the prior quarter. An asset-sensitive position means that net interest income will generally move in the same direction as interest rates. For instance, if interest rates increase, net interest income can be expected to increase, and if interest rates decrease, net interest income can be expected to decrease. The Company attempts to mitigate interest rate risk by matching funding assets and liabilities with similar rate instruments. The quarterly revaluation adjustment to the servicing asset, however, adjusts in an opposite direction to interest rate changes. Asset/liability sensitivity is primarily derived from the prime-based loans that adjust as the prime interest rate changes and the longer duration of indeterminate term deposits.

Capital

The maintenance of appropriate levels of capital is a management priority and is monitored on a regular basis. The Company’s principal goals related to the maintenance of capital are to provide adequate capital to support the Company’s risk profile consistent with the risk appetite approved by the Board of Directors; provide financial flexibility to support future growth and client needs; comply with relevant laws, regulations, and supervisory guidance; achieve optimal credit ratings for the Company and its subsidiaries; and provide a competitive return to shareholders. Management regularly monitors the capital position of the Company on both a consolidated and bank level basis. In this regard, management’s goal is to maintain capital at levels that are in excess of the regulatory “well capitalized” levels. Risk-based capital ratios, which include Tier 1 Capital, Total Capital and Common Equity Tier 1 Capital, are calculated based on regulatory guidance related to the measurement of capital and risk-weighted assets.

The Basel III Capital Rules, a comprehensive capital framework for U.S. banking organizations, became effective for the Company and Bank on January 1, 2015 (subject to a phase-in period for certain provisions). Quantitative measures established by the Basel III Capital Rules to ensure capital adequacy require the maintenance of minimum amounts and ratios (set forth in the table below) of Common Equity Tier 1 capital, Tier 1 capital and Total capital (as defined in the regulations) to risk-weighted assets (as defined), and of Tier 1 capital to adjusted quarterly average assets (as defined).

When fully phased in on January 1, 2019, the Basel III Capital Rules will require the Company and Bank to maintain (i) a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of at least 4.5%, plus a 2.5% "capital conservation buffer" (which is added to the 4.5% Common Equity Tier 1 capital ratio as that buffer is phased in, effectively resulting in a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of at least 7.0% upon full implementation), (ii) a minimum ratio of Tier 1 capital to risk-weighted assets of at least 6.0%, plus the capital conservation buffer (which is added to the 6.0% Tier 1 capital ratio as that buffer is phased in, effectively resulting in a minimum Tier 1 capital ratio of 8.5% upon full implementation), (iii) a minimum ratio of Total capital (that is, Tier 1 plus Tier 2) to risk-weighted assets of at least 8.0%, plus the capital conservation buffer (which is added to the 8.0% total capital ratio as that buffer is phased in, effectively resulting in a minimum total capital ratio of 10.5% upon full implementation) and (iv) a minimum leverage ratio of 4.0%, calculated as the ratio of Tier 1 capital to average quarterly assets.

The implementation of the capital conservation buffer began on January 1, 2016 at the 0.625% level and will be phased in over a three-year period (increasing by that amount on each subsequent January 1, until it reaches 2.5% on January 1, 2019). Banking institutions with a ratio of Common Equity Tier 1 capital to risk-weighted assets below the effective minimum (4.5% plus the capital conservation buffer) will face constraints on dividends, equity repurchases and compensation based on the amount of the shortfall.

61

Capital amounts and ratios as of September 30, 2018 and December 31, 2017, are presented in the table below.

	Actual				Minimum Capital Requirement				Minimum To Be Well Capitalized Under Prompt Corrective Action Provisions (1)
	Amount		Ratio		Amount		Ratio		Amount		Ratio
Consolidated - September 30, 2018
Common Equity Tier 1 (to Risk-Weighted Assets)	$	428,224	16.95	%	$	113,671	4.50	%	N/A		N/A
Total Capital (to Risk-Weighted Assets)	$	455,021	18.01	%	$	202,082	8.00	%	N/A		N/A
Tier 1 Capital (to Risk-Weighted Assets)	$	428,224	16.95	%	$	151,561	6.00	%	N/A		N/A
Tier 1 Capital (to Average Assets)	$	428,224	12.53	%	$	136,662	4.00	%	N/A		N/A
Bank - September 30, 2018
Common Equity Tier 1 (to Risk-Weighted Assets)	$	348,522	13.97	%	$	112,261	4.50	%	$	162,155	6.50	%
Total Capital (to Risk-Weighted Assets)	$	375,490	15.05	%	$	199,576	8.00	%	$	249,470	10.00	%
Tier 1 Capital (to Risk-Weighted Assets)	$	348,522	13.97	%	$	149,682	6.00	%	$	199,576	8.00	%
Tier 1 Capital (to Average Assets)	$	348,522	10.35	%	$	134,636	4.00	%	$	168,295	5.00	%
Consolidated - December 31, 2017
Common Equity Tier 1 (to Risk-Weighted Assets)	$	390,816	17.81	%	$	98,764	4.50	%	N/A		N/A
Total Capital (to Risk-Weighted Assets)	$	415,006	18.91	%	$	175,580	8.00	%	N/A		N/A
Tier 1 Capital (to Risk-Weighted Assets)	$	390,816	17.81	%	$	131,685	6.00	%	N/A		N/A
Tier 1 Capital (to Average Assets)	$	390,816	15.50	%	$	100,828	4.00	%	N/A		N/A
Bank - December 31, 2017
Common Equity Tier 1 (to Risk-Weighted Assets)	$	277,943	12.89	%	$	97,060	4.50	%	$	140,197	6.50	%
Total Capital (to Risk-Weighted Assets)	$	302,385	14.02	%	$	172,551	8.00	%	$	215,688	10.00	%
Tier 1 Capital (to Risk-Weighted Assets)	$	277,943	12.89	%	$	129,413	6.00	%	$	172,551	8.00	%
Tier 1 Capital (to Average Assets)	$	277,943	11.36	%	$	97,864	4.00	%	$	122,330	5.00	%

(1) Prompt corrective action provisions are not applicable at the bank holding company level.

Critical Accounting Policies and Estimates

The preparation of consolidated financial statements in accordance with GAAP requires the Company to make estimates and judgments that affect reported amounts of assets, liabilities, income and expenses and related disclosure of contingent assets and liabilities. The Company bases estimates on historical experience and on various other assumptions that are believed to be reasonable under current circumstances, results of which form the basis for making judgments about the carrying value of certain assets and liabilities that are not readily available from other sources. Estimates are evaluated on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions.

Accounting policies, as described in detail in the Notes to the Company’s Unaudited Condensed Consolidated Financial Statements in this report, are an integral part of the Company’s consolidated financial statements. A thorough understanding of these accounting policies is essential when reviewing the Company’s reported results of operations and financial position. Management believes that the critical accounting policies and estimates listed below require the Company to make difficult, subjective or complex judgments about matters that are inherently uncertain.

• Determination of the allowance for loan and lease losses;

• Valuation of servicing assets;

• Income taxes;

• Restricted stock unit awards with market price conditions;

• Valuation of foreclosed assets;

• Business combination and goodwill; and

62

• Unconsolidated joint ventures.

Changes in these estimates, that are likely to occur from period to period, or the use of different estimates that the Company could have reasonably used in the current period, would have a material impact on the Company’s financial position, results of operations or liquidity.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Management considers interest rate risk the most significant market risk. Interest rate risk is the exposure to adverse changes in net interest income due to changes in interest rates. Consistency of net interest income is largely dependent upon the effective management of interest rate risk.

The Company’s Asset/Liability Management Committee (“ALCO”), which includes senior management representatives and reports to the Board of Directors, monitors and manages interest rate risk. See “Asset/Liability Management and Interest Rate Sensitivity” in Item 2 of this Form 10-Q for further discussion.

The objective of asset/liability management is the maximization of net interest income within the Company’s risk guidelines. This objective is accomplished through management of the balance sheet composition, maturities, liquidity, and interest rate risk exposures arising from changing economic conditions, interest rates and customer preferences.

To identify and manage its interest rate risk, the Company employs an earnings simulation model to analyze net interest income sensitivity to changing interest rates. The model is based on contractual cash flows and repricing characteristics and incorporates market-based assumptions regarding the effect of changing interest rates on the prepayment rates of certain assets and liabilities. The model also includes management projections for activity levels in each of the product lines offered by the Bank. Assumptions are inherently uncertain, and the measurement of net interest income or the impact of rate fluctuations on net interest income cannot be precisely predicted. Actual results may differ materially from simulated results due to timing, magnitude, and frequency of interest rate changes as well as changes in market conditions and management strategies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

An evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), was carried out under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer as of September 30, 2018, the last day of the period covered by this Quarterly Report. The Company’s Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective as of September 30, 2018 in ensuring that the information required to be disclosed in the reports the Company files or submits under the Exchange Act is (i) accumulated and communicated to management (including the Company’s Chief Executive Officer and Chief Financial Officer) as appropriate to allow timely decisions regarding required disclosures, and (ii) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting during the three months ended September 30, 2018 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

63

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

In the ordinary course of operations, the Company is party to various legal proceedings. The Company is not involved in, nor has it terminated during the three and nine months ended September 30, 2018, any pending legal proceedings other than nonmaterial proceedings occurring in the ordinary course of business.

Item 1A. Risk Factors

There have been no material changes to the risk factors that have been previously disclosed in the Company’s 2017 Annual Report filed with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibits to this report are listed in the Index to Exhibits section of this report.

64

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Live Oak Bancshares, Inc.
	(Registrant)
Date: November 7, 2018	By:	/s/  S. Brett Caines
		S. Brett Caines
		Chief Financial Officer

65

INDEX TO EXHIBITS

Exhibit No.	Description of Exhibit
3.1	Amended and Restated Articles of Incorporation of Live Oak Bancshares, Inc. (incorporated by reference to Exhibit 3.1 of the registration statement on Form S-1, filed on June 19, 2015)
3.2	Amended Bylaws of Live Oak Bancshares, Inc. (incorporated by reference to Exhibit 3.2 of the amended registration statement on Form S-1, filed on July 13, 2015)
4.1	Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the registration statement on Form S-1, filed on June 19, 2015)
4.2	Registration and Other Rights Agreement between Live Oak Bancshares, Inc. and Wellington purchasers (incorporated by reference to Exhibit 4.2 of the registration statement on Form S-1, filed on June 19, 2015)
31.1	Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2	Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32	Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101	Interactive data files pursuant to Rule 405 of Regulation S-T: (i) Condensed Consolidated Balance Sheets as of September 30, 2018 and December 31, 2017; (ii) Condensed Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2018 and 2017; (iii) Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2018 and 2017; (iv) Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Nine Months Ended September 30, 2018 and 2017; (v) Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2018 and 2017; and (vi) Notes to Unaudited Condensed Consolidated Financial Statements*

*    Indicates a document being filed with this Form 10-Q.

** Furnished herewith. This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

66

EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, James S. Mahan III, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Live Oak Bancshares, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 7, 2018	/s/  James S. Mahan III
	James S. Mahan III
	Chief Executive Officer
	(principal executive officer)

EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, S. Brett Caines, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Live Oak Bancshares, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 7, 2018	/s/  S. Brett Caines
	S. Brett Caines
	Chief Financial Officer
	(principal financial officer)

EX-32

Exhibit 32

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Live Oak Bancshares, Inc., a North Carolina corporation (the “Company”), does hereby certify that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 7, 2018	/s/  James S. Mahan III
	James S. Mahan III
	Chief Executive Officer
	(principal executive officer)
Date: November 7, 2018	/s/  S. Brett Caines
	S. Brett Caines
	Chief Financial Officer
	(principal financial officer)

This certification is being furnished solely to accompany the Form 10-Q pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of the Form 10-Q, irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 06, 2018
Document Information [Line Items]
Entity Registrant Name	Live Oak Bancshares, Inc.
Entity Central Index Key	0001462120
Trading Symbol	LOB
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Emerging Growth Company	true
Entity Small Business	false
Entity Ex Transition Period	false
Entity Voting Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		35,503,535
Entity Nonvoting Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		4,643,530

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	[1]
Assets
Cash and due from banks	$ 368,565	$ 295,271
Certificates of deposit with other banks	750	3,000
Investment securities available-for-sale	374,284	93,355
Loans held for sale	646,475	680,454
Loans and leases held for investment	1,631,337	1,343,973
Allowance for loan and lease losses	(26,797)	(24,190)
Net loans and leases	1,604,540	1,319,783
Premises and equipment, net	263,861	178,790
Foreclosed assets	1,429	1,281
Servicing assets	49,261	52,298
Other assets	135,592	134,242
Total assets	3,444,757	2,758,474
Deposits:
Noninterest-bearing	48,622	57,868
Interest-bearing	2,875,666	2,202,395
Total deposits	2,924,288	2,260,263
Long term borrowings	1,506	26,564
Other liabilities	41,733	34,714
Total liabilities	2,967,527	2,321,541
Shareholders’ equity
Retained earnings	157,839	120,241
Accumulated other comprehensive loss	(6,608)	(1,033)
Total equity	477,230	436,933
Total liabilities and shareholders’ equity	3,444,757	2,758,474
Preferred Stock Undefined
Shareholders’ equity
Preferred stock, no par value, 1,000,000 authorized, none issued or outstanding at September 30, 2018 and December 31, 2017	0	0
Class A Common Stock
Shareholders’ equity
Common stock	276,831	268,557
Class B Common Stock
Shareholders’ equity
Common stock	$ 49,168	$ 49,168

[1] Derived from audited consolidated financial statements.

XML

Condensed Consolidated Balance Sheets (Parenthetical) - shares	Sep. 30, 2018	Dec. 31, 2017	[1]
Preferred Stock Undefined
Preferred stock authorized (in shares)	1,000,000	1,000,000
Preferred stock issued (in shares)	0	0
Preferred stock outstanding (in shares)	0	0
Class A Common Stock
Common stock authorized (in shares)	100,000,000	100,000,000
Common stock issued (in shares)	35,496,887	35,252,053
Common stock outstanding (in shares)	35,496,887	35,252,053
Class B Common Stock
Common stock authorized (in shares)	10,000,000	10,000,000
Common stock issued (in shares)	4,643,530	4,643,530
Common stock outstanding (in shares)	4,643,530	4,643,530

[1] Derived from audited consolidated financial statements.

XML

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Interest income
Loans and fees on loans	$ 37,724	$ 26,977	$ 106,682	$ 70,290
Investment securities, taxable	2,528	325	6,175	964
Other interest earning assets	1,638	870	5,032	1,682
Total interest income	41,890	28,172	117,889	72,936
Interest expense
Deposits	14,165	6,758	38,510	16,893
Borrowings	1	389	131	985
Total interest expense	14,166	7,147	38,641	17,878
Net interest income	27,724	21,025	79,248	55,058
Provision for (recovery of) loan and lease losses	(243)	2,426	6,236	5,481
Net interest income after provision for loan and lease losses	27,967	18,599	73,012	49,577
Noninterest income
Loan servicing revenue	7,506	6,490	21,369	18,587
Loan servicing asset revaluation	(9,380)	(3,691)	(18,138)	(6,864)
Net gains on sales of loans	22,004	18,148	69,483	55,276
Lease income	2,194	682	5,722	691
Construction supervision fee income	578	362	1,954	1,077
Title insurance income	479	1,968	2,775	5,803
Other noninterest income	950	1,101	2,535	2,910
Total noninterest income	24,331	25,060	85,700	77,480
Noninterest expense
Salaries and employee benefits	20,553	19,037	62,908	55,687
Travel expense	2,003	2,289	5,887	6,035
Professional services expense	1,228	1,068	3,645	4,228
Advertising and marketing expense	1,462	1,516	4,992	4,977
Data processing expense	3,661	1,982	9,404	5,536
Equipment expense	3,649	2,228	10,094	5,005
Other loan origination and maintenance expense	1,742	1,601	4,485	3,587
FDIC insurance	1,105	858	2,687	2,308
Title insurance closing services expense	114	687	912	1,877
Impairment expense on goodwill and other intangibles, net	2,680	0	2,680	0
Other expense	1,459	3,117	7,125	8,883
Total noninterest expense	41,244	35,856	120,146	102,141
Income before taxes	11,054	7,803	38,566	24,916
Income tax benefit	(3,198)	(5,059)	(2,392)	(3,853)
Net income	$ 14,252	$ 12,862	$ 40,958	$ 28,769
Basic earnings per share (in dollars per share)	$ 0.36	$ 0.34	$ 1.02	$ 0.81
Diluted earnings per share (in dollars per share)	$ 0.34	$ 0.33	$ 0.98	$ 0.78
Occupancy
Noninterest expense
Occupancy expense	$ 1,588	$ 1,473	$ 5,327	$ 4,018

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Statement of Comprehensive Income [Abstract]
Net income	$ 14,252	$ 12,862	$ 40,958	$ 28,769
Other comprehensive (loss) income before tax:
Net unrealized (loss) gain on investment securities arising during the period	(2,094)	(168)	(7,014)	52
Reclassification adjustment for (gain) loss on sale of securities available-for-sale included in net income	0	0	0	0
Other comprehensive (loss) income before tax	(2,094)	(168)	(7,014)	52
Income tax benefit (expense)	502	65	1,683	(20)
Other comprehensive (loss) income, net of tax	(1,592)	(103)	(5,331)	32
Total comprehensive income	$ 12,660	$ 12,759	$ 35,627	$ 28,801

XML

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total		Common stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Retained earnings	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2016				29,530,072	4,723,530
Beginning balance at Dec. 31, 2016	$ 222,847		$ 199,981			$ 23,518	$ (652)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	28,769					28,769
Other comprehensive income	32						32
Issuance of restricted stock (in shares)				306,902
Issuance of restricted stock	0
Withholding cash issued in lieu of restricted stock issuance	(4,891)		(4,891)
Employee stock purchase program (in shares)				22,634
Employee stock purchase program	$ 445		445
Stock option exercises (in shares)	76,285			76,285
Stock option exercises	$ 602		602
Stock option based compensation expense	1,496		1,496
Restricted stock expense	4,210		4,210
Stock issued in acquisition of Reltco, Inc. (in shares)				27,724
Stock issued in acquisition of Reltco, Inc.	565		565
Non-voting common stock converted to voting common stock-private sale (in shares)				80,000	80,000
Issuance of common stock in connection with secondary offering, net of issue costs (in shares)				5,175,000
Issuance of common stock in connection with secondary offering, net of issue costs	113,096		113,096
Cash dividends	(2,580)					(2,580)
Ending balance (in shares) at Sep. 30, 2017				35,218,617	4,643,530
Ending balance at Sep. 30, 2017	364,591		315,504			49,707	(620)
Beginning balance (in shares) at Dec. 31, 2017				35,252,053	4,643,530
Beginning balance at Dec. 31, 2017	436,933	[1]	317,725			120,241	(1,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40,958					40,958
Other comprehensive income	(5,331)						(5,331)
Issuance of restricted stock (in shares)				59,162
Issuance of restricted stock	0
Withholding cash issued in lieu of restricted stock issuance	(708)		(708)
Employee stock purchase program (in shares)				14,339
Employee stock purchase program	$ 342		342
Stock option exercises (in shares)	171,333			171,333
Stock option exercises	$ 1,587		1,587
Stock option based compensation expense	1,310		1,310
Restricted stock expense	5,743		5,743
Reclassification of accumulated other comprehensive income due to tax rate change						244	(244)
Cash dividends	(3,604)					(3,604)
Ending balance (in shares) at Sep. 30, 2018				35,496,887	4,643,530
Ending balance at Sep. 30, 2018	$ 477,230		$ 325,999			$ 157,839	$ (6,608)

[1] Derived from audited consolidated financial statements.

XML

Condensed Consolidated Statements of Changes in Shareholders' Equity Condensed Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) - $ / shares	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Statement of Stockholders' Equity [Abstract]
Cash dividends (in dollars per share)	$ 0.09	$ 0.07

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018		Sep. 30, 2017
Cash flows from operating activities
Net income	$ 40,958		$ 28,769
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization	12,009		7,020
Provision for (recovery of) loan and lease losses	6,236		5,481
Amortization of premium on securities, net of accretion	576		355
Amortization of discount on unguaranteed loans, net	5,282		1,263
Impairment expense on goodwill and other intangibles, net	2,680		0
Deferred tax (benefit) expense	(2,392)		413
Originations of loans held for sale	(826,478)		(884,741)
Proceeds from sales of loans held for sale	966,076		648,300
Net gains on sale of loans held for sale	(69,483)		(55,276)
Net loss on sale of foreclosed assets	19		30
Net increase (decrease) in servicing assets	3,037		(1,398)
Net loss on disposal of premises and equipment	37		213
Stock option based compensation expense	1,310		1,496
Restricted stock expense	5,743		4,210
Stock based compensation expense excess tax benefits	110		1,073
Business combination contingent consideration fair value adjustment	(260)		350
Changes in assets and liabilities:
Other assets	(4,158)		(17,661)
Other liabilities	2,665		3,875
Net cash provided (used) by operating activities	143,967		(256,228)
Cash flows from investing activities
Purchases of securities available-for-sale	(327,422)		(13,009)
Proceeds from sales, maturities, calls, and principal paydowns of securities available-for-sale	36,813		7,187
Proceeds from sale/collection of foreclosed assets	392		50
Business combination, net of cash acquired	0		(7,696)
Sale of title insurance business, net of cash sold	(209)		0
Maturities of certificates of deposit with other banks	2,250		4,000
Loan and lease originations and principal collections, net	(332,115)		(273,501)
Proceeds from sale of premises and equipment	865		0
Purchases of premises and equipment, net	(87,831)		(71,420)
Net cash used by investing activities	(707,257)		(354,389)
Cash flows from financing activities
Net increase in deposits	664,025		527,815
Proceeds from long term borrowings	18		16,900
Repayment of long term borrowings	(25,076)		(25,971)
Proceeds from short term borrowings	0		23,100
Repayment of short term borrowings	0		(15,000)
Stock option exercises	1,587		602
Employee stock purchase program	342		445
Withholding cash issued in lieu of restricted stock	(708)		(4,891)
Sale of common stock, net of issuance costs	0		113,096
Shareholder dividend distributions	(3,604)		(2,580)
Net cash provided by financing activities	636,584		633,516
Net increase in cash and cash equivalents	73,294		22,899
Cash and cash equivalents, beginning	295,271	[1]	238,008
Cash and cash equivalents, ending	368,565		260,907
Supplemental disclosure of cash flow information
Interest paid	38,598		17,927
Income tax (refunds) payments, net	(383)		7,094
Supplemental disclosures of noncash operating, investing, and financing activities
Unrealized holding (losses) gains on available-for-sale securities, net of taxes	(5,331)		32
Transfers from loans and leases to foreclosed real estate and other repossessions	346		663
Net transfers from SBA receivable to foreclosed real estate	213		0
Transfer of loans held for sale to loans and leases held for investment	43,185		5,713
Transfer of loans and leases held for investment to loans held for sale	89,980		18,990
Transfers from short term borrowings to long term borrowings	0		8,100
Accrued premises and equipment additions	10,518		6
Loans to finance sale of other assets	3,642		0
Business combination:
Assets acquired (excluding goodwill)	0		5,766
Liabilities assumed	0		4,681
Purchase price	0		8,363
Goodwill recorded	$ 0		$ 7,278

[1] Derived from audited consolidated financial statements.

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

Nature of Operations

Live Oak Bancshares, Inc. (the “Company” or “LOB”) is a bank holding company headquartered in Wilmington, North Carolina incorporated under the laws of North Carolina in December 2008. The Company conducts business operations primarily through its commercial bank subsidiary, Live Oak Banking Company (the “Bank”). The Bank was organized and incorporated under the laws of the State of North Carolina on February 25, 2008 and commenced operations on May 12, 2008. The Bank specializes in providing lending services to small businesses nationwide. The Bank identifies and grows lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A significant portion of the loans originated by the Bank are guaranteed by the Small Business Administration (“SBA”) under the 7(a) Loan Program and the U.S. Department of Agriculture ("USDA") Rural Energy for America Program ("REAP") and Business & Industry ("B&I") loan programs. On July 28, 2015 the Company completed its initial public offering with a secondary offering completed in August of 2017.

In 2010, the Bank formed Live Oak Number One, Inc., a wholly-owned subsidiary, to hold properties foreclosed on by the Bank.

In addition to the Bank, the Company owns Live Oak Grove, LLC, opened in September 2015 for the purpose of providing Company employees and business visitors an on-site restaurant location; Government Loan Solutions, Inc. (“GLS”), a management and technology consulting firm that specializes in the settlement, accounting, and securitization processes for government guaranteed loans, including loans originated under the SBA 7(a) loan program and USDA-guaranteed loans; and 504 Fund Advisors, LLC (“504FA”), formed to serve as the investment adviser to the 504 Fund, a closed-end mutual fund organized to invest in SBA section 504 loans.

In August 2016, the Company formed Live Oak Ventures, Inc. (formerly known as “Canapi, Inc.”) for the purpose of investing in businesses that align with the Company's strategic initiative to be a leader in financial technology.

In November 2016, the Company formed Live Oak Clean Energy Financing LLC for the purpose of providing financing to entities for renewable energy applications.

On February 1, 2017, the Company completed its acquisition of Reltco Inc. and National Assurance Title, Inc. (collectively referred to as "Reltco"), two nationwide title agencies under common control based in Tampa, Florida. Effective August 1, 2018, Reltco was sold. For more information regarding the sale, see subheading Sale of Title Insurance Business.

In June 2018, the Bank formed Live Oak Private Wealth, LLC for the purpose of providing high-net-worth individuals and families with strategic wealth and investment management services.

The Company earns revenue primarily from the sale of SBA and USDA-guaranteed loans and net interest income. Income from the sale of loans is comprised of net gains on the sale of loans, revenues on the servicing of sold loans and valuation of loan servicing rights. Offsetting these revenues are the cost of funding sources, provision for loan and lease losses, any costs related to foreclosed assets and other operating costs such as salaries and employee benefits, travel, professional services, occupancy, advertising and marketing, data processing, equipment and tax expense.

General

In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the nine months ended September 30, 2018 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2018. The consolidated balance sheet as of December 31, 2017 has been derived from the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities Exchange Commission on March 8, 2018 (SEC File No. 001-37497) (the "2017 Annual Report"). A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s 2017 Annual Report. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes in the Company's 2017 Annual Report.

The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.

Amounts in all tables in the Notes to Unaudited Condensed Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated.

Business Segments

Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment.

Unconsolidated Joint Venture

On October 1, 2017, the Company started the digital banking joint venture between Live Oak Banking Company and First Data Corporation ("First Data"). The new company, named Apiture, combines First Data's and the Bank's digital banking platforms, products, services, and certain human resources used in the creation and delivery of technology solutions for financial institutions. The contributed assets of both the Company and First Data are considered businesses in accordance with relevant accounting standards. At closing, both the Bank and First Data received equal voting interests in Apiture in exchange for their respective contributions. As a term of the closing agreements, First Data is entitled to a preference in Apiture's cash earnings from the date of closing through December 31, 2017 and all of 2018, not to exceed $18.0 million and $18.9 million, respectively.

As a result of the above cash earnings preference, income (loss) is allocated utilizing the hypothetical liquidation at book value ("HLBV") method. Under the HLBV method, we allocate income or loss based on the change in each unitholders’ claim on the net assets of Apiture at period end, after adjusting for any distributions or contributions made during such period. As a result of the HLBV method there was no net income or loss attributed to the Company related to its ownership interest in Apiture during the three and nine months ended September 30, 2018.

As of September 30, 2018 and December 31, 2017 the Company had a $68.0 million equity method investment included in other assets on the consolidated balance sheet for this investment.

Derivative Financial Instruments

Interest Rate Futures Contracts

During the fourth quarter of 2016, the Company began using exchange-traded interest rate futures contracts to manage interest rate risk that may impact expected gains arising from future secondary market loan sales. Upon entering into a futures contract, the Company is required to pledge to the counterparty an amount of cash equal to a certain percentage of the contract amount, also known as an initial margin deposit. Subsequent payments, known as variation margin, are made or received by the Company each day to settle the daily fluctuations in the fair value of the underlying contract. Investments in these derivative contracts are subject to risks that can result in a loss of all or part of an investment. Credit risk is considered low because the counterparties are futures exchanges. The Company has not designated any derivative as a hedging instrument under applicable accounting guidance. Changes in fair value of the derivative contracts is recorded as a component of "net gains on sales of loans" on the consolidated statement of income. The fair value of the derivative contracts on the balance sheet date is zero due to the daily cash settlement of contracts.

Equity Warrant Assets

In connection with negotiated credit facilities and certain other services, the Company may obtain equity warrant assets giving the Company the right to acquire stock in private companies in certain verticals. These assets are held for prospective investment gains and are not used to hedge any economic risks. Further, the Company does not use other derivative instruments to hedge economic risks stemming from equity warrant assets.

Equity warrant assets in certain private client companies are recorded as derivatives when they contain net settlement terms and other qualifying criteria under Accounting Standards Codification 815. Equity warrant assets entitle the Company to purchase a specific number of shares of stock at a specific price within a specific time period, generally 10 years. Certain equity warrant assets contain contingent provisions, which adjust the underlying number of shares or purchase price upon the occurrence of certain future events to prevent dilution of the Company’s implied ownership represented by the warrants. Certain warrant agreements contain net share settlement provisions, which permit the receipt of, upon exercise, a share count equal to the intrinsic value of the warrant divided by the share price (otherwise known as a “cashless” exercise). These equity warrant assets are recorded at fair value and are classified as derivative assets, a component of other assets, on the consolidated balance sheet at the time they are obtained.

The grant date fair values of equity warrant assets classified as derivatives received in connection with the issuance of a credit facility are deemed to be loan fees and recognized as an adjustment of loan yield through loan interest income. Similar to other loan fees, the yield adjustment related to grant date fair value of warrants is recognized over the life of that credit facility.

Any changes in fair value from the grant date fair value of equity warrant assets classified as derivatives will be recognized as increases or decreases to other assets on the consolidated balance sheet and as net gains or losses on derivative instruments, in other noninterest income, a component of consolidated net income. When a portfolio company is acquired, the Company may exercise these equity warrant assets for shares or cash.

The fair value of equity warrant assets classified as derivatives is reviewed quarterly using a Black-Scholes option pricing model.

For those equity warrant assets that do not contain net share settlement provisions, the Company considers these to be equity investments without readily determinable market values and records the asset at cost.

Sale of Title Insurance Business

On August 1, 2018, the Company financed the sale of its entire interest in Reltco, Inc. and National Assurance Title, Inc. for $3.0 million. The Company's divestiture was driven by expectations of future profitability under current market conditions impacting the mortgage industry. As a result of these expectations, the Company recorded a $3.0 million reserve against the amount financed on the date of the sale. In total, the transaction resulted in a net cost of $2.7 million which is recorded as “Impairment expense on goodwill and other intangibles, net” on the consolidated statements of income.

Revenue Recognition

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts with Customers” (Topic 606) and all subsequent ASUs that modified Topic 606. The implementation of the new standard did not have a material impact on the measurement or recognition of revenue and a cumulative effect adjustment to opening retained earnings was not necessary. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts were not adjusted and continue to be reported in accordance with the Company's historic accounting under Topic 605.

Topic 606 does not apply to revenue associated with financial instruments, including revenue from loans and lease financings or investment securities. In addition, certain noninterest income streams such as fees associated with servicing rights, financial guarantees, derivatives, title insurance, and equity and equity security investments are also not in scope of the new guidance. Therefore, the recognition of these revenue streams did not change upon adoption of Topic 606. Substantially all of the Company’s revenue is generated from contracts with customers. Noninterest revenue streams in-scope of Topic 606 are discussed below.

Other noninterest income

Other noninterest income consists of other recurring revenue streams from administration of trust assets held by the Company's trust department and from services provided by GLS to its clients for settlement, accounting, and valuation for government guaranteed loan sales and holdings. Trust account administration performance obligations are generally satisfied over time and fees are recognized monthly, based on the month-end market value of assets in fiduciary accounts and the applicable fee rate. Payment is generally received after month-end through a direct charge to customers' accounts. The Company does not earn performance-based incentives from trust account administration services. GLS provides services when requested by clients. Each requested service represents a specific performance obligation with a transaction price outlined by GLS' fee schedule. Revenue is recognized as the requested services are completed and payment is generally received the following month.

Contract Balances

A contract asset balance occurs when an entity performs a service for a customer before the customer pays consideration (resulting in a contract receivable) or before payment is due (resulting in a contract asset). A contract liability balance is an entity’s obligation to transfer a service to a customer for which the entity has already received payment (or payment is due) from the customer. The Company’s noninterest revenue streams are largely based on transactional activity, or standard month-end revenue accruals such as trust administration fees based on month-end market values. Consideration is often received immediately or shortly after the Company satisfies its performance obligation and revenue is recognized. The Company does not typically enter into long-term revenue contracts with customers, and therefore, does not experience significant contract balances. As of September 30, 2018 and December 31, 2017, the Company did not have any significant contract balances.

Contract Acquisition Costs

In connection with the adoption of Topic 606, an entity is required to capitalize, and subsequently amortize into expense, certain incremental costs of obtaining a contract with a customer if these costs are expected to be recovered. The incremental costs of obtaining a contract are those costs that an entity incurs to obtain a contract with a customer that it would not have incurred if the contract had not been obtained (for example, sales commission). The Company utilizes the practical expedient which allows entities to immediately expense contract acquisition costs when the asset that would have resulted from capitalizing these costs would have been amortized in one year or less. Upon adoption of Topic 606, the Company did not capitalize any contract acquisition cost.

Reclassifications

Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Basic earnings per share:
Net income available to common shareholders	$	14,252	$	12,862	$	40,958	$	28,769
Weighted-average basic shares outstanding	40,119,561		37,366,041		40,025,265		35,485,371
Basic earnings per share	$	0.36	$	0.34	$	1.02	$	0.81
Diluted earnings per share:
Net income available to common shareholders, for diluted earnings per share	$	14,252	$	12,862	$	40,958	$	28,769
Total weighted-average basic shares outstanding	40,119,561		37,366,041		40,025,265		35,485,371
Add effect of dilutive stock options and restricted stock grants	1,568,869		1,278,636		1,561,722		1,244,683
Total weighted-average diluted shares outstanding	41,688,430		38,644,677		41,586,987		36,730,054
Diluted earnings per share	$	0.34	$	0.33	$	0.98	$	0.78
Anti-dilutive shares	—		243,199		—		250,698

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In January 2016, the FASB issued ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01, among other things, (i) requires equity investments, with certain exceptions, to be measured at fair value with changes in fair value recognized in net income, (ii) simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment, (iii) eliminates the requirement for public business entities to disclose the methods and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet, (iv) requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, (v) requires an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments, (vi) requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statements and (viii) clarifies that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale. The Company adopted the standard in the first quarter of 2018 with no material impact on the consolidated financial statements. In accordance with (iv) above, the Company measured the fair value of the loan and lease portfolio using an exit price notion. See Note 10. Fair Value of Financial Instruments for additional information.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The FASB issued this ASU to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet by lessees for those leases classified as operating leases under current GAAP and disclosing key information about leasing arrangements. The amendments in this ASU are effective for the Company on January 1, 2019. The Company has created an implementation team that is currently evaluating the impact this standard will have on the consolidated financial statements upon adoption. Furthermore, the Company expects to adopt on a prospective basis.

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This new guidance replaces the incurred loss impairment methodology in current standards with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts and requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU 2016-13 will be effective for the Company on January 1, 2020. The Company is currently evaluating the potential impact of ASU 2016-13 on the consolidated financial statements. In that regard, a cross-functional working group has been formed, under the direction of the Company's Chief Financial Officer and Chief Credit Officer. The working group is comprised of individuals from various functional areas including credit, risk management, finance and information technology, among others. Implementation efforts continue with model development, ongoing system requirements evaluation and the identification of data and resource needs, among other things. The Company has also engaged a third-party vendor solution to assist in the application of ASU 2016-13. While the Company is currently unable to reasonably estimate the impact of adopting ASU 2016-13, the impact of adoption is expected to be significantly influenced by the composition, characteristics and quality of loan and securities portfolios as well as the prevailing economic conditions and forecasts as of the adoption date.

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805) - Clarifying the Definition of a Business” (“ASU 2017-01”).  ASU 2017-01 clarifies the definition and provides a more robust framework to use in determining when a set of assets and activities constitutes a business. ASU 2017-01 is intended to provide guidance when evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In February 2017, the FASB issued ASU No. 2017-05, “Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20) - Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets” (“ASU 2017-05”). ASU 2017-05 clarifies the scope of Subtopic 610-20 and adds guidance on nonfinancial asset derecognition as well as the accounting for partial sales of nonfinancial assets. The amendments conform the derecognition guidance on nonfinancial assets with the model for transactions in the new revenue standard. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In May 2017, the FASB issued ASU No. 2017-09, “Compensation - Stock Compensation (Topic 718) - Scope of Modification Accounting” (“ASU 2017-09”). ASU 2017-09 clarifies when changes to the terms or conditions of a share-based payment award should be accounted for as a modification. This guidance indicates modification accounting is required when the fair value, vesting conditions, or classification of the award changes. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In February 2018, the FASB issued ASU No. 2018-02, “Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (“ASU 2018-02”). ASU 2018-02 addresses the income tax accounting treatment of the stranded tax effects within other comprehensive income. The ASU allows for an entity to reclassify the stranded tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive income to retained earnings. ASU 2018-02 will be effective for the Company on January 1, 2019, with early adoption permitted. The Company early adopted ASU 2018-02 in the first quarter of 2018 and reclassified its stranded tax credit of $244 thousand within accumulated other comprehensive income to retained earnings at March 31, 2018.

In February 2018, the FASB issued ASU No. 2018-03, “Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2018-03”). ASU 2018-03 amendments clarify certain aspects of the guidance issued in ASU 2016-01. The amendments are effective for the Company for fiscal year 2018 with adoption as of July 1, 2018. The Company adopted the standard in the third quarter of 2018 with no material impact on the consolidated financial statements.

In March 2018, the FASB issued ASU No. 2018-05, “Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 118” (“ASU 2018-05”). ASU 2018-05 amends Accounting Standard Codification 740 to include recent SEC guidance pursuant to the issuance of SAB 118. These amendments address situations when a registrant does not have the necessary information available, prepared, or analyzed in reasonable detail to complete the accounting for certain income tax effects of the Tax Cuts and Jobs Act. The amendments were effective upon issuance and do not have a material effect on the Company's consolidated financial statements.

In June 2018, the FASB issued ASU No. 2018-07, “Compensation - Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018-07”). ASU 2018-07 amends Accounting Standard Codification 718 to largely align accounting for share-based payment awards issued to employees and nonemployees. Under the new guidance, existing employee guidance will generally apply to nonemployee share-based transactions, except for specific guidance on inputs into option pricing models and the attribution of cost. The amendments are effective for the Company on January 1, 2019 with early adoption permitted. The Company does not expect these amendments to have a material effect on its consolidated financial statements.

In July 2018, the FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases” (“ASU 2018-10”). ASU 2018-10 provides clarification on narrow aspects to Topic 842 and to correct unintended application of the guidance. The amendments are effective for the Company on January 1, 2019. The Company is currently assessing the effect the adoption of these amendments will have on the consolidated financial statements. See ASU 2016-02 for further discussion of implementation efforts.

In July 2018, the FASB issued ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements” (“ASU 2018-11”). ASU 2018-11 provides an additional transition method to adopt ASU 2016-02. The transition method allows an entity to apply ASU 2016-02 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. An entity that elects this transition method must provide required disclosures under Topic 840 for all periods that are in accordance with Topic 840. ASU 2018-11 also provides lessors with a practical expedient to not separate non-lease components from lease components by class of underlying asset. The amendments in this ASU are effective for the Company on January 1, 2019. The Company is currently assessing the effect the adoption of these amendments will have on the consolidated financial statements. See ASU 2016-02 for further discussion of implementation efforts.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes, modifies and adds certain fair value disclosure requirements on fair value measurements. The amendments are effective for the Company on January 1, 2020 with early adoption permitted. The Company does not expect these amendments to have a material effect on its consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendments are effective for the Company on January 1, 2020 with early adoption permitted. The Company is currently assessing the effect that the adoption of this standard will have on the consolidated financial statements.

XML

Investment Securities

9 Months Ended

Sep. 30, 2018

Investments, Debt and Equity Securities [Abstract]

Investment Securities

Investment Securities

The carrying amount of investment securities and their approximate fair values are reflected in the following table:

	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
September 30, 2018
US treasury securities	$	4,965	$	—	$	31	$	4,934
US government agencies	33,598		—		523		33,075
Residential mortgage-backed securities	344,415		14		8,154		336,275
Total	$	382,978	$	14	$	8,708	$	374,284
December 31, 2017
US government agencies	$	22,778	$	3	$	157	$	22,624
Residential mortgage-backed securities	70,167		1		1,472		68,696
Mutual fund (1)	2,090		—		55		2,035
Total	$	95,035	$	4	$	1,684	$	93,355

(1) The following mutual fund was reclassified from investment securities available-for-sale to other assets in accordance with the adoption of ASU 2016-01.

There were no sales of securities during the three and nine months ended September 30, 2018 and 2017.

The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position.

	Less Than 12 Months				12 Months or More				Total
September 30, 2018	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
US treasury securities	$	4,934	$	31	$	—	$	—	$	4,934	$	31
US government agencies	26,603		486		6,472		37		33,075		523
Residential mortgage-backed securities	286,015		5,426		47,812		2,728		333,827		8,154
Total	$	317,552	$	5,943	$	54,284	$	2,765	$	371,836	$	8,708
	Less Than 12 Months				12 Months or More				Total
December 31, 2017	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
US government agencies	$	14,842	$	100	$	6,465	$	57	$	21,307	$	157
Residential mortgage-backed securities	23,481		439		40,648		1,033		64,129		1,472
Mutual fund	—		—		2,035		55		2,035		55
Total	$	38,323	$	539	$	49,148	$	1,145	$	87,471	$	1,684

At September 30, 2018, there were twenty-nine residential mortgage-backed securities and three US government agency securities in unrealized loss positions for greater than 12 months and one US treasury security, forty residential mortgage-backed securities and eight US government agency securities in unrealized loss positions for less than 12 months. Unrealized losses at December 31, 2017 were comprised of twenty-three residential mortgage-backed securities, three US government agencies and the 504 mutual fund in unrealized loss positions for greater than 12 months and five US government agency securities and eight residential mortgage-backed securities in unrealized loss positions for less than 12 months.

These unrealized losses are primarily the result of volatility in the market and are related to market interest rates. Since none of the unrealized losses relate to marketability of the securities or the issuer’s ability to honor redemption obligations and the Company has the intent and ability to hold the securities for a sufficient period of time to recover unrealized losses, none of the securities are deemed to be other than temporarily impaired.

All residential mortgage-backed securities in the Company’s portfolio at September 30, 2018 and December 31, 2017 were backed by U.S. government sponsored enterprises (“GSEs”).

The following is a summary of investment securities by maturity:

	September 30, 2018
	Available-for-Sale
	Amortized cost		Fair value
US treasury securities
One to five years	$	4,965	$	4,934
Total	4,965		4,934
US government agencies
Within one year	6,510		6,472
One to five years	27,088		26,603
Total	33,598		33,075
Residential mortgage-backed securities
One to five years	3,806		3,617
Five to ten years	48,752		47,673
After 10 years	291,857		284,985
Total	344,415		336,275
Total	$	382,978	$	374,284

The table above reflects contractual maturities. Actual results will differ as the loans underlying the residential mortgage-backed securities may repay sooner than scheduled.

At September 30, 2018 and December 31, 2017, an investment security with a fair market value of $98 thousand and $100 thousand, respectively, was pledged to the Ohio State Treasurer to allow the Company's trust department to conduct business in the state of Ohio and investment securities with a fair market value of $2.5 million were pledged to the Company's trust department for uninsured trust assets held by the trust department.

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses

9 Months Ended

Sep. 30, 2018

Receivables [Abstract]

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses

Loan and Lease Portfolio Segments

The following describes the risk characteristics relevant to each of the portfolio segments. Each loan and lease category is assigned a risk grade during the origination and closing process based on criteria described later in this section.

Commercial and Industrial

Commercial and industrial loans (C&I) receive similar underwriting treatment as commercial real estate loans in that the repayment source is analyzed to determine its ability to meet cash flow coverage requirements as set forth by Bank policies. Repayment of the Bank’s C&I loans generally comes from the generation of cash flow as the result of the borrower’s business operations. This business cycle itself brings a certain level of risk to the portfolio. In some instances, these loans may carry a higher degree of risk due to a variety of reasons – illiquid collateral, specialized equipment, highly depreciable assets, uncollectable accounts receivable, revolving balances, or simply being unsecured. As a result of these characteristics, the SBA guarantee on these loans is an important factor in mitigating risk.

Construction and Development

Construction and development loans are for the purpose of acquisition and development of land to be improved through the construction of commercial buildings. Such loans are usually paid off through the conversion to permanent financing for the long-term benefit of the borrower’s ongoing operations. At the completion of the project, if the loan is converted to permanent financing or if scheduled loan amortization begins, it is then reclassified to the “Commercial Real Estate” segment. Underwriting of construction and development loans typically includes analysis of not only the borrower’s financial condition and ability to meet the required debt obligations, but also the general market conditions associated with the area and type of project being funded.

Commercial Real Estate

Commercial real estate loans are extensions of credit secured by owner occupied and non-owner occupied collateral. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Such repayment of commercial real estate loans is commonly derived from the successful ongoing operations of the business occupying the property. These typically include small businesses and professional practices.

Commercial Land

Commercial land loans are extensions of credit secured by farmland. Such loans are often for land improvements related to agricultural endeavors that may include construction of new specialized facilities. These loans are usually repaid through the conversion to permanent financing, or if scheduled loans amortization begins, for the long-term benefit of the borrower’s ongoing operations. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies.

Each of the loan types referenced in the sections above is further segmented into verticals in which the Bank chooses to operate. The Bank chooses to finance businesses operating in specific industries because of certain similarities. The similarities range from historical default and loss characteristics to business operations. However, there are differences that create the necessity to underwrite these loans according to varying criteria and guidelines. When underwriting a loan, the Bank considers numerous factors such as cash flow coverage, the credit scores of the guarantors, revenue growth, practice ownership experience and debt service capacity. Minimum guidelines have been set with regard to these various factors and deviations from those guidelines require compensating strengths when considering a proposed loan.

Loans and leases consist of the following:

	September 30, 2018			December 31, 2017
Commercial & Industrial
Agriculture	$	4,980		$	3,274
Death Care Management	16,665			13,495
Healthcare	47,324			43,301
Independent Pharmacies	108,026			99,920
Registered Investment Advisors	91,334			93,770
Veterinary Industry	47,821			46,387
Other Industries	216,157			184,903
Total	532,307			485,050
Construction & Development
Agriculture	31,213			34,188
Death Care Management	9,366			6,119
Healthcare	71,429			49,770
Independent Pharmacies	2,314			1,496
Registered Investment Advisors	1,276			376
Veterinary Industry	19,522			13,184
Other Industries	78,807			58,120
Total	213,927			163,253
Commercial Real Estate
Agriculture	52,353			46,717
Death Care Management	69,514			67,381
Healthcare	167,365			126,631
Independent Pharmacies	18,872			19,028
Registered Investment Advisors	8,121			11,789
Veterinary Industry	122,537			113,932
Other Industries	233,856			134,172
Total	672,618			519,650
Commercial Land
Agriculture	220,326			178,897
Total	220,326			178,897
Total Loans and Leases1	1,639,178			1,346,850
Net Deferred Costs	7,336			8,545
Discount on SBA 7(a) and USDA Unguaranteed2	(15,177		)	(11,422		)
Loans and Leases, Net of Unearned	$	1,631,337		$	1,343,973

1 Total loans and leases include $192.4 million and $99.7 million of U.S. government guaranteed loans as of September 30, 2018 and December 31, 2017, respectively.

2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales.

Credit Risk Profile

The Bank uses internal loan and lease reviews to assess the performance of individual loans and leases by industry segment. An independent review of the loan and lease portfolio is performed annually by an external firm. The goal of the Bank’s annual review of select borrowers' financial performance is to validate the adequacy of the risk grade assigned.

The Bank uses a grading system to rank the quality of each loan and lease. The grade is periodically evaluated and adjusted as performance dictates. Loan and lease grades 1 through 4 are passing grades and grade 5 is special mention. Collectively, grades 6 through 8 represent classified loans and leases in the Bank’s portfolio. The following guidelines govern the assignment of these risk grades:

Exceptional (1 Rated): These loans and leases are of the highest quality, with strong, well-documented sources of repayment. Debt service coverage (“DSC”) is over 2.00X based on historical results. Borrower has ownership experience and has demonstrated excellent revenue growth and/or profitability. Guarantors have credit scores above 750 and have strong personal liquidity.

Quality (2 Rated): These loans and leases are of good quality, with good, well-documented sources of repayment. DSC is over 1.74X based on historical results. Borrower has ownership experience and has demonstrated very good revenue growth and/or profitability. Guarantors have credit scores above 724 and have good personal liquidity.

Acceptable (3 rated): These loans and leases are of acceptable quality, with acceptable sources of repayment. DSC of over 1.24X based on historical or pro-forma results. Companies that do not meet these credit metrics must be evaluated to determine if they should be graded below this level.

Acceptable (4 rated): These loans and leases are considered very weak pass. These loans and leases are riskier than a 3-rated credit, but due to various mitigating factors are not considered a Special mention or worse. The mitigating factors must clearly be identified to offset further downgrade. Examples of loans and leases that may be put in this category include start-up loans and leases and loans and leases with less than 1:1 cash flow coverage with other sources of repayment.

Special mention (5 rated): These loans and leases are considered as emerging problems, with potentially unsatisfactory characteristics. These loans and leases require greater management attention. A loan or lease may be put into this category if the Bank is unable to obtain financial reporting from a company to fully evaluate its position.

Substandard (6 rated): Loans and leases graded Substandard are inadequately protected by current sound net worth, paying capacity of the borrower, or pledged collateral. They typically have unsatisfactory characteristics causing more than acceptable levels of risk, and have one or more well-defined weaknesses that could jeopardize the repayment of the debt.

Doubtful (7 rated): Loans and leases graded Doubtful have inherent weaknesses that make collection or liquidation in full questionable. Loans and leases graded Doubtful must be placed on non-accrual status.

Loss (8 rated): Loss rated loans and leases are considered uncollectible and of such little value that their continuance as an active Bank asset is not warranted. The asset should be charged off, even though partial recovery may be possible in the future.

The following tables summarize the risk grades of each category:

	Risk Grades 1 - 4		Risk Grade 5		Risk Grades 6 - 8		Total
September 30, 2018
Commercial & Industrial
Agriculture	$	4,775	$	205	$	—	$	4,980
Death Care Management	16,464		195		6		16,665
Healthcare	37,035		3,179		7,110		47,324
Independent Pharmacies	92,735		4,545		10,746		108,026
Registered Investment Advisors	86,713		1,407		3,214		91,334
Veterinary Industry	44,374		1,171		2,276		47,821
Other Industries	198,875		15,860		1,422		216,157
Total	480,971		26,562		24,774		532,307
Construction & Development
Agriculture	31,213		—		—		31,213
Death Care Management	9,366		—		—		9,366
Healthcare	67,862		1,420		2,147		71,429
Independent Pharmacies	2,314		—		—		2,314
Registered Investment Advisors	1,276		—		—		1,276
Veterinary Industry	19,522		—		—		19,522
Other Industries	78,807		—		—		78,807
Total	210,360		1,420		2,147		213,927
Commercial Real Estate
Agriculture	51,786		567		—		52,353
Death Care Management	62,600		3,823		3,091		69,514
Healthcare	141,583		7,682		18,100		167,365
Independent Pharmacies	12,959		3,369		2,544		18,872
Registered Investment Advisors	7,993		128		—		8,121
Veterinary Industry	102,781		4,869		14,887		122,537
Other Industries	231,798		2,058		—		233,856
Total	611,500		22,496		38,622		672,618
Commercial Land
Agriculture	200,608		8,514		11,204		220,326
Total	200,608		8,514		11,204		220,326
Total1	$	1,503,439	$	58,992	$	76,747	$	1,639,178

	Risk Grades 1 - 4		Risk Grade 5		Risk Grades 6 - 8		Total
December 31, 2017
Commercial & Industrial
Agriculture	$	3,052	$	222	$	—	$	3,274
Death Care Management	13,371		117		7		13,495
Healthcare	36,530		2,246		4,525		43,301
Independent Pharmacies	86,152		5,541		8,227		99,920
Registered Investment Advisors	90,911		2,134		725		93,770
Veterinary Industry	42,313		1,704		2,370		46,387
Other Industries	184,540		363		—		184,903
Total	456,869		12,327		15,854		485,050
Construction & Development
Agriculture	31,738		2,450		—		34,188
Death Care Management	6,119		—		—		6,119
Healthcare	47,813		699		1,258		49,770
Independent Pharmacies	1,496		—		—		1,496
Registered Investment Advisors	376		—		—		376
Veterinary Industry	13,184		—		—		13,184
Other Industries	58,120		—		—		58,120
Total	158,846		3,149		1,258		163,253
Commercial Real Estate
Agriculture	46,717		—		—		46,717
Death Care Management	60,671		3,881		2,829		67,381
Healthcare	112,321		9,992		4,318		126,631
Independent Pharmacies	15,641		1,825		1,562		19,028
Registered Investment Advisors	11,649		140		—		11,789
Veterinary Industry	97,065		2,948		13,919		113,932
Other Industries	133,493		679		—		134,172
Total	477,557		19,465		22,628		519,650
Commercial Land
Agriculture	176,811		2,086		—		178,897
Total	176,811		2,086		—		178,897
Total1	$	1,270,083	$	37,027	$	39,740	$	1,346,850

1 Total loans and leases include $192.4 million of U.S. government guaranteed loans as of September 30, 2018, segregated by risk grade as follows: Risk Grades 1 – 4 = $126.4 million, Risk Grade 5 = $9.9 million, Risk Grades 6 – 8 = $56.1 million. As of December 31, 2017, total loans and leases include $99.7 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $65.0 million, Risk Grade 5 = $6.7 million, Risk Grades 6 – 8 = $28.0 million.

Past Due Loans and Leases

Loans and leases are considered past due if the required principal and interest payments have not been received as of the date such payments were due. Loans and leases less than 30 days past due and accruing are included within current loans and leases shown below. The following tables show an age analysis of past due loans and leases as of the dates presented.

	Less Than 30 Days Past Due & Not Accruing		30-89 Days Past Due & Accruing		30-89 Days Past Due & Not Accruing		90 Days or More Past Due		Total Not Accruing & Past Due		Current		Total Loans and Leases		90 Days or More Past Due & Still Accruing
September 30, 2018
Commercial & Industrial
Agriculture	$	—	$	—	$	—	$	—	$	—	$	4,980	$	4,980	$	—
Death Care Management	—		74		—		—		74		16,591		16,665		—
Healthcare	44		2,874		687		2,680		6,285		41,039		47,324		—
Independent Pharmacies	—		—		3,869		6,573		10,442		97,584		108,026		—
Registered Investment Advisors	—		241		—		2,856		3,097		88,237		91,334		—
Veterinary Industry	162		—		569		796		1,527		46,294		47,821		—
Other Industries	—		1,123		—		651		1,774		214,383		216,157		—
Total	206		4,312		5,125		13,556		23,199		509,108		532,307		—
Construction & Development
Agriculture	—		—		—		—		—		31,213		31,213		—
Death Care Management	—		—		—		—		—		9,366		9,366		—
Healthcare	—		2,147		—		—		2,147		69,282		71,429		—
Independent Pharmacies	—		—		—		—		—		2,314		2,314		—
Registered Investment Advisors	—		—		—		—		—		1,276		1,276		—
Veterinary Industry	—		—		—		—		—		19,522		19,522		—
Other Industries	—		—		—		—		—		78,807		78,807		—
Total	—		2,147		—		—		2,147		211,780		213,927		—
Commercial Real Estate
Agriculture	—		—		—		—		—		52,353		52,353		—
Death Care Management	153		—		—		2,789		2,942		66,572		69,514		—
Healthcare	44		687		—		7,134		7,865		159,500		167,365		—
Independent Pharmacies	—		446		—		2,544		2,990		15,882		18,872		—
Registered Investment Advisors	—		—		—		—		—		8,121		8,121		—
Veterinary Industry	1,709		3,173		—		8,246		13,128		109,409		122,537		—
Other Industries	—		—		—		—		—		233,856		233,856		—
Total	1,906		4,306		—		20,713		26,925		645,693		672,618		—
Commercial Land
Agriculture	6,288		—		2,482		2,433		11,203		209,123		220,326		—
Total	6,288		—		2,482		2,433		11,203		209,123		220,326		—
Total1	$	8,400	$	10,765	$	7,607	$	36,702	$	63,474	$	1,575,704	$	1,639,178	$	—

	Less Than  30 Days Past Due & Not Accruing		30-89 Days Past Due & Accruing		30-89 Days Past Due & Not Accruing		90 Days or More Past Due		Total Not Accruing & Past Due		Current		Total Loans and Leases		90 Days or More Past Due & Still Accruing
December 31, 2017
Commercial & Industrial
Agriculture	$	—	$	—	$	—	$	—	$	—	$	3,274	$	3,274	$	—
Death Care Management	—		—		—		—		—		13,495		13,495		—
Healthcare	788		131		14		3,004		3,937		39,364		43,301		—
Independent Pharmacies	236		2,930		1,349		3,376		7,891		92,029		99,920		—
Registered Investment Advisors	—		321		—		—		321		93,449		93,770		—
Veterinary Industry	212		594		508		797		2,111		44,276		46,387		—
Other Industries	—		—		—		—		—		184,903		184,903		—
Total	1,236		3,976		1,871		7,177		14,260		470,790		485,050		—
Construction & Development
Agriculture	—		—		—		—		—		34,188		34,188		—
Death Care Management	—		—		—		—		—		6,119		6,119		—
Healthcare	—		—		—		—		—		49,770		49,770		—
Independent Pharmacies	—		—		—		—		—		1,496		1,496		—
Registered Investment Advisors	—		—		—		—		—		376		376		—
Veterinary Industry	—		—		—		—		—		13,184		13,184		—
Other Industries	—		—		—		—		—		58,120		58,120		—
Total	—		—		—		—		—		163,253		163,253		—
Commercial Real Estate
Agriculture	—		—		—		—		—		46,717		46,717		—
Death Care Management	—		—		168		1,391		1,559		65,822		67,381		—
Healthcare	40		54		1,916		1,550		3,560		123,071		126,631		—
Independent Pharmacies	—		—		—		1,562		1,562		17,466		19,028		—
Registered Investment Advisors	—		—		—		—		—		11,789		11,789		—
Veterinary Industry	1,804		3,226		—		4,765		9,795		104,137		113,932		—
Other Industries	—		—		—		—		—		134,172		134,172		—
Total	1,844		3,280		2,084		9,268		16,476		503,174		519,650		—
Commercial Land
Agriculture	—		—		—		—		—		178,897		178,897		—
Total	—		—		—		—		—		178,897		178,897		—
Total1	$	3,080	$	7,256	$	3,955	$	16,445	$	30,736	$	1,316,114	$	1,346,850	$	—

1 Total loans and leases include $192.4 million of U.S. government guaranteed loans as of September 30, 2018, of which $30.3 million is greater than 90 days past due, $12.3 million is 30-89 days past due and $149.8 million is included in current loans and leases as presented above. As of December 31, 2017, total loans and leases include $99.7 million of U.S. government guaranteed loans, of which $15.0 million is greater than 90 days past due, $7.4 million is 30-89 days past due and $77.3 million is included in current loans and leases as presented above.

Nonaccrual Loans and Leases

Loans and leases that become 90 days delinquent, or in cases where there is evidence that the borrower’s ability to make the required payments is impaired, are placed in nonaccrual status and interest accrual is discontinued. If interest on nonaccrual loans and leases had been accrued in accordance with the original terms, interest income would have increased by approximately $800 thousand and $302 thousand for the three months ended September 30, 2018 and 2017, respectively, and for the nine months ended September 30, 2018 and 2017 interest income would have increased approximately $1.8 million and $831 thousand, respectively. All nonaccrual loans and leases are included in the held for investment portfolio.

Nonaccrual loans and leases as of September 30, 2018 and December 31, 2017 are as follows:

September 30, 2018	Loan and Lease Balance		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Healthcare	$	3,411	$	3,085	$	326
Independent Pharmacies	10,442		9,214		1,228
Registered Investment Advisors	2,856		2,536		320
Veterinary Industry	1,527		1,381		146
Other Industries	651		488		163
Total	18,887		16,704		2,183
Commercial Real Estate
Death Care Management	2,942		2,282		660
Healthcare	7,178		4,751		2,427
Independent Pharmacies	2,544		2,126		418
Veterinary Industry	9,955		8,452		1,503
Total	22,619		17,611		5,008
Commercial Land
Agriculture	11,203		5,497		5,706
Total	11,203		5,497		5,706
Total	$	52,709	$	39,812	$	12,897

December 31, 2017	Loan and Lease Balance		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Healthcare	$	3,806	$	3,235	$	571
Independent Pharmacies	4,961		3,906		1,055
Veterinary Industry	1,517		1,478		39
Total	10,284		8,619		1,665
Commercial Real Estate
Death Care Management	1,559		1,237		322
Healthcare	3,506		2,719		787
Independent Pharmacies	1,562		1,562		—
Veterinary Industry	6,569		5,733		836
Total	13,196		11,251		1,945
Total	$	23,480	$	19,870	$	3,610

Allowance for Loan and Lease Loss Methodology

The methodology and the estimation process for calculating the Allowance for Loan and Lease Losses (“ALLL”) is described below:

Estimated credit losses should meet the criteria for accrual of a loss contingency, i.e., a provision to the ALLL, set forth in GAAP. The Company’s methodology for determining the ALLL is based on the requirements of GAAP, the Interagency Policy Statement on the Allowance for Loan and Lease Losses and other regulatory and accounting pronouncements. The ALLL is determined by the sum of three separate components: (i) the impaired loan and lease component, which addresses specific reserves for impaired loans and leases; (ii) the general reserve component, which addresses reserves for pools of homogeneous loans and leases; and (iii) an unallocated reserve component (if any) based on management’s judgment and experience. The loan and lease pools and impaired loans and leases are mutually exclusive; any loan or lease that is impaired is excluded from its homogenous pool for purposes of that pool’s reserve calculation, regardless of the level of impairment.

The ALLL policy for pooled loans and leases is governed in accordance with banking regulatory guidance for homogenous pools of non-impaired loans and leases that have similar risk characteristics. The Company follows a consistent and structured approach for assessing the need for reserves within each individual loan and lease pool.

Loans and leases are considered impaired when, based on current information and events, it is probable that the creditor will be unable to collect all interest and principal payments due according to the originally contracted, or reasonably modified, terms of the loan or lease agreement. The Company has determined that loans and leases that meet the criteria defined below must be reviewed quarterly to determine if they are impaired.

• All commercial loans and leases classified substandard or worse.

• Any other delinquent loan or lease that is in a nonaccrual status, or any loan or lease that is delinquent 90 days or more and still accruing interest.

• Any loan or lease which has been modified such that it meets the definition of a Troubled Debt Restructuring (TDR).

The Company’s policy for impaired loan and lease accounting subjects all loans and leases to impairment recognition; however, loan and lease relationships with unguaranteed credit exposure of less than $100,000 are generally not evaluated on an individual basis for impairment and instead are evaluated collectively using a methodology based on historical specific reserves on similar sized loans and leases. Any loan or lease not meeting the above criteria and determined to be impaired is subjected to an impairment analysis, which is a calculation of the probable loss on the loan or lease. This portion is the loan's or lease’s “impairment,” and is established as a specific reserve against the loan or lease, or charged against the ALLL.

Individual specific reserve amounts imply probability of loss and may not be carried in the reserve indefinitely. When the amount of the actual loss becomes reasonably quantifiable, the amount of the loss is charged off against the ALLL, whether or not all liquidation and recovery efforts have been completed. If the total amount of the individual specific reserve that will eventually be charged off cannot yet be sufficiently quantified but some portion of the impairment can be viewed as a confirmed loss, then the confirmed loss portion should be charged off against the ALLL and the individual specific reserve reduced by a corresponding amount.

For impaired loans or leases, the reserve amount is calculated on a loan or lease-specific basis. The Company utilizes two methods of analyzing impaired loans and leases not guaranteed by the SBA:

• The Fair Market Value of Collateral method utilizes the value at which the collateral could be sold considering the appraised value, appraisal discount rate, prior liens and selling costs. The amount of the reserve is the deficit of the estimated collateral value compared to the loan or lease balance.

• The Present Value of Future Cash Flows method takes into account the amount and timing of cash flows and the effective interest rate used to discount the cash flows.

The following table details activity in the allowance for loan and lease losses by portfolio segment allowance for the periods presented:

Three months ended	Construction & Development			Commercial Real Estate			Commercial & Industrial			Commercial Land			Total
September 30, 2018
Beginning Balance	$	2,227		$	11,408		$	13,377		$	2,338		$	29,350
Charge offs	—			(397		)	(1,966		)	(106		)	(2,469		)
Recoveries	—			141			18			—			159
Provision	(555		)	(1,115		)	(148		)	1,575			(243		)
Ending Balance	$	1,672		$	10,037		$	11,281		$	3,807		$	26,797
September 30, 2017
Beginning Balance	$	1,603		$	7,494		$	8,351		$	2,112		$	19,560
Charge offs	—			(665		)	(343		)	—			(1,008		)
Recoveries	—			4			39			6			49
Provision	36			1,565			827			(2		)	2,426
Ending Balance	$	1,639		$	8,398		$	8,874		$	2,116		$	21,027

Nine months ended	Construction & Development			Commercial Real Estate			Commercial & Industrial			Commercial Land			Total
September 30, 2018
Beginning Balance	$	2,030		$	9,180		$	10,751		$	2,229		$	24,190
Charge offs	—			(816		)	(3,187		)	(106		)	(4,109		)
Recoveries	—			174			306			—			480
Provision	(358		)	1,499			3,411			1,684			6,236
Ending Balance	$	1,672		$	10,037		$	11,281		$	3,807		$	26,797
September 30, 2017
Beginning Balance	$	1,693		$	5,897		$	8,413		$	2,206		$	18,209
Charge offs	—			(952		)	(1,754		)	(35		)	(2,741		)
Recoveries	—			17			55			6			78
Provision	(54		)	3,436			2,160			(61		)	5,481
Ending Balance	$	1,639		$	8,398		$	8,874		$	2,116		$	21,027

The following tables detail the recorded allowance for loan and lease losses and the investment in loans and leases related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology:

September 30, 2018	Construction & Development		Commercial Real Estate		Commercial & Industrial		Commercial Land		Total
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	$	11	$	2,141	$	1,344	$	3,140	$	6,636
Loans and leases collectively evaluated for impairment2	1,661		7,896		9,937		667		20,161
Total allowance for loan and lease losses	$	1,672	$	10,037	$	11,281	$	3,807	$	26,797
Loans and leases receivable1:
Loans and leases individually evaluated for impairment	$	2,172	$	34,842	$	12,520	$	21,755	$	71,289
Loans and leases collectively evaluated for impairment2	211,755		637,776		519,787		198,571		1,567,889
Total loans and leases receivable	$	213,927	$	672,618	$	532,307	$	220,326	$	1,639,178

December 31, 2017	Construction & Development		Commercial Real Estate		Commercial & Industrial		Commercial Land		Total
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	$	157	$	1,502	$	1,126	$	—	$	2,785
Loans and leases collectively evaluated for impairment2	1,873		7,678		9,625		2,229		21,405
Total allowance for loan and lease losses	$	2,030	$	9,180	$	10,751	$	2,229	$	24,190
Loans and leases receivable1:
Loans and leases individually evaluated for impairment	$	1,237	$	17,105	$	8,672	$	—	$	27,014
Loans and leases collectively evaluated for impairment2	162,016		502,545		476,378		178,897		1,319,836
Total loans and leases receivable	$	163,253	$	519,650	$	485,050	$	178,897	$	1,346,850

1 Loans and leases receivable includes $192.4 million of U.S. government guaranteed loans as of September 30, 2018, of which $63.3 million are impaired. As of December 31, 2017, loans and leases receivable includes $99.7 million of U.S. government guaranteed loans, of which $28.1 million are considered impaired.

2 Included in loans and leases collectively evaluated for impairment are impaired loans and leases with individual unguaranteed exposure of less than $100 thousand. As of September 30, 2018, these balances totaled $17.3 million, of which $15.9 million are guaranteed by the U.S. government and $1.4 million are unguaranteed. As of December 31, 2017, these balances totaled $14.8 million, of which $13.2 million are guaranteed by the U.S. government and $1.6 million are unguaranteed.The allowance for loan and lease losses associated with these loans and leases totaled $397 thousand and $279 thousand as of September 30, 2018 and December 31, 2017, respectively.

Loans and leases classified as impaired as of the dates presented are summarized in the following tables.

September 30, 2018	Recorded Investment		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Death Care Management	$	6	$	—	$	6
Healthcare	7,159		5,488		1,671
Independent Pharmacies	10,057		8,458		1,599
Registered Investment Advisors	3,217		2,536		681
Veterinary Industry	2,382		1,861		521
Other Industries	1,435		648		787
Total	24,256		18,991		5,265
Construction & Development
Healthcare	2,172		1,610		562
Total	2,172		1,610		562
Commercial Real Estate
Death Care Management	3,088		2,282		806
Healthcare	18,757		13,275		5,482
Independent Pharmacies	2,543		2,126		417
Veterinary Industry	15,977		11,815		4,162
Total	40,365		29,498		10,867
Commercial Land
Agriculture	21,755		13,199		8,556
Total	21,755		13,199		8,556
Total	$	88,548	$	63,298	$	25,250

December 31, 2017	Recorded Investment		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Death Care Management	$	7	$	—	$	7
Healthcare	4,551		3,235		1,316
Independent Pharmacies	8,571		6,356		2,215
Registered Investment Advisors	733		—		733
Veterinary Industry	2,762		2,001		761
Total	16,624		11,592		5,032
Construction & Development
Healthcare	1,237		944		293
Total	1,237		944		293
Commercial Real Estate
Death Care Management	2,831		1,237		1,594
Healthcare	4,315		2,967		1,348
Independent Pharmacies	1,562		1,562		—
Veterinary Industry	15,266		9,768		5,498
Total	23,974		15,534		8,440
Commercial Land
Agriculture	—		—		—
Total	—		—		—
Total	$	41,835	$	28,070	$	13,765

The following table presents evaluated balances of loans and leases classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan and lease fees or costs.

	September 30, 2018
	Recorded Investment
	With a Recorded Allowance		With No Recorded Allowance		Total		Unpaid Principal Balance		Related Allowance Recorded
Commercial & Industrial
Death Care Management	$	—	$	6	$	6	$	6	$	—
Healthcare	7,093		66		7,159		7,402		416
Independent Pharmacies	9,758		299		10,057		11,680		415
Registered Investment Advisors	3,217		—		3,217		3,740		513
Veterinary Industry	2,259		123		2,382		2,657		129
Other Industries	979		456		1,435		1,998		213
Total	23,306		950		24,256		27,483		1,686
Construction & Development
Healthcare	2,172		—		2,172		2,147		11
Total	2,172		—		2,172		2,147		11
Commercial Real Estate
Death Care Management	2,786		302		3,088		3,226		16
Healthcare	18,523		234		18,757		18,751		1,174
Independent Pharmacies	2,543		—		2,543		2,835		14
Veterinary Industry	15,867		110		15,977		16,955		992
Total	39,719		646		40,365		41,767		2,196
Commercial Land
Agriculture	21,563		192		21,755		21,764		3,140
Total	21,563		192		21,755		21,764		3,140
Total Impaired Loans and Leases	$	86,760	$	1,788	$	88,548	$	93,161	$	7,033

	December 31, 2017
	Recorded Investment
	With a Recorded Allowance		With No Recorded Allowance		Total		Unpaid Principal Balance		Related Allowance Recorded
Commercial & Industrial
Death Care Management	$	—	$	7	$	7	$	7	$	—
Healthcare	3,521		1,030		4,551		5,643		165
Independent Pharmacies	8,154		417		8,571		9,078		521
Registered Investment Advisors	662		71		733		725		504
Veterinary Industry	2,505		257		2,762		3,113		182
Total	14,842		1,782		16,624		18,566		1,372
Construction & Development
Healthcare	1,237		—		1,237		1,258		157
Total	1,237		—		1,237		1,258		157
Commercial Real Estate
Death Care Management	2,221		610		2,831		2,964		260
Healthcare	3,717		598		4,315		4,332		192
Independent Pharmacies	1,562		—		1,562		1,933		8
Veterinary Industry	13,711		1,555		15,266		16,584		1,075
Total	21,211		2,763		23,974		25,813		1,535
Commercial Land
Agriculture	—		—		—		58		—
Total	—		—		—		58		—
Total Impaired Loans and Leases	$	37,290	$	4,545	$	41,835	$	45,695	$	3,064

The following table presents the average recorded investment of impaired loans and leases for each period presented and interest income recognized during the period in which the loans and leases were considered impaired.

	Three months ended September 30, 2018				Three months ended September 30, 2017
	Average Balance		Interest Income Recognized		Average Balance		Interest Income Recognized
Commercial & Industrial
Death Care Management	$	6	$	—	$	42	$	1
Healthcare	7,152		28		7,076		11
Independent Pharmacies	10,325		4		4,266		26
Registered Investment Advisors	3,589		7		894		14
Veterinary Industry	2,423		16		2,511		11
Other Industries	1,822		17		—		—
Total	25,317		72		14,789		63
Construction & Development
Healthcare	2,162		12		602		2
Total	2,162		12		602		2
Commercial Real Estate
Death Care Management	3,098		24		2,512		13
Healthcare	18,765		150		3,079		11
Independent Pharmacies	2,739		—		1,985		—
Veterinary Industry	16,731		98		13,950		132
Total	41,333		272		21,526		156
Commercial Land
Agriculture	21,792		38		23		—
Total	21,792		38		23		—
Total	$	90,604	$	394	$	36,940	$	221

	Nine months ended September 30, 2018				Nine months ended September 30, 2017
	Average Balance		Interest Income Recognized		Average Balance		Interest Income Recognized
Commercial & Industrial
Death Care Management	$	7	$	—	$	313	$	3
Healthcare	7,232		59		4,996		25
Independent Pharmacies	10,180		31		7,998		52
Registered Investment Advisors	3,007		31		1,438		28
Veterinary Industry	2,488		54		4,329		24
Other Industries	1,875		22		—		—
Total	24,789		197		19,074		132
Construction & Development
Healthcare	2,162		63		120		2
Total	2,162		63		120		2
Commercial Real Estate
Death Care Management	3,115		88		2,030		30
Healthcare	17,535		230		2,940		24
Independent Pharmacies	2,763		1		149		—
Veterinary Industry	17,081		333		13,069		278
Total	40,494		652		18,188		332
Commercial Land
Agriculture	21,803		68		199		—
Total	21,803		68		199		—
Total	$	89,248	$	980	$	37,581	$	466

The following tables represent the types of TDRs that were made during the periods presented:

	Three months ended September 30, 2018					Three months ended September 30, 2017
	All Restructurings					All Restructurings
	Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment		Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment
Interest Only and Rate Concession
Commercial Land
Agriculture	4	$	10,276	$	10,276	—	$	—	$	—
Total Interest Only and Rate Concession	4	10,276		10,276		—	—		—
Extended Amortization
Commercial Land
Agriculture	1	8		8		—	—		—
Total Extended Amortization	1	8		8		—	—		—
Payment Deferral
Commercial & Industrial
Veterinary Industry	—	—		—		2	559		559
Total Payment Deferral	—	—		—		2	559		559
Total	5	$	10,284	$	10,284	2	$	559	$	559

	Nine months ended September 30, 2018					Nine months ended September 30, 2017
	All Restructurings					All Restructurings
	Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment		Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment
Interest Only
Construction and Development
Healthcare	1	$	612	$	612	—	$	—	$	—
Total Interest Only	1	612		612		—	—		—
Interest Only and Rate Concession
Commercial Land
Agriculture	4	10,276		10,276		—	—		—
Total Interest Only and Rate Concession	4	10,276		10,276		—	—		—
Extended Amortization
Commercial Land
Agriculture	1	8		8		—	—		—
Total Extended Amortization	1	8		8		—	—		—
Payment Deferral and Extended Amortization
Commercial & Industrial
Independent Pharmacies	—	—		—		1	262		262
Total Payment Deferral and Extended Amortization	—	—		—		1	262		262
Payment Deferral
Commercial & Industrial
Veterinary Industry	—	—		—		2	559		559
Total Payment Deferral	—	—		—		2	559		559
Total	6	$	10,896	$	10,896	3	$	821	$	821

Concessions made to improve a loan and lease’s performance have varying degrees of success. No TDRs that were modified within the twelve months ended September 30, 2018 and 2017 subsequently defaulted during the three and nine months ended September 30, 2018 and 2017.

XML

Equipment Leasing

9 Months Ended

Sep. 30, 2018

Leases [Abstract]

Equipment Leasing

Equipment Leasing

The Company purchases new equipment for the purpose of leasing such equipment to customers within its verticals. Equipment purchased to fulfill commitments to commercial renewable energy projects is rented out under operating leases while leases of equipment outside of the renewable energy vertical are generally direct financing leases. Accordingly, leased assets under operating leases are included in premises and equipment while leased assets under direct financing leases are included in loans and leases held for investment.

Direct Financing Leases

Interest income on direct financing leases is recognized when earned.  Unearned interest is recognized over the lease term on a basis which results in a constant rate of return on the unrecovered lease investment.  The term of each lease is generally 3-7 years which is consistent with the useful life of the equipment with no residual value.  The gross lease payments receivable and the net investment included in accounts receivable for such leases are as follows:

	As of
	September 30, 2018			December 31, 2017
Gross direct finance lease payments receivable	$	6,548		$	2,399
Less – unearned interest	(1,116		)	(373		)
Net investment in direct financing leases	$	5,432		$	2,026

Future minimum lease payments under finance leases are as follows:

As of September 30, 2018	Amount
2018	$	325
2019	1,384
2020	1,373
2021	1,287
2022	1,107
Thereafter	1,072
Total	$	6,548

Interest income of $100 thousand and $14 thousand was recognized in the three months ended September 30, 2018 and 2017, respectively. Interest income of $220 thousand and $21 thousand was recognized in the nine months ended September 30, 2018 and 2017, respectively.

Operating Leases

The term of each operating lease is generally 10 to 15 years. The Company retains ownership of the equipment and associated tax benefits such as investment tax credits and accelerated depreciation. At the end of the lease term, the lessee has the option to renew the lease for two additional terms or purchase the equipment at the then current fair market value.

Rental revenue from operating leases is recognized over a straight-line basis over the term of the lease. Rental equipment is recorded at cost and depreciated to an estimated residual value on a straight-line basis over the estimated useful life. The useful lives generally range from 20 to 25 years and residual values generally range from 20% to 40%, however, they are subject to periodic evaluation. Changes in useful lives or residual values will impact depreciation expense and any gain or loss from the sale of used equipment. The estimated useful lives and residual values of the Company's leasing equipment are based on industry disposal experience and the Company's expectations for future sale prices.

If the Company decides to sell or otherwise dispose of rental equipment, it is carried at the lower of cost or fair value less costs to sell or dispose.   Repair and maintenance costs that do not extend the lives of the rental equipment are charged to direct operating expenses at the time the costs are incurred.

As of September 30, 2018, the Company had a net investment of $144.9 million in assets included in premises and equipment that are subject to operating leases. Of the net investment, the gross balance of the assets was $153.0 million and accumulated depreciation was $8.1 million as of September 30, 2018. Depreciation expense recognized on these assets for the three and nine months ended September 30, 2018 was $2.2 million and $5.9 million, respectively. Depreciation expense recognized for the three and nine months ended September 30, 2017 was $840 thousand and $1.1 million, respectively.

A maturity analysis of future minimum lease payments under non-cancelable operating leases is as follows:

As of September 30, 2018	Amount
2018	$	1,765
2019	8,284
2020	8,341
2021	8,385
2022	8,417
Thereafter	53,939
Total	$	89,131

XML

Servicing Assets

9 Months Ended

Sep. 30, 2018

Transfers and Servicing [Abstract]

Servicing Assets

Servicing Assets

Loans serviced for others are not included in the accompanying balance sheet. The unpaid principal balances of loans serviced for others requiring recognition of a servicing asset were $2.70 billion and $2.44 billion at September 30, 2018 and December 31, 2017, respectively. The unpaid principal balance for all loans serviced for others was $2.78 billion and $2.54 billion at September 30, 2018 and December 31, 2017, respectively.

The following summarizes the activity pertaining to servicing rights:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
Balance at beginning of period	$	52,689		$	53,675		$	52,298		$	51,994
Additions, net	5,558			3,527			14,634			9,412
Fair value changes:
Due to changes in valuation inputs or assumptions	(5,336		)	(789		)	(7,336		)	342
Decay due to increases in principal paydowns or runoff	(3,650		)	(3,021		)	(10,335		)	(8,356		)
Balance at end of period	$	49,261		$	53,392		$	49,261		$	53,392

The fair value of servicing rights was determined using a weighted average discount rate of 16.1% on September 30, 2018 and 12.6% on September 30, 2017. The fair value of servicing rights was determined using a weighted average prepayment speed of 11.1% on September 30, 2018 and 7.3% on September 30, 2017, depending on the stratification of the specific right. Changes to fair value are reported in loan servicing asset revaluation within the consolidated statements of income.

The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Changes in prepayment speed assumptions have the most significant impact on the fair value of servicing rights. Generally, as interest rates rise on variable rate loans, loan prepayments increase due to an increase in refinance activity, which results in a decrease in the fair value of servicing assets. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time, and those assumptions may not be appropriate if they are applied at a different time.

XML

Borrowings

9 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Borrowings

Borrowings

Total outstanding short and long term borrowings consisted of the following:

	September 30, 2018		December 31, 2017
Short term borrowings
On October 20, 2017, the Company entered into a revolving line of credit of $20 million with an unaffiliated commercial bank. The note is unsecured and accrues interest at LIBOR plus 1.750% for a term of 12 months. Payments are interest only with all principal and accrued interest due on October 19, 2018. On October 2, 2018, the Company renewed the revolving line of credit for an additional 12 months with a maturity date of October 18, 2019. The terms of this loan require the Company to maintain minimum capital and debt service coverage ratios. No advances have been made to this line of credit and there is $20 million of available credit remaining at September 30, 2018.	$	—	$	—
On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank. On April 18, 2017, the Company renewed and increased the revolving line of credit to $25 million. The note is unsecured and accrues interest at Prime minus 0.50% for a term of 24 months. Payments are interest only with all principal and accrued interest due on April 30, 2019. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. This line of credit was paid in full on August 25, 2017, and there is $25 million of available credit remaining at September 30, 2018.	—		—
Total short term borrowings	$	—	$	—

	September 30, 2018		December 31, 2017
Long term borrowings
On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus with a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments were interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments of $146 thousand began in October 2016 with all principal and accrued interest due on September 11, 2021. This note was repaid in full on January 31, 2018.	$	—	$	22,990
On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. One of the loans with an outstanding balance of $1.3 million was paid in full on August 17, 2018. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at September 30, 2018 is 6.00%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $1.5 million at September 30, 2018. Underlying loan carries a risk grade of 3 and is current with no delinquencies.	1,489		3,574
In October 2017, the Company entered into a capital lease of $19 thousand with an unaffiliated equipment lease company, secured by fitness equipment which is included in premises and equipment on the consolidated balance sheet. Payments are principal and interest due monthly starting December 15, 2017 over a term of 60 months. At the end of the lease term there is a $1.00 bargain purchase option.	17		—
Total long term borrowings	$	1,506	$	26,564

The Company may purchase federal funds through unsecured federal funds lines of credit with various correspondent banks, which totaled $72.5 million and $47.5 million as of September 30, 2018 and December 31, 2017, respectively. These lines are intended for short-term borrowings and are subject to restrictions limiting the frequency and terms of advances. These lines of credit are payable on demand and bear interest based upon the daily federal funds rate. The Company had no outstanding balances on the lines of credit as of September 30, 2018 and December 31, 2017.

The Company has entered into a repurchase agreement with a third party for $5.0 million as of September 30, 2018 and December 31, 2017. At the time the Company enters into a transaction with the third party, the Company must transfer securities or other assets against the funds received. The terms of the agreement are set at market conditions at the time the Company enters into such transaction. The Company had no outstanding balance on the repurchase agreement as of September 30, 2018 and December 31, 2017.

On June 18, 2018, the Company entered into a borrowing agreement with the Federal Home Loan Bank of Atlanta. These borrowings must be secured with eligible collateral approved by the Federal Home Loan Bank of Atlanta. As of September 30, 2018, there was $854.2 million of potential borrowing capacity available under this agreement. There is no collateral pledged and no advances outstanding as of September 30, 2018.

The Company may borrow funds through the Federal Reserve Bank’s discount window. These borrowings are secured by a blanket floating lien on qualifying loans with a balance of $376.9 million and $348.5 million as of September 30, 2018 and December 31, 2017, respectively. At September 30, 2018 and December 31, 2017, the Company had approximately $210.1 million and $189.1 million, respectively, in borrowing capacity available under these arrangements with no outstanding balance as of September 30, 2018 and December 31, 2017.

XML

Income Taxes

9 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company's effective tax rate is lower than the U.S. statutory rate primarily because of the anticipated effect of investment tax credits during 2018. The Company's effective tax rate in the future will depend on the actual investment tax credits earned as a part of its financing renewable energy applications.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair Value Hierarchy

There are three levels of inputs in the fair value hierarchy that may be used to measure fair value. Financial instruments are considered Level 1 when valuation can be based on quoted prices in active markets for identical assets or liabilities. Level 2 financial instruments are valued using quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or models using inputs that are observable or can be corroborated by observable market data of substantially the full term of the assets or liabilities. Financial instruments are considered Level 3 when their values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable and when determination of the fair value requires significant management judgment or estimation.

Financial Instruments Measured at Fair Value

The following sections provide a description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the fair value hierarchy:

Investment securities: Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, discounted cash flow or at net asset value per share. Level 2 securities would include U.S. government agency securities, mortgage-backed securities, obligations of states and political subdivisions and certain corporate, asset backed mutual fund and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy.

Impaired loans: Impairment of a loan is based on the fair value of the collateral of the loan for collateral-dependent loans. Fair value of the loan’s collateral, when the loan is dependent on collateral, is determined by appraisals or independent valuation which is then adjusted for the cost related to liquidation of the collateral. For non-collateral dependent loans, impairment is determined by the present value of expected future cash flows. Impaired loans classified as Level 3 are based on management’s judgment and estimation.

Servicing assets: Servicing rights do not trade in an active, open market with readily observable prices. While sales of servicing rights do occur, the precise terms and conditions typically are not readily available. Accordingly, the Company estimates the fair value of servicing rights using discounted cash flow models incorporating numerous assumptions from the perspective of a market participant including servicing income, servicing costs, market discount rates and prepayment speeds. Due to the nature of the valuation inputs, servicing rights are classified within Level 3 of the valuation hierarchy.

Foreclosed assets: Foreclosed real estate is adjusted to fair value less selling costs upon transfer of the loans to foreclosed real estate. Subsequently, foreclosed real estate is carried at the lower of carrying value or fair value less selling costs. Fair value is based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. Given the lack of observable market prices for identical properties and market discounts applied to appraised values, the Company generally classifies foreclosed assets as nonrecurring Level 3.

Mutual fund: The following mutual fund is registered with the Securities and Exchange Commission as a closed-end, non-diversified management investment company and operates as an interval fund. The fund primarily invests in the unguaranteed portion of SBA504 First Lien Loans secured by owner-occupied commercial real estate. This investment is valued using quoted prices in markets that are not active and is classified as Level 2 within the valuation hierarchy.

Equity warrant assets: Fair value measurements of equity warrant assets of private companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public companies that operate in similar industries as the companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. The Company classifies equity warrant assets within Level 3 of the valuation hierarchy.

Contingent consideration liability: Contingent consideration associated with the acquisition of Reltco will be adjusted to fair value quarterly until settled. The assumptions used to measure fair value are based on internal metrics that are unobservable and therefore the contingent consideration liability is classified within Level 3 of the valuation hierarchy.

Recurring Fair Value

The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis.

September 30, 2018	Total		Level 1		Level 2		Level 3
Investment securities available-for-sale
US treasury securities	$	4,934	$	—	$	4,934	$	—
US government agencies	33,075		—		33,075		—
Residential mortgage-backed securities	336,275		—		336,275		—
Servicing assets1	49,261		—		—		49,261
Mutual fund	2,068		—		2,068		—
Equity warrant assets	538		—		—		538
Total assets at fair value	$	426,151	$	—	$	376,352	$	49,799

December 31, 2017	Total		Level 1		Level 2		Level 3
Investment securities available-for-sale
US government agencies	$	22,624	$	—	$	22,624	$	—
Residential mortgage-backed securities	68,696		—		68,696		—
Mutual fund	2,035		—		2,035		—
Servicing assets1	52,298		—		—		52,298
Total assets at fair value	$	145,653	$	—	$	93,355	$	52,298
Contingent consideration liability2	$	1,900	$	—	$	—	$	1,900
Total liabilities at fair value	$	1,900	$	—	$	—	$	1,900

1 See Note 7 for a rollforward of recurring Level 3 fair values for servicing assets and various assumptions used in the fair value measurement.

2 Activity for the contingent consideration liability during the three months ended September 30, 2018 consisted of a $1.6 million write-off as a result of the disposition of Reltco during the quarter. During the nine months ended September 30, 2018, the Company recorded a $260 thousand negative fair value adjustment and $1.6 million write-off as a result of the disposition of Reltco. There was no activity for the contingent consideration liability during the three months ended September 30, 2017. During the nine months ended September 30, 2017, $4.3 million of contingent consideration was recorded upon the acquisition of Reltco as well as $350 thousand positive fair value adjustments.

Non-recurring Fair Value

The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis.

September 30, 2018	Total		Level 1		Level 2		Level 3
Impaired loans and leases	$	79,727	$	—	$	—	$	79,727
Foreclosed assets	1,429		—		—		1,429
Total assets at fair value	$	81,156	$	—	$	—	$	81,156

December 31, 2017	Total		Level 1		Level 2		Level 3
Impaired loans and leases	$	34,493	$	—	$	—	$	34,493
Foreclosed assets	1,281		—		—		1,281
Total assets at fair value	$	35,774	$	—	$	—	$	35,774

Level 3 Analysis

For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of September 30, 2018 and December 31, 2017 the significant unobservable inputs used in the fair value measurements were as follows:

September 30, 2018

Level 3 Assets with Significant Unobservable Inputs	Fair Value		Valuation Technique	Significant Unobservable Inputs	Range
Impaired loans and leases	$	79,727	Discounted appraisals Discounted expected cash flows	Appraisal adjustments (1) Interest rate & repayment term	10% to 48% Weighted average discount rate 6.16%
Foreclosed assets	$	1,429	Discounted appraisals	Appraisal adjustments (1)	9% to 37%
Equity warrant assets	$	538	Black-Scholes option pricing model	Volatility Risk-free interest rate Marketability discount Remaining life	20.00% 2.85% 20% 9-10 years

December 31, 2017

Level 3 Assets with Significant Unobservable Inputs	Fair Value		Valuation Technique	Significant Unobservable Inputs	Range
Impaired loans and leases	$	34,493	Discounted appraisals Discounted expected cash flows	Appraisal adjustments (1) Interest rate & repayment term	10% to 25% Weighted average discount rate 6.26%
Foreclosed assets	$	1,281	Discounted appraisals	Appraisal adjustments (1)	10% to 37%
Contingent consideration liability	$	1,900	Monte Carlo simulation	Volatility Risk-free rate of return Dividend yield Remaining life	25.00% 1.43% 0.51% 3.00 years

(1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments.

Estimated Fair Value of Other Financial Instruments

GAAP also requires disclosure of the fair value of financial instruments carried at book value on the consolidated balance sheet. The carrying amounts and estimated fair values of the Company’s financial instruments are as follows:

September 30, 2018	Carrying Amount		Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
Financial assets
Cash and due from banks	$	368,565	$	368,565	$	—	$	—	$	368,565
Certificates of deposit with other banks	750		748		—		—		748
Investment securities, available-for-sale	374,284		—		374,284		—		374,284
Loans held for sale(1)	646,475		—		—		649,054		649,054
Loans and leases, net of allowance for loan and lease losses(1)	1,604,540		—		—		1,594,589		1,594,589
Servicing assets	49,261		—		—		49,261		49,261
Accrued interest receivable	14,147		14,147		—		—		14,147
Financial liabilities
Deposits	2,924,288		—		2,871,159		—		2,871,159
Accrued interest payable	410		410		—		—		410
Long term borrowings	1,506		—		—		1,507		1,507

December 31, 2017	Carrying Amount		Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
Financial assets
Cash and due from banks	$	295,271	$	295,271	$	—	$	—	$	295,271
Certificates of deposit with other banks	3,000		2,993		—		—		2,993
Investment securities, available-for-sale	93,355		—		93,355		—		93,355
Loans held for sale (1)	680,454		—		—		706,972		706,972
Loans and leases, net of allowance for loan and lease losses(1)	1,319,783		—		—		1,319,615		1,319,615
Servicing assets	52,298		—		—		52,298		52,298
Accrued interest receivable	10,160		10,160		—		—		10,160
Financial liabilities
Deposits	2,260,263		—		2,232,370		—		2,232,370
Accrued interest payable	367		367		—		—		367
Long term borrowings	26,564		—		—		27,390		27,390

(1) In accordance with the adoption of ASU 2016-01, as of September 30, 2018, the fair value of loans and leases were measured using an exit price notion. As of December 31, 2017, the fair value of loans and leases were measured using an entry price notion.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Litigation

In the normal course of business the Company is involved in various legal proceedings. Management believes that the outcome of such proceedings will not materially affect the financial position, results of operations or cash flows of the Company.

Financial Instruments with Off-balance-sheet Risk

The Company is party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. These instruments involve, to varying degrees, credit risk in excess of the amount recognized in the balance sheet.

The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as for on-balance-sheet instruments. A summary of the Company’s commitments is as follows:

	September 30, 2018		December 31, 2017
Commitments to extend credit	$	1,432,771	$	1,701,137
Standby letters of credit	2,279		2,298
Solar purchase commitments	10,158		106,921
Airplane purchase agreement commitments	10,450		25,450
Total unfunded off-balance-sheet credit risk	$	1,455,658	$	1,835,806

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the party. Collateral held varies, but may include accounts receivable, inventory, property and equipment, residential real estate and income-producing commercial properties. In 2012, the Company began issuing commitment letters after approval of the loan by the Credit Department. Commitment letters generally expire ninety days after issuance.

Standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. Collateral held varies as specified above and is required in instances which the Company deems necessary.

Solar purchase commitments are commitments to purchase solar assets to fulfill leasing obligations.

As of September 30, 2018 and December 31, 2017, the Company had unfunded commitments to provide capital contributions for on-balance sheet investments in the amount of $3.0 million and $3.5 million, respectively.

Concentrations of Credit Risk

Although the Company is not subject to any geographic concentrations, a substantial amount of the Company’s loans, leases, and commitments to extend credit have been granted to customers in the agriculture, healthcare and veterinary verticals. The concentrations of credit by type of loan are set forth in Note 5. The distribution of commitments to extend credit approximates the distribution of loans outstanding. The Company does not have a significant number of credits to any single borrower or group of related borrowers whereby their retained unguaranteed exposure exceeds $7.5 million, except for ten relationships that have a retained unguaranteed exposure of $121.1 million of which $102.3 million of the unguaranteed exposure has been disbursed.

Additionally, the Company has future minimum lease payments due under non-cancelable operating leases totaling $89.1 million, of which $67.4 million is due from four relationships.

The Company from time-to-time may have cash and cash equivalents on deposit with financial institutions that exceed federally-insured limits.

XML

Stock Plans

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Plans

Stock Plans

On March 20, 2015, the Company adopted the 2015 Omnibus Stock Incentive Plan which replaced the previously existing Amended Incentive Stock Option Plan and Nonstatutory Stock Option Plan. Subsequently on May 24, 2016, the 2015 Omnibus Stock Incentive Plan was amended to authorize awards covering a maximum of 7,000,000 common voting shares and has an expiration date of March 20, 2025. On May 15, 2018, the Amended and Restated 2015 Omnibus Stock Incentive Plan was amended to authorize awards covering a maximum of 8,750,000 common voting shares. Options or restricted shares granted under the Amended and Restated 2015 Omnibus Stock Incentive Plan (the "Plan") expire no more than 10 years from the date of grant. Exercise prices under the Plan are set by the Board of Directors at the date of grant, but shall not be less than 100% of fair market value of the related stock at the date of the grant. Options or restricted shares vest over a minimum of three years from the date of the grant.

Stock Options

Compensation cost relating to share-based payment transactions are recognized in the financial statements with measurement based upon the fair value of the equity or liability instruments issued. For the three months ended September 30, 2018 and 2017, the Company recognized $470 thousand and $536 thousand in compensation expense for stock options, respectively. For the nine months ended September 30, 2018 and 2017, the Company recognized $1.2 million and $1.4 million in compensation expense for stock options, respectively.

Stock option activity under the Plan during the nine month periods ended September 30, 2018 and 2017 is summarized below.

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at December 31, 2017	3,058,459	$	11.30
Exercised	171,333	9.26
Forfeited	174,845	13.69
Granted	—	—
Outstanding at September 30, 2018	2,712,281	$	11.27	6.28 years	$	47,005,905
Exercisable at September 30, 2018	813,730	$	10.67	6.11 years	$	14,587,733

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at December 31, 2016	3,478,208	$	11.51
Exercised	76,285	7.89
Forfeited	203,671	14.12
Granted	—	—
Outstanding at September 30, 2017	3,198,252	$	11.43	7.31 years	$	38,411,802
Exercisable at September 30, 2017	703,425	$	10.41	7.06 years	$	9,171,805

The following is a summary of non-vested stock option activity for the Company for the nine months ended September 30, 2018 and 2017.

	Shares		Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	2,364,999		$	4.65
Granted	—		—
Vested	(291,603	)	3.95
Forfeited	(174,845	)	5.98
Non-vested at September 30, 2018	1,898,551		4.63

	Shares		Weighted Average Grant Date Fair Value
Non-vested at December 31, 2016	3,016,100		$	4.78
Granted	—		—
Vested	(317,602	)	4.17
Forfeited	(203,671	)	6.03
Non-vested at September 30, 2017	2,494,827		4.75

The total intrinsic value of options exercised at September 30, 2018 and 2017 was $3.3 million and $1.1 million, respectively.

At September 30, 2018, unrecognized compensation costs relating to stock options amounted to $6.6 million which will be recognized over a weighted average period of 2.31 years.

The weighted average fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts. There were no stock options granted during the three and nine months ended September 30, 2018 or 2017.

Restricted Stock

Restricted stock awards are authorized in the form of restricted stock awards or units ("RSU"s) and restricted stock awards or units with a market price condition ("Market RSU"s).

RSUs have a restriction based on the passage of time and may also have a restriction based on a non-market-related performance criteria. The fair value of the RSUs is based on the closing price on the date of the grant.

Market RSUs also have a restriction based on the passage of time and non-market-related performance criteria, but also have a restriction based on market price criteria related to the Company’s share price closing at or above a specified price ranging from $34.00 to $55.00 per share for at least twenty (20) consecutive trading days at any time prior to expiration date. The amount of Market RSUs earned will not exceed 100% of the Market RSUs awarded. The fair value of the Market RSUs and the implied service period is calculated using the Monte Carlo simulation method.

RSU stock activity under the Plan during the first nine months of 2018 is summarized below.

	Shares	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	181,814	$	20.03
Granted	230,599	28.72
Vested	83,829	23.68
Forfeited	38,793	22.96
Non-vested at September 30, 2018	289,791	25.50

For the three months ended September 30, 2018 and 2017, the Company recognized $401 thousand and $191 thousand in compensation expense for RSUs, respectively. For the nine months ended September 30, 2018 and 2017, the Company recognized $2.2 million and $517 thousand in compensation expense for RSUs, respectively.

At September 30, 2018, unrecognized compensation costs relating to RSUs amounted to $6.6 million which will be recognized over a weighted average period of 5.19 years.

Market RSU stock activity under the Plan during the first nine months of 2018 is summarized below.

	Shares	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	2,532,808	$	8.78
Granted	485,000	15.73
Vested	—	—
Forfeited	223,128	9.08
Non-vested at September 30, 2018	2,794,680	9.96

The compensation expense for Market RSUs is measured based on their grant date fair value as calculated using the Monte Carlo simulation and is recognized on a straight-line basis over the average vesting period. The Monte Carlo simulation used 100,000 simulation paths to assess the expected date of achieving the market price criteria.

Related to the 75,000 Market RSUs granted on May 14, 2018, the share price simulation was based on the Cox, Ross & Rubinstein option pricing methodology for a period of 7.0 years. The implied term of the restricted stock was 3.3 years. The Monte Carlo Simulation used various assumptions that included a risk free rate of return of 2.96%, expected volatility of 27.00% and a dividend yield of 0.42%.

Related to the 410,000 Market RSUs granted on August 10, 2018, the share price simulation was based on the Cox, Ross & Rubinstein option pricing methodology for a period of 7.0 years. The implied term of the restricted stock ranges from 1.6 years to 3.5 years. The Monte Carlo Simulation used various assumptions that included a risk free rate of return of 2.78%, expected volatility of 28.10% and a dividend yield of 0.40%.

For the three months ended September 30, 2018 and 2017, the Company recognized $1.6 million and $1.3 million in compensation expense for Market RSUs, respectively. For the nine months ended September 30, 2018 and 2017, the Company recognized $3.5 million and $3.7 million in compensation expense for Market RSUs, respectively.

At September 30, 2018, unrecognized compensation costs relating to Market RSUs amounted to $18.4 million which will be recognized over a weighted average period of 2.66 years.

Employee Stock Purchase Plan

The Company adopted an Employee Stock Purchase Plan on October 8, 2014. On May 24, 2016, the plan was amended and the Amended and Restated Employee Stock Purchase Plan (the "ESPP") became effective within the meaning of Section 423 of the Internal Revenue Code of 1986, as amended. Under the ESPP, eligible employees are able to purchase available shares with post-tax dollars as of the grant date. In order for employees to be eligible to participate in the ESPP they must be employed or on an authorized leave of absence from the Company or any subsidiary immediately prior to the grant date. ESPP stock purchases cannot exceed $25 thousand in fair market value per employee per calendar year. Options to purchase shares under the ESPP are granted at a 15% discount to fair market value. For the three months ended September 30, 2018 and 2017, the Company recognized $31 thousand and $36 thousand, respectively. For the nine months ended September 30, 2018 and 2017 the Company recognized $60 thousand and $79 thousand expense, respectively.

XML

Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

General

General

In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the nine months ended September 30, 2018 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2018. The consolidated balance sheet as of December 31, 2017 has been derived from the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities Exchange Commission on March 8, 2018 (SEC File No. 001-37497) (the "2017 Annual Report"). A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s 2017 Annual Report. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes in the Company's 2017 Annual Report.

The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.

Amounts in all tables in the Notes to Unaudited Condensed Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated.

Business Segments

Business Segments

Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment.

Unconsolidated Joint Venture

Unconsolidated Joint Venture

On October 1, 2017, the Company started the digital banking joint venture between Live Oak Banking Company and First Data Corporation ("First Data"). The new company, named Apiture, combines First Data's and the Bank's digital banking platforms, products, services, and certain human resources used in the creation and delivery of technology solutions for financial institutions. The contributed assets of both the Company and First Data are considered businesses in accordance with relevant accounting standards. At closing, both the Bank and First Data received equal voting interests in Apiture in exchange for their respective contributions. As a term of the closing agreements, First Data is entitled to a preference in Apiture's cash earnings from the date of closing through December 31, 2017 and all of 2018, not to exceed $18.0 million and $18.9 million, respectively.

As a result of the above cash earnings preference, income (loss) is allocated utilizing the hypothetical liquidation at book value ("HLBV") method. Under the HLBV method, we allocate income or loss based on the change in each unitholders’ claim on the net assets of Apiture at period end, after adjusting for any distributions or contributions made during such period. As a result of the HLBV method there was no net income or loss attributed to the Company related to its ownership interest in Apiture during the three and nine months ended September 30, 2018.

Derivative Financial Instruments

Derivative Financial Instruments

Interest Rate Futures Contracts

During the fourth quarter of 2016, the Company began using exchange-traded interest rate futures contracts to manage interest rate risk that may impact expected gains arising from future secondary market loan sales. Upon entering into a futures contract, the Company is required to pledge to the counterparty an amount of cash equal to a certain percentage of the contract amount, also known as an initial margin deposit. Subsequent payments, known as variation margin, are made or received by the Company each day to settle the daily fluctuations in the fair value of the underlying contract. Investments in these derivative contracts are subject to risks that can result in a loss of all or part of an investment. Credit risk is considered low because the counterparties are futures exchanges. The Company has not designated any derivative as a hedging instrument under applicable accounting guidance. Changes in fair value of the derivative contracts is recorded as a component of "net gains on sales of loans" on the consolidated statement of income. The fair value of the derivative contracts on the balance sheet date is zero due to the daily cash settlement of contracts.

Equity Warrant Assets

In connection with negotiated credit facilities and certain other services, the Company may obtain equity warrant assets giving the Company the right to acquire stock in private companies in certain verticals. These assets are held for prospective investment gains and are not used to hedge any economic risks. Further, the Company does not use other derivative instruments to hedge economic risks stemming from equity warrant assets.

Equity warrant assets in certain private client companies are recorded as derivatives when they contain net settlement terms and other qualifying criteria under Accounting Standards Codification 815. Equity warrant assets entitle the Company to purchase a specific number of shares of stock at a specific price within a specific time period, generally 10 years. Certain equity warrant assets contain contingent provisions, which adjust the underlying number of shares or purchase price upon the occurrence of certain future events to prevent dilution of the Company’s implied ownership represented by the warrants. Certain warrant agreements contain net share settlement provisions, which permit the receipt of, upon exercise, a share count equal to the intrinsic value of the warrant divided by the share price (otherwise known as a “cashless” exercise). These equity warrant assets are recorded at fair value and are classified as derivative assets, a component of other assets, on the consolidated balance sheet at the time they are obtained.

The grant date fair values of equity warrant assets classified as derivatives received in connection with the issuance of a credit facility are deemed to be loan fees and recognized as an adjustment of loan yield through loan interest income. Similar to other loan fees, the yield adjustment related to grant date fair value of warrants is recognized over the life of that credit facility.

Any changes in fair value from the grant date fair value of equity warrant assets classified as derivatives will be recognized as increases or decreases to other assets on the consolidated balance sheet and as net gains or losses on derivative instruments, in other noninterest income, a component of consolidated net income. When a portfolio company is acquired, the Company may exercise these equity warrant assets for shares or cash.

The fair value of equity warrant assets classified as derivatives is reviewed quarterly using a Black-Scholes option pricing model.

For those equity warrant assets that do not contain net share settlement provisions, the Company considers these to be equity investments without readily determinable market values and records the asset at cost.

Revenue Recognition

Revenue Recognition

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts with Customers” (Topic 606) and all subsequent ASUs that modified Topic 606. The implementation of the new standard did not have a material impact on the measurement or recognition of revenue and a cumulative effect adjustment to opening retained earnings was not necessary. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts were not adjusted and continue to be reported in accordance with the Company's historic accounting under Topic 605.

Topic 606 does not apply to revenue associated with financial instruments, including revenue from loans and lease financings or investment securities. In addition, certain noninterest income streams such as fees associated with servicing rights, financial guarantees, derivatives, title insurance, and equity and equity security investments are also not in scope of the new guidance. Therefore, the recognition of these revenue streams did not change upon adoption of Topic 606. Substantially all of the Company’s revenue is generated from contracts with customers. Noninterest revenue streams in-scope of Topic 606 are discussed below.

Other noninterest income

Other noninterest income consists of other recurring revenue streams from administration of trust assets held by the Company's trust department and from services provided by GLS to its clients for settlement, accounting, and valuation for government guaranteed loan sales and holdings. Trust account administration performance obligations are generally satisfied over time and fees are recognized monthly, based on the month-end market value of assets in fiduciary accounts and the applicable fee rate. Payment is generally received after month-end through a direct charge to customers' accounts. The Company does not earn performance-based incentives from trust account administration services. GLS provides services when requested by clients. Each requested service represents a specific performance obligation with a transaction price outlined by GLS' fee schedule. Revenue is recognized as the requested services are completed and payment is generally received the following month.

Contract Balances

A contract asset balance occurs when an entity performs a service for a customer before the customer pays consideration (resulting in a contract receivable) or before payment is due (resulting in a contract asset). A contract liability balance is an entity’s obligation to transfer a service to a customer for which the entity has already received payment (or payment is due) from the customer. The Company’s noninterest revenue streams are largely based on transactional activity, or standard month-end revenue accruals such as trust administration fees based on month-end market values. Consideration is often received immediately or shortly after the Company satisfies its performance obligation and revenue is recognized. The Company does not typically enter into long-term revenue contracts with customers, and therefore, does not experience significant contract balances. As of September 30, 2018 and December 31, 2017, the Company did not have any significant contract balances.

Contract Acquisition Costs

In connection with the adoption of Topic 606, an entity is required to capitalize, and subsequently amortize into expense, certain incremental costs of obtaining a contract with a customer if these costs are expected to be recovered. The incremental costs of obtaining a contract are those costs that an entity incurs to obtain a contract with a customer that it would not have incurred if the contract had not been obtained (for example, sales commission). The Company utilizes the practical expedient which allows entities to immediately expense contract acquisition costs when the asset that would have resulted from capitalizing these costs would have been amortized in one year or less. Upon adoption of Topic 606, the Company did not capitalize any contract acquisition cost.

Reclassifications

Reclassifications

Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications.

Recent Accounting Pronouncements

In January 2016, the FASB issued ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01, among other things, (i) requires equity investments, with certain exceptions, to be measured at fair value with changes in fair value recognized in net income, (ii) simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment, (iii) eliminates the requirement for public business entities to disclose the methods and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet, (iv) requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, (v) requires an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments, (vi) requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statements and (viii) clarifies that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale. The Company adopted the standard in the first quarter of 2018 with no material impact on the consolidated financial statements. In accordance with (iv) above, the Company measured the fair value of the loan and lease portfolio using an exit price notion. See Note 10. Fair Value of Financial Instruments for additional information.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The FASB issued this ASU to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet by lessees for those leases classified as operating leases under current GAAP and disclosing key information about leasing arrangements. The amendments in this ASU are effective for the Company on January 1, 2019. The Company has created an implementation team that is currently evaluating the impact this standard will have on the consolidated financial statements upon adoption. Furthermore, the Company expects to adopt on a prospective basis.

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This new guidance replaces the incurred loss impairment methodology in current standards with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts and requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU 2016-13 will be effective for the Company on January 1, 2020. The Company is currently evaluating the potential impact of ASU 2016-13 on the consolidated financial statements. In that regard, a cross-functional working group has been formed, under the direction of the Company's Chief Financial Officer and Chief Credit Officer. The working group is comprised of individuals from various functional areas including credit, risk management, finance and information technology, among others. Implementation efforts continue with model development, ongoing system requirements evaluation and the identification of data and resource needs, among other things. The Company has also engaged a third-party vendor solution to assist in the application of ASU 2016-13. While the Company is currently unable to reasonably estimate the impact of adopting ASU 2016-13, the impact of adoption is expected to be significantly influenced by the composition, characteristics and quality of loan and securities portfolios as well as the prevailing economic conditions and forecasts as of the adoption date.

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805) - Clarifying the Definition of a Business” (“ASU 2017-01”).  ASU 2017-01 clarifies the definition and provides a more robust framework to use in determining when a set of assets and activities constitutes a business. ASU 2017-01 is intended to provide guidance when evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In February 2017, the FASB issued ASU No. 2017-05, “Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20) - Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets” (“ASU 2017-05”). ASU 2017-05 clarifies the scope of Subtopic 610-20 and adds guidance on nonfinancial asset derecognition as well as the accounting for partial sales of nonfinancial assets. The amendments conform the derecognition guidance on nonfinancial assets with the model for transactions in the new revenue standard. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In May 2017, the FASB issued ASU No. 2017-09, “Compensation - Stock Compensation (Topic 718) - Scope of Modification Accounting” (“ASU 2017-09”). ASU 2017-09 clarifies when changes to the terms or conditions of a share-based payment award should be accounted for as a modification. This guidance indicates modification accounting is required when the fair value, vesting conditions, or classification of the award changes. The Company adopted the standard in the first quarter of 2018 with no effect on the consolidated financial statements.

In February 2018, the FASB issued ASU No. 2018-02, “Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (“ASU 2018-02”). ASU 2018-02 addresses the income tax accounting treatment of the stranded tax effects within other comprehensive income. The ASU allows for an entity to reclassify the stranded tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive income to retained earnings. ASU 2018-02 will be effective for the Company on January 1, 2019, with early adoption permitted. The Company early adopted ASU 2018-02 in the first quarter of 2018 and reclassified its stranded tax credit of $244 thousand within accumulated other comprehensive income to retained earnings at March 31, 2018.

In February 2018, the FASB issued ASU No. 2018-03, “Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2018-03”). ASU 2018-03 amendments clarify certain aspects of the guidance issued in ASU 2016-01. The amendments are effective for the Company for fiscal year 2018 with adoption as of July 1, 2018. The Company adopted the standard in the third quarter of 2018 with no material impact on the consolidated financial statements.

In March 2018, the FASB issued ASU No. 2018-05, “Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 118” (“ASU 2018-05”). ASU 2018-05 amends Accounting Standard Codification 740 to include recent SEC guidance pursuant to the issuance of SAB 118. These amendments address situations when a registrant does not have the necessary information available, prepared, or analyzed in reasonable detail to complete the accounting for certain income tax effects of the Tax Cuts and Jobs Act. The amendments were effective upon issuance and do not have a material effect on the Company's consolidated financial statements.

In June 2018, the FASB issued ASU No. 2018-07, “Compensation - Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018-07”). ASU 2018-07 amends Accounting Standard Codification 718 to largely align accounting for share-based payment awards issued to employees and nonemployees. Under the new guidance, existing employee guidance will generally apply to nonemployee share-based transactions, except for specific guidance on inputs into option pricing models and the attribution of cost. The amendments are effective for the Company on January 1, 2019 with early adoption permitted. The Company does not expect these amendments to have a material effect on its consolidated financial statements.

In July 2018, the FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases” (“ASU 2018-10”). ASU 2018-10 provides clarification on narrow aspects to Topic 842 and to correct unintended application of the guidance. The amendments are effective for the Company on January 1, 2019. The Company is currently assessing the effect the adoption of these amendments will have on the consolidated financial statements. See ASU 2016-02 for further discussion of implementation efforts.

In July 2018, the FASB issued ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements” (“ASU 2018-11”). ASU 2018-11 provides an additional transition method to adopt ASU 2016-02. The transition method allows an entity to apply ASU 2016-02 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. An entity that elects this transition method must provide required disclosures under Topic 840 for all periods that are in accordance with Topic 840. ASU 2018-11 also provides lessors with a practical expedient to not separate non-lease components from lease components by class of underlying asset. The amendments in this ASU are effective for the Company on January 1, 2019. The Company is currently assessing the effect the adoption of these amendments will have on the consolidated financial statements. See ASU 2016-02 for further discussion of implementation efforts.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 removes, modifies and adds certain fair value disclosure requirements on fair value measurements. The amendments are effective for the Company on January 1, 2020 with early adoption permitted. The Company does not expect these amendments to have a material effect on its consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendments are effective for the Company on January 1, 2020 with early adoption permitted. The Company is currently assessing the effect that the adoption of this standard will have on the consolidated financial statements.

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Basic earnings per share:
Net income available to common shareholders	$	14,252	$	12,862	$	40,958	$	28,769
Weighted-average basic shares outstanding	40,119,561		37,366,041		40,025,265		35,485,371
Basic earnings per share	$	0.36	$	0.34	$	1.02	$	0.81
Diluted earnings per share:
Net income available to common shareholders, for diluted earnings per share	$	14,252	$	12,862	$	40,958	$	28,769
Total weighted-average basic shares outstanding	40,119,561		37,366,041		40,025,265		35,485,371
Add effect of dilutive stock options and restricted stock grants	1,568,869		1,278,636		1,561,722		1,244,683
Total weighted-average diluted shares outstanding	41,688,430		38,644,677		41,586,987		36,730,054
Diluted earnings per share	$	0.34	$	0.33	$	0.98	$	0.78
Anti-dilutive shares	—		243,199		—		250,698

XML

Investment Securities (Tables)

9 Months Ended

Sep. 30, 2018

Investments, Debt and Equity Securities [Abstract]

Carrying Amount and Fair Value of Investment Securities

The carrying amount of investment securities and their approximate fair values are reflected in the following table:

	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
September 30, 2018
US treasury securities	$	4,965	$	—	$	31	$	4,934
US government agencies	33,598		—		523		33,075
Residential mortgage-backed securities	344,415		14		8,154		336,275
Total	$	382,978	$	14	$	8,708	$	374,284
December 31, 2017
US government agencies	$	22,778	$	3	$	157	$	22,624
Residential mortgage-backed securities	70,167		1		1,472		68,696
Mutual fund (1)	2,090		—		55		2,035
Total	$	95,035	$	4	$	1,684	$	93,355

(1) The following mutual fund was reclassified from investment securities available-for-sale to other assets in accordance with the adoption of ASU 2016-01.

Gross Unrealized Losses and Fair Value of Securities in a Continuous Unrealized Loss Position

The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position.

	Less Than 12 Months				12 Months or More				Total
September 30, 2018	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
US treasury securities	$	4,934	$	31	$	—	$	—	$	4,934	$	31
US government agencies	26,603		486		6,472		37		33,075		523
Residential mortgage-backed securities	286,015		5,426		47,812		2,728		333,827		8,154
Total	$	317,552	$	5,943	$	54,284	$	2,765	$	371,836	$	8,708
	Less Than 12 Months				12 Months or More				Total
December 31, 2017	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
US government agencies	$	14,842	$	100	$	6,465	$	57	$	21,307	$	157
Residential mortgage-backed securities	23,481		439		40,648		1,033		64,129		1,472
Mutual fund	—		—		2,035		55		2,035		55
Total	$	38,323	$	539	$	49,148	$	1,145	$	87,471	$	1,684

Summary of Investment Securities by Maturity

The following is a summary of investment securities by maturity:

	September 30, 2018
	Available-for-Sale
	Amortized cost		Fair value
US treasury securities
One to five years	$	4,965	$	4,934
Total	4,965		4,934
US government agencies
Within one year	6,510		6,472
One to five years	27,088		26,603
Total	33,598		33,075
Residential mortgage-backed securities
One to five years	3,806		3,617
Five to ten years	48,752		47,673
After 10 years	291,857		284,985
Total	344,415		336,275
Total	$	382,978	$	374,284

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses (Tables)

9 Months Ended

Sep. 30, 2018

Receivables [Abstract]

Composition of Loans and Leases

Loans and leases consist of the following:

	September 30, 2018			December 31, 2017
Commercial & Industrial
Agriculture	$	4,980		$	3,274
Death Care Management	16,665			13,495
Healthcare	47,324			43,301
Independent Pharmacies	108,026			99,920
Registered Investment Advisors	91,334			93,770
Veterinary Industry	47,821			46,387
Other Industries	216,157			184,903
Total	532,307			485,050
Construction & Development
Agriculture	31,213			34,188
Death Care Management	9,366			6,119
Healthcare	71,429			49,770
Independent Pharmacies	2,314			1,496
Registered Investment Advisors	1,276			376
Veterinary Industry	19,522			13,184
Other Industries	78,807			58,120
Total	213,927			163,253
Commercial Real Estate
Agriculture	52,353			46,717
Death Care Management	69,514			67,381
Healthcare	167,365			126,631
Independent Pharmacies	18,872			19,028
Registered Investment Advisors	8,121			11,789
Veterinary Industry	122,537			113,932
Other Industries	233,856			134,172
Total	672,618			519,650
Commercial Land
Agriculture	220,326			178,897
Total	220,326			178,897
Total Loans and Leases1	1,639,178			1,346,850
Net Deferred Costs	7,336			8,545
Discount on SBA 7(a) and USDA Unguaranteed2	(15,177		)	(11,422		)
Loans and Leases, Net of Unearned	$	1,631,337		$	1,343,973

1 Total loans and leases include $192.4 million and $99.7 million of U.S. government guaranteed loans as of September 30, 2018 and December 31, 2017, respectively.

2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales.

Summary of Risk Grades of Each Category of Loans

The following tables summarize the risk grades of each category:

	Risk Grades 1 - 4		Risk Grade 5		Risk Grades 6 - 8		Total
September 30, 2018
Commercial & Industrial
Agriculture	$	4,775	$	205	$	—	$	4,980
Death Care Management	16,464		195		6		16,665
Healthcare	37,035		3,179		7,110		47,324
Independent Pharmacies	92,735		4,545		10,746		108,026
Registered Investment Advisors	86,713		1,407		3,214		91,334
Veterinary Industry	44,374		1,171		2,276		47,821
Other Industries	198,875		15,860		1,422		216,157
Total	480,971		26,562		24,774		532,307
Construction & Development
Agriculture	31,213		—		—		31,213
Death Care Management	9,366		—		—		9,366
Healthcare	67,862		1,420		2,147		71,429
Independent Pharmacies	2,314		—		—		2,314
Registered Investment Advisors	1,276		—		—		1,276
Veterinary Industry	19,522		—		—		19,522
Other Industries	78,807		—		—		78,807
Total	210,360		1,420		2,147		213,927
Commercial Real Estate
Agriculture	51,786		567		—		52,353
Death Care Management	62,600		3,823		3,091		69,514
Healthcare	141,583		7,682		18,100		167,365
Independent Pharmacies	12,959		3,369		2,544		18,872
Registered Investment Advisors	7,993		128		—		8,121
Veterinary Industry	102,781		4,869		14,887		122,537
Other Industries	231,798		2,058		—		233,856
Total	611,500		22,496		38,622		672,618
Commercial Land
Agriculture	200,608		8,514		11,204		220,326
Total	200,608		8,514		11,204		220,326
Total1	$	1,503,439	$	58,992	$	76,747	$	1,639,178

	Risk Grades 1 - 4		Risk Grade 5		Risk Grades 6 - 8		Total
December 31, 2017
Commercial & Industrial
Agriculture	$	3,052	$	222	$	—	$	3,274
Death Care Management	13,371		117		7		13,495
Healthcare	36,530		2,246		4,525		43,301
Independent Pharmacies	86,152		5,541		8,227		99,920
Registered Investment Advisors	90,911		2,134		725		93,770
Veterinary Industry	42,313		1,704		2,370		46,387
Other Industries	184,540		363		—		184,903
Total	456,869		12,327		15,854		485,050
Construction & Development
Agriculture	31,738		2,450		—		34,188
Death Care Management	6,119		—		—		6,119
Healthcare	47,813		699		1,258		49,770
Independent Pharmacies	1,496		—		—		1,496
Registered Investment Advisors	376		—		—		376
Veterinary Industry	13,184		—		—		13,184
Other Industries	58,120		—		—		58,120
Total	158,846		3,149		1,258		163,253
Commercial Real Estate
Agriculture	46,717		—		—		46,717
Death Care Management	60,671		3,881		2,829		67,381
Healthcare	112,321		9,992		4,318		126,631
Independent Pharmacies	15,641		1,825		1,562		19,028
Registered Investment Advisors	11,649		140		—		11,789
Veterinary Industry	97,065		2,948		13,919		113,932
Other Industries	133,493		679		—		134,172
Total	477,557		19,465		22,628		519,650
Commercial Land
Agriculture	176,811		2,086		—		178,897
Total	176,811		2,086		—		178,897
Total1	$	1,270,083	$	37,027	$	39,740	$	1,346,850

1 Total loans and leases include $192.4 million of U.S. government guaranteed loans as of September 30, 2018, segregated by risk grade as follows: Risk Grades 1 – 4 = $126.4 million, Risk Grade 5 = $9.9 million, Risk Grades 6 – 8 = $56.1 million. As of December 31, 2017, total loans and leases include $99.7 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $65.0 million, Risk Grade 5 = $6.7 million, Risk Grades 6 – 8 = $28.0 million.

Age Analysis of Past Due Loans and Leases

The following tables show an age analysis of past due loans and leases as of the dates presented.

	Less Than 30 Days Past Due & Not Accruing		30-89 Days Past Due & Accruing		30-89 Days Past Due & Not Accruing		90 Days or More Past Due		Total Not Accruing & Past Due		Current		Total Loans and Leases		90 Days or More Past Due & Still Accruing
September 30, 2018
Commercial & Industrial
Agriculture	$	—	$	—	$	—	$	—	$	—	$	4,980	$	4,980	$	—
Death Care Management	—		74		—		—		74		16,591		16,665		—
Healthcare	44		2,874		687		2,680		6,285		41,039		47,324		—
Independent Pharmacies	—		—		3,869		6,573		10,442		97,584		108,026		—
Registered Investment Advisors	—		241		—		2,856		3,097		88,237		91,334		—
Veterinary Industry	162		—		569		796		1,527		46,294		47,821		—
Other Industries	—		1,123		—		651		1,774		214,383		216,157		—
Total	206		4,312		5,125		13,556		23,199		509,108		532,307		—
Construction & Development
Agriculture	—		—		—		—		—		31,213		31,213		—
Death Care Management	—		—		—		—		—		9,366		9,366		—
Healthcare	—		2,147		—		—		2,147		69,282		71,429		—
Independent Pharmacies	—		—		—		—		—		2,314		2,314		—
Registered Investment Advisors	—		—		—		—		—		1,276		1,276		—
Veterinary Industry	—		—		—		—		—		19,522		19,522		—
Other Industries	—		—		—		—		—		78,807		78,807		—
Total	—		2,147		—		—		2,147		211,780		213,927		—
Commercial Real Estate
Agriculture	—		—		—		—		—		52,353		52,353		—
Death Care Management	153		—		—		2,789		2,942		66,572		69,514		—
Healthcare	44		687		—		7,134		7,865		159,500		167,365		—
Independent Pharmacies	—		446		—		2,544		2,990		15,882		18,872		—
Registered Investment Advisors	—		—		—		—		—		8,121		8,121		—
Veterinary Industry	1,709		3,173		—		8,246		13,128		109,409		122,537		—
Other Industries	—		—		—		—		—		233,856		233,856		—
Total	1,906		4,306		—		20,713		26,925		645,693		672,618		—
Commercial Land
Agriculture	6,288		—		2,482		2,433		11,203		209,123		220,326		—
Total	6,288		—		2,482		2,433		11,203		209,123		220,326		—
Total1	$	8,400	$	10,765	$	7,607	$	36,702	$	63,474	$	1,575,704	$	1,639,178	$	—

	Less Than  30 Days Past Due & Not Accruing		30-89 Days Past Due & Accruing		30-89 Days Past Due & Not Accruing		90 Days or More Past Due		Total Not Accruing & Past Due		Current		Total Loans and Leases		90 Days or More Past Due & Still Accruing
December 31, 2017
Commercial & Industrial
Agriculture	$	—	$	—	$	—	$	—	$	—	$	3,274	$	3,274	$	—
Death Care Management	—		—		—		—		—		13,495		13,495		—
Healthcare	788		131		14		3,004		3,937		39,364		43,301		—
Independent Pharmacies	236		2,930		1,349		3,376		7,891		92,029		99,920		—
Registered Investment Advisors	—		321		—		—		321		93,449		93,770		—
Veterinary Industry	212		594		508		797		2,111		44,276		46,387		—
Other Industries	—		—		—		—		—		184,903		184,903		—
Total	1,236		3,976		1,871		7,177		14,260		470,790		485,050		—
Construction & Development
Agriculture	—		—		—		—		—		34,188		34,188		—
Death Care Management	—		—		—		—		—		6,119		6,119		—
Healthcare	—		—		—		—		—		49,770		49,770		—
Independent Pharmacies	—		—		—		—		—		1,496		1,496		—
Registered Investment Advisors	—		—		—		—		—		376		376		—
Veterinary Industry	—		—		—		—		—		13,184		13,184		—
Other Industries	—		—		—		—		—		58,120		58,120		—
Total	—		—		—		—		—		163,253		163,253		—
Commercial Real Estate
Agriculture	—		—		—		—		—		46,717		46,717		—
Death Care Management	—		—		168		1,391		1,559		65,822		67,381		—
Healthcare	40		54		1,916		1,550		3,560		123,071		126,631		—
Independent Pharmacies	—		—		—		1,562		1,562		17,466		19,028		—
Registered Investment Advisors	—		—		—		—		—		11,789		11,789		—
Veterinary Industry	1,804		3,226		—		4,765		9,795		104,137		113,932		—
Other Industries	—		—		—		—		—		134,172		134,172		—
Total	1,844		3,280		2,084		9,268		16,476		503,174		519,650		—
Commercial Land
Agriculture	—		—		—		—		—		178,897		178,897		—
Total	—		—		—		—		—		178,897		178,897		—
Total1	$	3,080	$	7,256	$	3,955	$	16,445	$	30,736	$	1,316,114	$	1,346,850	$	—

1 Total loans and leases include $192.4 million of U.S. government guaranteed loans as of September 30, 2018, of which $30.3 million is greater than 90 days past due, $12.3 million is 30-89 days past due and $149.8 million is included in current loans and leases as presented above. As of December 31, 2017, total loans and leases include $99.7 million of U.S. government guaranteed loans, of which $15.0 million is greater than 90 days past due, $7.4 million is 30-89 days past due and $77.3 million is included in current loans and leases as presented above.

Nonaccrual Loans and Leases

Nonaccrual loans and leases as of September 30, 2018 and December 31, 2017 are as follows:

September 30, 2018	Loan and Lease Balance		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Healthcare	$	3,411	$	3,085	$	326
Independent Pharmacies	10,442		9,214		1,228
Registered Investment Advisors	2,856		2,536		320
Veterinary Industry	1,527		1,381		146
Other Industries	651		488		163
Total	18,887		16,704		2,183
Commercial Real Estate
Death Care Management	2,942		2,282		660
Healthcare	7,178		4,751		2,427
Independent Pharmacies	2,544		2,126		418
Veterinary Industry	9,955		8,452		1,503
Total	22,619		17,611		5,008
Commercial Land
Agriculture	11,203		5,497		5,706
Total	11,203		5,497		5,706
Total	$	52,709	$	39,812	$	12,897

December 31, 2017	Loan and Lease Balance		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Healthcare	$	3,806	$	3,235	$	571
Independent Pharmacies	4,961		3,906		1,055
Veterinary Industry	1,517		1,478		39
Total	10,284		8,619		1,665
Commercial Real Estate
Death Care Management	1,559		1,237		322
Healthcare	3,506		2,719		787
Independent Pharmacies	1,562		1,562		—
Veterinary Industry	6,569		5,733		836
Total	13,196		11,251		1,945
Total	$	23,480	$	19,870	$	3,610

Activity in the Allowance for Loan and Lease Losses by Portfolio Segment

The following table details activity in the allowance for loan and lease losses by portfolio segment allowance for the periods presented:

Three months ended	Construction & Development			Commercial Real Estate			Commercial & Industrial			Commercial Land			Total
September 30, 2018
Beginning Balance	$	2,227		$	11,408		$	13,377		$	2,338		$	29,350
Charge offs	—			(397		)	(1,966		)	(106		)	(2,469		)
Recoveries	—			141			18			—			159
Provision	(555		)	(1,115		)	(148		)	1,575			(243		)
Ending Balance	$	1,672		$	10,037		$	11,281		$	3,807		$	26,797
September 30, 2017
Beginning Balance	$	1,603		$	7,494		$	8,351		$	2,112		$	19,560
Charge offs	—			(665		)	(343		)	—			(1,008		)
Recoveries	—			4			39			6			49
Provision	36			1,565			827			(2		)	2,426
Ending Balance	$	1,639		$	8,398		$	8,874		$	2,116		$	21,027

Nine months ended	Construction & Development			Commercial Real Estate			Commercial & Industrial			Commercial Land			Total
September 30, 2018
Beginning Balance	$	2,030		$	9,180		$	10,751		$	2,229		$	24,190
Charge offs	—			(816		)	(3,187		)	(106		)	(4,109		)
Recoveries	—			174			306			—			480
Provision	(358		)	1,499			3,411			1,684			6,236
Ending Balance	$	1,672		$	10,037		$	11,281		$	3,807		$	26,797
September 30, 2017
Beginning Balance	$	1,693		$	5,897		$	8,413		$	2,206		$	18,209
Charge offs	—			(952		)	(1,754		)	(35		)	(2,741		)
Recoveries	—			17			55			6			78
Provision	(54		)	3,436			2,160			(61		)	5,481
Ending Balance	$	1,639		$	8,398		$	8,874		$	2,116		$	21,027

The following tables detail the recorded allowance for loan and lease losses and the investment in loans and leases related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology:

September 30, 2018	Construction & Development		Commercial Real Estate		Commercial & Industrial		Commercial Land		Total
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	$	11	$	2,141	$	1,344	$	3,140	$	6,636
Loans and leases collectively evaluated for impairment2	1,661		7,896		9,937		667		20,161
Total allowance for loan and lease losses	$	1,672	$	10,037	$	11,281	$	3,807	$	26,797
Loans and leases receivable1:
Loans and leases individually evaluated for impairment	$	2,172	$	34,842	$	12,520	$	21,755	$	71,289
Loans and leases collectively evaluated for impairment2	211,755		637,776		519,787		198,571		1,567,889
Total loans and leases receivable	$	213,927	$	672,618	$	532,307	$	220,326	$	1,639,178

December 31, 2017	Construction & Development		Commercial Real Estate		Commercial & Industrial		Commercial Land		Total
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	$	157	$	1,502	$	1,126	$	—	$	2,785
Loans and leases collectively evaluated for impairment2	1,873		7,678		9,625		2,229		21,405
Total allowance for loan and lease losses	$	2,030	$	9,180	$	10,751	$	2,229	$	24,190
Loans and leases receivable1:
Loans and leases individually evaluated for impairment	$	1,237	$	17,105	$	8,672	$	—	$	27,014
Loans and leases collectively evaluated for impairment2	162,016		502,545		476,378		178,897		1,319,836
Total loans and leases receivable	$	163,253	$	519,650	$	485,050	$	178,897	$	1,346,850

1 Loans and leases receivable includes $192.4 million of U.S. government guaranteed loans as of September 30, 2018, of which $63.3 million are impaired. As of December 31, 2017, loans and leases receivable includes $99.7 million of U.S. government guaranteed loans, of which $28.1 million are considered impaired.

2 Included in loans and leases collectively evaluated for impairment are impaired loans and leases with individual unguaranteed exposure of less than $100 thousand. As of September 30, 2018, these balances totaled $17.3 million, of which $15.9 million are guaranteed by the U.S. government and $1.4 million are unguaranteed. As of December 31, 2017, these balances totaled $14.8 million, of which $13.2 million are guaranteed by the U.S. government and $1.6 million are unguaranteed.The allowance for loan and lease losses associated with these loans and leases totaled $397 thousand and $279 thousand as of September 30, 2018 and December 31, 2017, respectively.

Impaired Loans and Leases

The following table presents evaluated balances of loans and leases classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan and lease fees or costs.

	September 30, 2018
	Recorded Investment
	With a Recorded Allowance		With No Recorded Allowance		Total		Unpaid Principal Balance		Related Allowance Recorded
Commercial & Industrial
Death Care Management	$	—	$	6	$	6	$	6	$	—
Healthcare	7,093		66		7,159		7,402		416
Independent Pharmacies	9,758		299		10,057		11,680		415
Registered Investment Advisors	3,217		—		3,217		3,740		513
Veterinary Industry	2,259		123		2,382		2,657		129
Other Industries	979		456		1,435		1,998		213
Total	23,306		950		24,256		27,483		1,686
Construction & Development
Healthcare	2,172		—		2,172		2,147		11
Total	2,172		—		2,172		2,147		11
Commercial Real Estate
Death Care Management	2,786		302		3,088		3,226		16
Healthcare	18,523		234		18,757		18,751		1,174
Independent Pharmacies	2,543		—		2,543		2,835		14
Veterinary Industry	15,867		110		15,977		16,955		992
Total	39,719		646		40,365		41,767		2,196
Commercial Land
Agriculture	21,563		192		21,755		21,764		3,140
Total	21,563		192		21,755		21,764		3,140
Total Impaired Loans and Leases	$	86,760	$	1,788	$	88,548	$	93,161	$	7,033

	December 31, 2017
	Recorded Investment
	With a Recorded Allowance		With No Recorded Allowance		Total		Unpaid Principal Balance		Related Allowance Recorded
Commercial & Industrial
Death Care Management	$	—	$	7	$	7	$	7	$	—
Healthcare	3,521		1,030		4,551		5,643		165
Independent Pharmacies	8,154		417		8,571		9,078		521
Registered Investment Advisors	662		71		733		725		504
Veterinary Industry	2,505		257		2,762		3,113		182
Total	14,842		1,782		16,624		18,566		1,372
Construction & Development
Healthcare	1,237		—		1,237		1,258		157
Total	1,237		—		1,237		1,258		157
Commercial Real Estate
Death Care Management	2,221		610		2,831		2,964		260
Healthcare	3,717		598		4,315		4,332		192
Independent Pharmacies	1,562		—		1,562		1,933		8
Veterinary Industry	13,711		1,555		15,266		16,584		1,075
Total	21,211		2,763		23,974		25,813		1,535
Commercial Land
Agriculture	—		—		—		58		—
Total	—		—		—		58		—
Total Impaired Loans and Leases	$	37,290	$	4,545	$	41,835	$	45,695	$	3,064

The following table presents the average recorded investment of impaired loans and leases for each period presented and interest income recognized during the period in which the loans and leases were considered impaired.

	Three months ended September 30, 2018				Three months ended September 30, 2017
	Average Balance		Interest Income Recognized		Average Balance		Interest Income Recognized
Commercial & Industrial
Death Care Management	$	6	$	—	$	42	$	1
Healthcare	7,152		28		7,076		11
Independent Pharmacies	10,325		4		4,266		26
Registered Investment Advisors	3,589		7		894		14
Veterinary Industry	2,423		16		2,511		11
Other Industries	1,822		17		—		—
Total	25,317		72		14,789		63
Construction & Development
Healthcare	2,162		12		602		2
Total	2,162		12		602		2
Commercial Real Estate
Death Care Management	3,098		24		2,512		13
Healthcare	18,765		150		3,079		11
Independent Pharmacies	2,739		—		1,985		—
Veterinary Industry	16,731		98		13,950		132
Total	41,333		272		21,526		156
Commercial Land
Agriculture	21,792		38		23		—
Total	21,792		38		23		—
Total	$	90,604	$	394	$	36,940	$	221

	Nine months ended September 30, 2018				Nine months ended September 30, 2017
	Average Balance		Interest Income Recognized		Average Balance		Interest Income Recognized
Commercial & Industrial
Death Care Management	$	7	$	—	$	313	$	3
Healthcare	7,232		59		4,996		25
Independent Pharmacies	10,180		31		7,998		52
Registered Investment Advisors	3,007		31		1,438		28
Veterinary Industry	2,488		54		4,329		24
Other Industries	1,875		22		—		—
Total	24,789		197		19,074		132
Construction & Development
Healthcare	2,162		63		120		2
Total	2,162		63		120		2
Commercial Real Estate
Death Care Management	3,115		88		2,030		30
Healthcare	17,535		230		2,940		24
Independent Pharmacies	2,763		1		149		—
Veterinary Industry	17,081		333		13,069		278
Total	40,494		652		18,188		332
Commercial Land
Agriculture	21,803		68		199		—
Total	21,803		68		199		—
Total	$	89,248	$	980	$	37,581	$	466

Loans and leases classified as impaired as of the dates presented are summarized in the following tables.

September 30, 2018	Recorded Investment		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Death Care Management	$	6	$	—	$	6
Healthcare	7,159		5,488		1,671
Independent Pharmacies	10,057		8,458		1,599
Registered Investment Advisors	3,217		2,536		681
Veterinary Industry	2,382		1,861		521
Other Industries	1,435		648		787
Total	24,256		18,991		5,265
Construction & Development
Healthcare	2,172		1,610		562
Total	2,172		1,610		562
Commercial Real Estate
Death Care Management	3,088		2,282		806
Healthcare	18,757		13,275		5,482
Independent Pharmacies	2,543		2,126		417
Veterinary Industry	15,977		11,815		4,162
Total	40,365		29,498		10,867
Commercial Land
Agriculture	21,755		13,199		8,556
Total	21,755		13,199		8,556
Total	$	88,548	$	63,298	$	25,250

December 31, 2017	Recorded Investment		Guaranteed Balance		Unguaranteed Exposure
Commercial & Industrial
Death Care Management	$	7	$	—	$	7
Healthcare	4,551		3,235		1,316
Independent Pharmacies	8,571		6,356		2,215
Registered Investment Advisors	733		—		733
Veterinary Industry	2,762		2,001		761
Total	16,624		11,592		5,032
Construction & Development
Healthcare	1,237		944		293
Total	1,237		944		293
Commercial Real Estate
Death Care Management	2,831		1,237		1,594
Healthcare	4,315		2,967		1,348
Independent Pharmacies	1,562		1,562		—
Veterinary Industry	15,266		9,768		5,498
Total	23,974		15,534		8,440
Commercial Land
Agriculture	—		—		—
Total	—		—		—
Total	$	41,835	$	28,070	$	13,765

Troubled Debt Restructurings on Financing Receivables

The following tables represent the types of TDRs that were made during the periods presented:

	Three months ended September 30, 2018					Three months ended September 30, 2017
	All Restructurings					All Restructurings
	Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment		Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment
Interest Only and Rate Concession
Commercial Land
Agriculture	4	$	10,276	$	10,276	—	$	—	$	—
Total Interest Only and Rate Concession	4	10,276		10,276		—	—		—
Extended Amortization
Commercial Land
Agriculture	1	8		8		—	—		—
Total Extended Amortization	1	8		8		—	—		—
Payment Deferral
Commercial & Industrial
Veterinary Industry	—	—		—		2	559		559
Total Payment Deferral	—	—		—		2	559		559
Total	5	$	10,284	$	10,284	2	$	559	$	559

	Nine months ended September 30, 2018					Nine months ended September 30, 2017
	All Restructurings					All Restructurings
	Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment		Number of Loans	Pre- modification Recorded Investment		Post- modification Recorded Investment
Interest Only
Construction and Development
Healthcare	1	$	612	$	612	—	$	—	$	—
Total Interest Only	1	612		612		—	—		—
Interest Only and Rate Concession
Commercial Land
Agriculture	4	10,276		10,276		—	—		—
Total Interest Only and Rate Concession	4	10,276		10,276		—	—		—
Extended Amortization
Commercial Land
Agriculture	1	8		8		—	—		—
Total Extended Amortization	1	8		8		—	—		—
Payment Deferral and Extended Amortization
Commercial & Industrial
Independent Pharmacies	—	—		—		1	262		262
Total Payment Deferral and Extended Amortization	—	—		—		1	262		262
Payment Deferral
Commercial & Industrial
Veterinary Industry	—	—		—		2	559		559
Total Payment Deferral	—	—		—		2	559		559
Total	6	$	10,896	$	10,896	3	$	821	$	821

XML

Equipment Leasing (Tables)

9 Months Ended

Sep. 30, 2018

Leases [Abstract]

Net Lease Investment

The gross lease payments receivable and the net investment included in accounts receivable for such leases are as follows:

	As of
	September 30, 2018			December 31, 2017
Gross direct finance lease payments receivable	$	6,548		$	2,399
Less – unearned interest	(1,116		)	(373		)
Net investment in direct financing leases	$	5,432		$	2,026

Future Minimum Capital Lease Payments

Future minimum lease payments under finance leases are as follows:

As of September 30, 2018	Amount
2018	$	325
2019	1,384
2020	1,373
2021	1,287
2022	1,107
Thereafter	1,072
Total	$	6,548

Future Minimum Operating Lease Payments

A maturity analysis of future minimum lease payments under non-cancelable operating leases is as follows:

As of September 30, 2018	Amount
2018	$	1,765
2019	8,284
2020	8,341
2021	8,385
2022	8,417
Thereafter	53,939
Total	$	89,131

XML

Servicing Assets (Tables)

9 Months Ended

Sep. 30, 2018

Transfers and Servicing [Abstract]

Summary of Activity Pertaining to Servicing Rights

The following summarizes the activity pertaining to servicing rights:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
Balance at beginning of period	$	52,689		$	53,675		$	52,298		$	51,994
Additions, net	5,558			3,527			14,634			9,412
Fair value changes:
Due to changes in valuation inputs or assumptions	(5,336		)	(789		)	(7,336		)	342
Decay due to increases in principal paydowns or runoff	(3,650		)	(3,021		)	(10,335		)	(8,356		)
Balance at end of period	$	49,261		$	53,392		$	49,261		$	53,392

XML

Borrowings (Tables)

9 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Total Outstanding Short and Long-Term Borrowings

Total outstanding short and long term borrowings consisted of the following:

	September 30, 2018		December 31, 2017
Short term borrowings
On October 20, 2017, the Company entered into a revolving line of credit of $20 million with an unaffiliated commercial bank. The note is unsecured and accrues interest at LIBOR plus 1.750% for a term of 12 months. Payments are interest only with all principal and accrued interest due on October 19, 2018. On October 2, 2018, the Company renewed the revolving line of credit for an additional 12 months with a maturity date of October 18, 2019. The terms of this loan require the Company to maintain minimum capital and debt service coverage ratios. No advances have been made to this line of credit and there is $20 million of available credit remaining at September 30, 2018.	$	—	$	—
On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank. On April 18, 2017, the Company renewed and increased the revolving line of credit to $25 million. The note is unsecured and accrues interest at Prime minus 0.50% for a term of 24 months. Payments are interest only with all principal and accrued interest due on April 30, 2019. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. This line of credit was paid in full on August 25, 2017, and there is $25 million of available credit remaining at September 30, 2018.	—		—
Total short term borrowings	$	—	$	—

	September 30, 2018		December 31, 2017
Long term borrowings
On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus with a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments were interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments of $146 thousand began in October 2016 with all principal and accrued interest due on September 11, 2021. This note was repaid in full on January 31, 2018.	$	—	$	22,990
On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. One of the loans with an outstanding balance of $1.3 million was paid in full on August 17, 2018. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at September 30, 2018 is 6.00%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $1.5 million at September 30, 2018. Underlying loan carries a risk grade of 3 and is current with no delinquencies.	1,489		3,574
In October 2017, the Company entered into a capital lease of $19 thousand with an unaffiliated equipment lease company, secured by fitness equipment which is included in premises and equipment on the consolidated balance sheet. Payments are principal and interest due monthly starting December 15, 2017 over a term of 60 months. At the end of the lease term there is a $1.00 bargain purchase option.	17		—
Total long term borrowings	$	1,506	$	26,564

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Record Amount of Assets and Liabilities Measured at Fair Value on a Recurring Basis

The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis.

September 30, 2018	Total		Level 1		Level 2		Level 3
Investment securities available-for-sale
US treasury securities	$	4,934	$	—	$	4,934	$	—
US government agencies	33,075		—		33,075		—
Residential mortgage-backed securities	336,275		—		336,275		—
Servicing assets1	49,261		—		—		49,261
Mutual fund	2,068		—		2,068		—
Equity warrant assets	538		—		—		538
Total assets at fair value	$	426,151	$	—	$	376,352	$	49,799

December 31, 2017	Total		Level 1		Level 2		Level 3
Investment securities available-for-sale
US government agencies	$	22,624	$	—	$	22,624	$	—
Residential mortgage-backed securities	68,696		—		68,696		—
Mutual fund	2,035		—		2,035		—
Servicing assets1	52,298		—		—		52,298
Total assets at fair value	$	145,653	$	—	$	93,355	$	52,298
Contingent consideration liability2	$	1,900	$	—	$	—	$	1,900
Total liabilities at fair value	$	1,900	$	—	$	—	$	1,900

1 See Note 7 for a rollforward of recurring Level 3 fair values for servicing assets and various assumptions used in the fair value measurement.

2 Activity for the contingent consideration liability during the three months ended September 30, 2018 consisted of a $1.6 million write-off as a result of the disposition of Reltco during the quarter. During the nine months ended September 30, 2018, the Company recorded a $260 thousand negative fair value adjustment and $1.6 million write-off as a result of the disposition of Reltco. There was no activity for the contingent consideration liability during the three months ended September 30, 2017. During the nine months ended September 30, 2017, $4.3 million of contingent consideration was recorded upon the acquisition of Reltco as well as $350 thousand positive fair value adjustments.

Recorded Amount of Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis.

September 30, 2018	Total		Level 1		Level 2		Level 3
Impaired loans and leases	$	79,727	$	—	$	—	$	79,727
Foreclosed assets	1,429		—		—		1,429
Total assets at fair value	$	81,156	$	—	$	—	$	81,156

December 31, 2017	Total		Level 1		Level 2		Level 3
Impaired loans and leases	$	34,493	$	—	$	—	$	34,493
Foreclosed assets	1,281		—		—		1,281
Total assets at fair value	$	35,774	$	—	$	—	$	35,774

Analysis of Level 3 Valuation Techniques

For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of September 30, 2018 and December 31, 2017 the significant unobservable inputs used in the fair value measurements were as follows:

September 30, 2018

Level 3 Assets with Significant Unobservable Inputs	Fair Value		Valuation Technique	Significant Unobservable Inputs	Range
Impaired loans and leases	$	79,727	Discounted appraisals Discounted expected cash flows	Appraisal adjustments (1) Interest rate & repayment term	10% to 48% Weighted average discount rate 6.16%
Foreclosed assets	$	1,429	Discounted appraisals	Appraisal adjustments (1)	9% to 37%
Equity warrant assets	$	538	Black-Scholes option pricing model	Volatility Risk-free interest rate Marketability discount Remaining life	20.00% 2.85% 20% 9-10 years

December 31, 2017

Level 3 Assets with Significant Unobservable Inputs	Fair Value		Valuation Technique	Significant Unobservable Inputs	Range
Impaired loans and leases	$	34,493	Discounted appraisals Discounted expected cash flows	Appraisal adjustments (1) Interest rate & repayment term	10% to 25% Weighted average discount rate 6.26%
Foreclosed assets	$	1,281	Discounted appraisals	Appraisal adjustments (1)	10% to 37%
Contingent consideration liability	$	1,900	Monte Carlo simulation	Volatility Risk-free rate of return Dividend yield Remaining life	25.00% 1.43% 0.51% 3.00 years

(1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments.

Carrying Amount and Estimated Fair Value of Financial Instruments

The carrying amounts and estimated fair values of the Company’s financial instruments are as follows:

September 30, 2018	Carrying Amount		Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
Financial assets
Cash and due from banks	$	368,565	$	368,565	$	—	$	—	$	368,565
Certificates of deposit with other banks	750		748		—		—		748
Investment securities, available-for-sale	374,284		—		374,284		—		374,284
Loans held for sale(1)	646,475		—		—		649,054		649,054
Loans and leases, net of allowance for loan and lease losses(1)	1,604,540		—		—		1,594,589		1,594,589
Servicing assets	49,261		—		—		49,261		49,261
Accrued interest receivable	14,147		14,147		—		—		14,147
Financial liabilities
Deposits	2,924,288		—		2,871,159		—		2,871,159
Accrued interest payable	410		410		—		—		410
Long term borrowings	1,506		—		—		1,507		1,507

December 31, 2017	Carrying Amount		Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Fair Value
Financial assets
Cash and due from banks	$	295,271	$	295,271	$	—	$	—	$	295,271
Certificates of deposit with other banks	3,000		2,993		—		—		2,993
Investment securities, available-for-sale	93,355		—		93,355		—		93,355
Loans held for sale (1)	680,454		—		—		706,972		706,972
Loans and leases, net of allowance for loan and lease losses(1)	1,319,783		—		—		1,319,615		1,319,615
Servicing assets	52,298		—		—		52,298		52,298
Accrued interest receivable	10,160		10,160		—		—		10,160
Financial liabilities
Deposits	2,260,263		—		2,232,370		—		2,232,370
Accrued interest payable	367		367		—		—		367
Long term borrowings	26,564		—		—		27,390		27,390

(1) In accordance with the adoption of ASU 2016-01, as of September 30, 2018, the fair value of loans and leases were measured using an exit price notion. As of December 31, 2017, the fair value of loans and leases were measured using an entry price notion.

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Summary of Commitments

A summary of the Company’s commitments is as follows:

	September 30, 2018		December 31, 2017
Commitments to extend credit	$	1,432,771	$	1,701,137
Standby letters of credit	2,279		2,298
Solar purchase commitments	10,158		106,921
Airplane purchase agreement commitments	10,450		25,450
Total unfunded off-balance-sheet credit risk	$	1,455,658	$	1,835,806

XML

Stock Plans (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Option Activity

Stock option activity under the Plan during the nine month periods ended September 30, 2018 and 2017 is summarized below.

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at December 31, 2017	3,058,459	$	11.30
Exercised	171,333	9.26
Forfeited	174,845	13.69
Granted	—	—
Outstanding at September 30, 2018	2,712,281	$	11.27	6.28 years	$	47,005,905
Exercisable at September 30, 2018	813,730	$	10.67	6.11 years	$	14,587,733

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at December 31, 2016	3,478,208	$	11.51
Exercised	76,285	7.89
Forfeited	203,671	14.12
Granted	—	—
Outstanding at September 30, 2017	3,198,252	$	11.43	7.31 years	$	38,411,802
Exercisable at September 30, 2017	703,425	$	10.41	7.06 years	$	9,171,805

Summary of Non-vested Stock Option Activity

The following is a summary of non-vested stock option activity for the Company for the nine months ended September 30, 2018 and 2017.

	Shares		Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	2,364,999		$	4.65
Granted	—		—
Vested	(291,603	)	3.95
Forfeited	(174,845	)	5.98
Non-vested at September 30, 2018	1,898,551		4.63

	Shares		Weighted Average Grant Date Fair Value
Non-vested at December 31, 2016	3,016,100		$	4.78
Granted	—		—
Vested	(317,602	)	4.17
Forfeited	(203,671	)	6.03
Non-vested at September 30, 2017	2,494,827		4.75

Restricted Stock Unit Activity

Market RSU stock activity under the Plan during the first nine months of 2018 is summarized below.

	Shares	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	2,532,808	$	8.78
Granted	485,000	15.73
Vested	—	—
Forfeited	223,128	9.08
Non-vested at September 30, 2018	2,794,680	9.96

RSU stock activity under the Plan during the first nine months of 2018 is summarized below.

	Shares	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	181,814	$	20.03
Granted	230,599	28.72
Vested	83,829	23.68
Forfeited	38,793	22.96
Non-vested at September 30, 2018	289,791	25.50

XML

Basis of Presentation - Narrative (Details) $ in Thousands			3 Months Ended				9 Months Ended		12 Months Ended
	Aug. 01, 2018 USD ($)	Feb. 01, 2017 business	Sep. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)		Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($) Segment	Sep. 30, 2017 USD ($)	Dec. 31, 2018 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)
Schedule of Equity Method Investments [Line Items]
Number of businesses acquired | business		2
Number of significant operation segments | Segment							1
Term of warrant							10 years
Loans and receivable, allowance			$ 26,797	$ 24,190	[1]	$ 21,027	$ 26,797	$ 21,027		$ 29,350	$ 19,560	$ 18,209
Impairment expense on goodwill and other intangibles, net			2,680			$ 0	2,680	$ 0
Apiture
Schedule of Equity Method Investments [Line Items]
Equity method investments			$ 68,000	68,000			$ 68,000
Reltco, Inc. and National Assurance Title
Schedule of Equity Method Investments [Line Items]
Loans receivable, net	$ 3,000
Loans and receivable, allowance	3,000
Impairment expense on goodwill and other intangibles, net	$ 2,700
First Data | Apiture
Schedule of Equity Method Investments [Line Items]
Cash earnings preference, maximum amount				$ 18,000
Scenario, Forecast | First Data | Apiture
Schedule of Equity Method Investments [Line Items]
Cash earnings preference, maximum amount									$ 18,900

[1] Derived from audited consolidated financial statements.

XML

Recent Accounting Pronouncements Recent Accounting Pronouncements (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($)
Accounting Policies [Abstract]
Reclassification of accumulated other comprehensive income due to tax rate change	$ 244

XML

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Basic earnings per share:
Net income available to common shareholders	$ 14,252	$ 12,862	$ 40,958	$ 28,769
Weighted-average basic shares outstanding (in shares)	40,119,561	37,366,041	40,025,265	35,485,371
Basic earnings per share (in dollars per share)	$ 0.36	$ 0.34	$ 1.02	$ 0.81
Diluted earnings per share:
Net income available to common shareholders, for diluted earnings per share	$ 14,252	$ 12,862	$ 40,958	$ 28,769
Total weighted-average basic shares outstanding (in shares)	40,119,561	37,366,041	40,025,265	35,485,371
Add effect of dilutive stock options and restricted stock grants (in shares)	1,568,869	1,278,636	1,561,722	1,244,683
Total weighted-average diluted shares outstanding (in shares)	41,688,430	38,644,677	41,586,987	36,730,054
Diluted earnings per share (in dollars per share)	$ 0.34	$ 0.33	$ 0.98	$ 0.78
Anti-dilutive shares (in shares)	0	243,199	0	250,698

XML

Investment Securities - Carrying Amount and Fair Value of Investment Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 382,978
Unrealized Gains	14
Unrealized Losses	8,708
Investment securities available-for-sale	374,284	$ 93,355	[1]
Available-for-sale, Amortized Cost		95,035
Available-for-sale, Unrealized Gains		4
Available-for-sale, Unrealized Losses		1,684
Available-for-sale, Fair Value		93,355
US treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	4,965
Unrealized Gains	0
Unrealized Losses	31
Investment securities available-for-sale	4,934
US government agencies
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	33,598	22,778
Unrealized Gains	0	3
Unrealized Losses	523	157
Investment securities available-for-sale	33,075	22,624
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	344,415	70,167
Unrealized Gains	14	1
Unrealized Losses	8,154	1,472
Investment securities available-for-sale	$ 336,275	68,696
Mutual fund
Debt Securities, Available-for-sale [Line Items]
Equity securities, Amortized Cost		2,090
Equity securities, Unrealized Gains		0
Equity securities, Unrealized Losses		55
Equity securities, Fair Value		$ 2,035

[1] Derived from audited consolidated financial statements.

XML

Investment Securities - Gross Unrealized Losses and Fair Value of Securities in a Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Debt Securities, Available-for-sale [Line Items]
Securities in unrealized loss position, less than 12 months, fair value	$ 317,552
Securities in unrealized loss position, less than 12 months, unrealized losses	5,943
Securities in unrealized loss position, 12 months or more, fair value	54,284
Securities in unrealized loss position, 12 months or more, unrealized losses	2,765
Securities in unrealized loss position, fair value	371,836
Securities in unrealized loss position, unrealized losses	8,708
Securities in unrealized loss position, less than 12 months, fair value		$ 38,323
Securities in unrealized loss position, less than 12 months, unrealized losses		539
Securities in unrealized loss position, 12 months or more, fair value		49,148
Securities in unrealized loss position, 12 months or more, unrealized losses		1,145
Securities in unrealized loss position, fair value		87,471
Securities in unrealized loss position, unrealized losses		1,684
US treasury securities
Debt Securities, Available-for-sale [Line Items]
Securities in unrealized loss position, less than 12 months, fair value	4,934
Securities in unrealized loss position, less than 12 months, unrealized losses	31
Securities in unrealized loss position, 12 months or more, fair value	0
Securities in unrealized loss position, 12 months or more, unrealized losses	0
Securities in unrealized loss position, fair value	4,934
Securities in unrealized loss position, unrealized losses	31
US government agencies
Debt Securities, Available-for-sale [Line Items]
Securities in unrealized loss position, less than 12 months, fair value	26,603	14,842
Securities in unrealized loss position, less than 12 months, unrealized losses	486	100
Securities in unrealized loss position, 12 months or more, fair value	6,472	6,465
Securities in unrealized loss position, 12 months or more, unrealized losses	37	57
Securities in unrealized loss position, fair value	33,075	21,307
Securities in unrealized loss position, unrealized losses	523	157
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Securities in unrealized loss position, less than 12 months, fair value	286,015	23,481
Securities in unrealized loss position, less than 12 months, unrealized losses	5,426	439
Securities in unrealized loss position, 12 months or more, fair value	47,812	40,648
Securities in unrealized loss position, 12 months or more, unrealized losses	2,728	1,033
Securities in unrealized loss position, fair value	333,827	64,129
Securities in unrealized loss position, unrealized losses	$ 8,154	1,472
Mutual fund
Debt Securities, Available-for-sale [Line Items]
Securities in unrealized loss position, less than 12 months, fair value		0
Securities in unrealized loss position, less than 12 months, unrealized losses		0
Securities in unrealized loss position, 12 months or more, fair value		2,035
Securities in unrealized loss position, 12 months or more, unrealized losses		55
Securities in unrealized loss position, fair value		2,035
Securities in unrealized loss position, unrealized losses		$ 55

XML

Investment Securities - Narrative (Details)	9 Months Ended
	Sep. 30, 2018 USD ($) Security	Dec. 31, 2017 USD ($) Security
Debt Securities, Available-for-sale [Line Items]
Other than temporary impairment losses | $	$ 0
Collateral Pledged | Ohio State Treasurer
Debt Securities, Available-for-sale [Line Items]
Debt securities, available-for-sale, restricted | $	98,000	$ 100,000
Collateral Pledged | Trust Department
Debt Securities, Available-for-sale [Line Items]
Debt securities, available-for-sale, restricted | $	$ 2,500,000	$ 2,500,000
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Number of securities in unrealized loss portions for longer than 12 months	29	23
Number of securities in unrealized loss positions for less than 12 months	40	8
US government agencies
Debt Securities, Available-for-sale [Line Items]
Number of securities in unrealized loss portions for longer than 12 months	3	3
Number of securities in unrealized loss positions for less than 12 months	8	5
US treasury securities
Debt Securities, Available-for-sale [Line Items]
Number of securities in unrealized loss positions for less than 12 months	1

XML

Investment Securities - Summary of Investment Securities by Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
Amortized Cost	$ 382,978
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Total, fair value	374,284	$ 93,355	[1]
US treasury securities
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
One to five years, amortized cost	4,965
Amortized Cost	4,965
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
One to five years, fair value	4,934
Total, fair value	4,934
US government agencies
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
Within one year, amortized cost	6,510
One to five years, amortized cost	27,088
Amortized Cost	33,598	22,778
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Within one year, fair value	6,472
One to five years, fair value	26,603
Total, fair value	33,075	22,624
Residential mortgage-backed securities
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
One to five years, amortized cost	3,806
Five to ten years, amortized cost	48,752
After 10 years, amortized cost	291,857
Amortized Cost	344,415	70,167
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
One to five years, fair value	3,617
Five to ten years, fair value	47,673
After 10 years, fair value	284,985
Total, fair value	336,275	$ 68,696
Excluding Mutual Fund
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
Amortized Cost	382,978
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Total, fair value	$ 374,284

[1] Derived from audited consolidated financial statements.

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Composition of Loans and Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	$ 1,639,178	$ 1,346,850
Net Deferred Costs	7,336	8,545
Discount on SBA 7(a) and USDA Unguaranteed	(15,177)	(11,422)
Loans and Leases, Net of Unearned	1,631,337	1,343,973	[1]
Loans Insured or Guaranteed by US Government Authorities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	192,400	99,700
Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	532,307	485,050
Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	213,927	163,253
Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	672,618	519,650
Commercial Land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	220,326	178,897
Agriculture | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	4,980	3,274
Agriculture | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	31,213	34,188
Agriculture | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	52,353	46,717
Agriculture | Commercial Land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	220,326	178,897
Death Care Management | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	16,665	13,495
Death Care Management | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	9,366	6,119
Death Care Management | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	69,514	67,381
Healthcare | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	47,324	43,301
Healthcare | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	71,429	49,770
Healthcare | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	167,365	126,631
Independent Pharmacies | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	108,026	99,920
Independent Pharmacies | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	2,314	1,496
Independent Pharmacies | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	18,872	19,028
Registered Investment Advisors | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	91,334	93,770
Registered Investment Advisors | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	1,276	376
Registered Investment Advisors | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	8,121	11,789
Veterinary Industry | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	47,821	46,387
Veterinary Industry | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	19,522	13,184
Veterinary Industry | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	122,537	113,932
Other Industries | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	216,157	184,903
Other Industries | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	78,807	58,120
Other Industries | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	$ 233,856	$ 134,172

[1] Derived from audited consolidated financial statements.

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Credit Risk Profile (Details)	9 Months Ended
	Sep. 30, 2018 Score
Minimum | Loans (1 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	2.0
Credit score	750
Minimum | Loans (2 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	1.74
Credit score	724
Minimum | Loans (3 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	1.24
Maximum | Loans (4 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash flow coverage	1.00

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Summary of Risk Grades of Each Category of Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	$ 1,639,178	$ 1,346,850
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	192,400	99,700
Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,503,439	1,270,083
Risk Grades 1 - 4 | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	126,400	65,000
Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	58,992	37,027
Risk Grade 5 | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	9,900	6,700
Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	76,747	39,740
Risk Grades 6 - 8 | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	56,100	28,000
Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	532,307	485,050
Commercial & Industrial | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	480,971	456,869
Commercial & Industrial | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	26,562	12,327
Commercial & Industrial | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	24,774	15,854
Commercial & Industrial | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	4,980	3,274
Commercial & Industrial | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	4,775	3,052
Commercial & Industrial | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	205	222
Commercial & Industrial | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Commercial & Industrial | Death Care Management
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	16,665	13,495
Commercial & Industrial | Death Care Management | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	16,464	13,371
Commercial & Industrial | Death Care Management | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	195	117
Commercial & Industrial | Death Care Management | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	6	7
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	47,324	43,301
Commercial & Industrial | Healthcare | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	37,035	36,530
Commercial & Industrial | Healthcare | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	3,179	2,246
Commercial & Industrial | Healthcare | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	7,110	4,525
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	108,026	99,920
Commercial & Industrial | Independent Pharmacies | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	92,735	86,152
Commercial & Industrial | Independent Pharmacies | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	4,545	5,541
Commercial & Industrial | Independent Pharmacies | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	10,746	8,227
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	91,334	93,770
Commercial & Industrial | Registered Investment Advisors | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	86,713	90,911
Commercial & Industrial | Registered Investment Advisors | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,407	2,134
Commercial & Industrial | Registered Investment Advisors | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	3,214	725
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	47,821	46,387
Commercial & Industrial | Veterinary Industry | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	44,374	42,313
Commercial & Industrial | Veterinary Industry | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,171	1,704
Commercial & Industrial | Veterinary Industry | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,276	2,370
Commercial & Industrial | Other Industries
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	216,157	184,903
Commercial & Industrial | Other Industries | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	198,875	184,540
Commercial & Industrial | Other Industries | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	15,860	363
Commercial & Industrial | Other Industries | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,422	0
Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	213,927	163,253
Construction & Development | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	210,360	158,846
Construction & Development | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,420	3,149
Construction & Development | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,147	1,258
Construction & Development | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	31,213	34,188
Construction & Development | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	31,213	31,738
Construction & Development | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	2,450
Construction & Development | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Death Care Management
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	9,366	6,119
Construction & Development | Death Care Management | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	9,366	6,119
Construction & Development | Death Care Management | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Death Care Management | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Healthcare
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	71,429	49,770
Construction & Development | Healthcare | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	67,862	47,813
Construction & Development | Healthcare | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,420	699
Construction & Development | Healthcare | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,147	1,258
Construction & Development | Independent Pharmacies
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,314	1,496
Construction & Development | Independent Pharmacies | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,314	1,496
Construction & Development | Independent Pharmacies | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Independent Pharmacies | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Registered Investment Advisors
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,276	376
Construction & Development | Registered Investment Advisors | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,276	376
Construction & Development | Registered Investment Advisors | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Registered Investment Advisors | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Veterinary Industry
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	19,522	13,184
Construction & Development | Veterinary Industry | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	19,522	13,184
Construction & Development | Veterinary Industry | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Veterinary Industry | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Other Industries
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	78,807	58,120
Construction & Development | Other Industries | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	78,807	58,120
Construction & Development | Other Industries | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Construction & Development | Other Industries | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	672,618	519,650
Commercial Real Estate | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	611,500	477,557
Commercial Real Estate | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	22,496	19,465
Commercial Real Estate | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	38,622	22,628
Commercial Real Estate | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	52,353	46,717
Commercial Real Estate | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	51,786	46,717
Commercial Real Estate | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	567	0
Commercial Real Estate | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Commercial Real Estate | Death Care Management
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	69,514	67,381
Commercial Real Estate | Death Care Management | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	62,600	60,671
Commercial Real Estate | Death Care Management | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	3,823	3,881
Commercial Real Estate | Death Care Management | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	3,091	2,829
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	167,365	126,631
Commercial Real Estate | Healthcare | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	141,583	112,321
Commercial Real Estate | Healthcare | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	7,682	9,992
Commercial Real Estate | Healthcare | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	18,100	4,318
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	18,872	19,028
Commercial Real Estate | Independent Pharmacies | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	12,959	15,641
Commercial Real Estate | Independent Pharmacies | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	3,369	1,825
Commercial Real Estate | Independent Pharmacies | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,544	1,562
Commercial Real Estate | Registered Investment Advisors
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,121	11,789
Commercial Real Estate | Registered Investment Advisors | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	7,993	11,649
Commercial Real Estate | Registered Investment Advisors | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	128	140
Commercial Real Estate | Registered Investment Advisors | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	122,537	113,932
Commercial Real Estate | Veterinary Industry | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	102,781	97,065
Commercial Real Estate | Veterinary Industry | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	4,869	2,948
Commercial Real Estate | Veterinary Industry | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	14,887	13,919
Commercial Real Estate | Other Industries
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	233,856	134,172
Commercial Real Estate | Other Industries | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	231,798	133,493
Commercial Real Estate | Other Industries | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,058	679
Commercial Real Estate | Other Industries | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	0	0
Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	220,326	178,897
Commercial Land | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	200,608	176,811
Commercial Land | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,514	2,086
Commercial Land | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	11,204	0
Commercial Land | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	220,326	178,897
Commercial Land | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	200,608	176,811
Commercial Land | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,514	2,086
Commercial Land | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	$ 11,204	$ 0

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Age Analysis of Past Due Loans and Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	$ 63,474	$ 30,736
Current	1,575,704	1,316,114
Total loans and leases receivable	1,639,178	1,346,850
90 days or more past due & still accruing	0	0
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	149,800	77,300
Total loans and leases receivable	192,400	99,700
Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	8,400	3,080
30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	10,765	7,256
30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	7,607	3,955
90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	36,702	16,445
90 Days or More Past Due | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	30,300	15,000
Financing Receivables 30 To 89 Days Past Due | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	12,300	7,400
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	23,199	14,260
Current	509,108	470,790
Total loans and leases receivable	532,307	485,050
90 days or more past due & still accruing	0	0
Commercial & Industrial | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	206	1,236
Commercial & Industrial | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	4,312	3,976
Commercial & Industrial | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	5,125	1,871
Commercial & Industrial | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	13,556	7,177
Commercial & Industrial | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	4,980	3,274
Total loans and leases receivable	4,980	3,274
90 days or more past due & still accruing	0	0
Commercial & Industrial | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Agriculture | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	74	0
Current	16,591	13,495
Total loans and leases receivable	16,665	13,495
90 days or more past due & still accruing	0	0
Commercial & Industrial | Death Care Management | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Death Care Management | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	74	0
Commercial & Industrial | Death Care Management | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Death Care Management | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	6,285	3,937
Current	41,039	39,364
Total loans and leases receivable	47,324	43,301
90 days or more past due & still accruing	0	0
Commercial & Industrial | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	44	788
Commercial & Industrial | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,874	131
Commercial & Industrial | Healthcare | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	687	14
Commercial & Industrial | Healthcare | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,680	3,004
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	10,442	7,891
Current	97,584	92,029
Total loans and leases receivable	108,026	99,920
90 days or more past due & still accruing	0	0
Commercial & Industrial | Independent Pharmacies | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	236
Commercial & Industrial | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	2,930
Commercial & Industrial | Independent Pharmacies | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	3,869	1,349
Commercial & Industrial | Independent Pharmacies | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	6,573	3,376
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	3,097	321
Current	88,237	93,449
Total loans and leases receivable	91,334	93,770
90 days or more past due & still accruing	0	0
Commercial & Industrial | Registered Investment Advisors | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Registered Investment Advisors | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	241	321
Commercial & Industrial | Registered Investment Advisors | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Registered Investment Advisors | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,856	0
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	1,527	2,111
Current	46,294	44,276
Total loans and leases receivable	47,821	46,387
90 days or more past due & still accruing	0	0
Commercial & Industrial | Veterinary Industry | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	162	212
Commercial & Industrial | Veterinary Industry | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	594
Commercial & Industrial | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	569	508
Commercial & Industrial | Veterinary Industry | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	796	797
Commercial & Industrial | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	1,774	0
Current	214,383	184,903
Total loans and leases receivable	216,157	184,903
90 days or more past due & still accruing	0	0
Commercial & Industrial | Other Industries | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	1,123	0
Commercial & Industrial | Other Industries | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial & Industrial | Other Industries | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	651	0
Construction & Development
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,147	0
Current	211,780	163,253
Total loans and leases receivable	213,927	163,253
90 days or more past due & still accruing	0	0
Construction & Development | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,147	0
Construction & Development | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	31,213	34,188
Total loans and leases receivable	31,213	34,188
90 days or more past due & still accruing	0	0
Construction & Development | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Agriculture | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	9,366	6,119
Total loans and leases receivable	9,366	6,119
90 days or more past due & still accruing	0	0
Construction & Development | Death Care Management | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Death Care Management | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Death Care Management | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Death Care Management | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,147	0
Current	69,282	49,770
Total loans and leases receivable	71,429	49,770
90 days or more past due & still accruing	0	0
Construction & Development | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,147	0
Construction & Development | Healthcare | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Healthcare | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	2,314	1,496
Total loans and leases receivable	2,314	1,496
90 days or more past due & still accruing	0	0
Construction & Development | Independent Pharmacies | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Independent Pharmacies | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Independent Pharmacies | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	1,276	376
Total loans and leases receivable	1,276	376
90 days or more past due & still accruing	0	0
Construction & Development | Registered Investment Advisors | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Registered Investment Advisors | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Registered Investment Advisors | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Registered Investment Advisors | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	19,522	13,184
Total loans and leases receivable	19,522	13,184
90 days or more past due & still accruing	0	0
Construction & Development | Veterinary Industry | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Veterinary Industry | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Veterinary Industry | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	78,807	58,120
Total loans and leases receivable	78,807	58,120
90 days or more past due & still accruing	0	0
Construction & Development | Other Industries | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Other Industries | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Construction & Development | Other Industries | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	26,925	16,476
Current	645,693	503,174
Total loans and leases receivable	672,618	519,650
90 days or more past due & still accruing	0	0
Commercial Real Estate | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	1,906	1,844
Commercial Real Estate | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	4,306	3,280
Commercial Real Estate | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	2,084
Commercial Real Estate | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	20,713	9,268
Commercial Real Estate | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	52,353	46,717
Total loans and leases receivable	52,353	46,717
90 days or more past due & still accruing	0	0
Commercial Real Estate | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Agriculture | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,942	1,559
Current	66,572	65,822
Total loans and leases receivable	69,514	67,381
90 days or more past due & still accruing	0	0
Commercial Real Estate | Death Care Management | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	153	0
Commercial Real Estate | Death Care Management | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Death Care Management | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	168
Commercial Real Estate | Death Care Management | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,789	1,391
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	7,865	3,560
Current	159,500	123,071
Total loans and leases receivable	167,365	126,631
90 days or more past due & still accruing	0	0
Commercial Real Estate | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	44	40
Commercial Real Estate | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	687	54
Commercial Real Estate | Healthcare | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	1,916
Commercial Real Estate | Healthcare | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	7,134	1,550
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,990	1,562
Current	15,882	17,466
Total loans and leases receivable	18,872	19,028
90 days or more past due & still accruing	0	0
Commercial Real Estate | Independent Pharmacies | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	446	0
Commercial Real Estate | Independent Pharmacies | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Independent Pharmacies | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,544	1,562
Commercial Real Estate | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	8,121	11,789
Total loans and leases receivable	8,121	11,789
90 days or more past due & still accruing	0	0
Commercial Real Estate | Registered Investment Advisors | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Registered Investment Advisors | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Registered Investment Advisors | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Registered Investment Advisors | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	13,128	9,795
Current	109,409	104,137
Total loans and leases receivable	122,537	113,932
90 days or more past due & still accruing	0	0
Commercial Real Estate | Veterinary Industry | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	1,709	1,804
Commercial Real Estate | Veterinary Industry | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	3,173	3,226
Commercial Real Estate | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Veterinary Industry | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	8,246	4,765
Commercial Real Estate | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Current	233,856	134,172
Total loans and leases receivable	233,856	134,172
90 days or more past due & still accruing	0	0
Commercial Real Estate | Other Industries | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Other Industries | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Real Estate | Other Industries | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	11,203	0
Current	209,123	178,897
Total loans and leases receivable	220,326	178,897
90 days or more past due & still accruing	0	0
Commercial Land | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	6,288	0
Commercial Land | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Land | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,482	0
Commercial Land | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,433	0
Commercial Land | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	11,203	0
Current	209,123	178,897
Total loans and leases receivable	220,326	178,897
90 days or more past due & still accruing	0	0
Commercial Land | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	6,288	0
Commercial Land | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	0	0
Commercial Land | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	2,482	0
Commercial Land | Agriculture | 90 Days or More Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	$ 2,433	$ 0

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Nonaccrual Loans and Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Financing Receivable, Recorded Investment, Past Due [Line Items]
Theoretical increase in interest if interest on nonaccrual loans had been accrued in accordance with original terms	$ 800	$ 302	$ 1,800	$ 831
Nonaccrual loans and leases balance	52,709		52,709		$ 23,480
Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	39,812		39,812		19,870
Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	12,897		12,897		3,610
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	18,887		18,887		10,284
Commercial & Industrial | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	16,704		16,704		8,619
Commercial & Industrial | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,183		2,183		1,665
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	3,411		3,411		3,806
Commercial & Industrial | Healthcare | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	3,085		3,085		3,235
Commercial & Industrial | Healthcare | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	326		326		571
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	10,442		10,442		4,961
Commercial & Industrial | Independent Pharmacies | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	9,214		9,214		3,906
Commercial & Industrial | Independent Pharmacies | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,228		1,228		1,055
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,856		2,856
Commercial & Industrial | Registered Investment Advisors | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,536		2,536
Commercial & Industrial | Registered Investment Advisors | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	320		320
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,527		1,527		1,517
Commercial & Industrial | Veterinary Industry | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,381		1,381		1,478
Commercial & Industrial | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	146		146		39
Commercial & Industrial | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	651		651
Commercial & Industrial | Other Industries | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	488		488
Commercial & Industrial | Other Industries | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	163		163
Commercial Real Estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	22,619		22,619		13,196
Commercial Real Estate | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	17,611		17,611		11,251
Commercial Real Estate | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,008		5,008		1,945
Commercial Real Estate | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,942		2,942		1,559
Commercial Real Estate | Death Care Management | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,282		2,282		1,237
Commercial Real Estate | Death Care Management | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	660		660		322
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	7,178		7,178		3,506
Commercial Real Estate | Healthcare | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	4,751		4,751		2,719
Commercial Real Estate | Healthcare | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,427		2,427		787
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,544		2,544		1,562
Commercial Real Estate | Independent Pharmacies | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,126		2,126		1,562
Commercial Real Estate | Independent Pharmacies | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	418		418		0
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	9,955		9,955		6,569
Commercial Real Estate | Veterinary Industry | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	8,452		8,452		5,733
Commercial Real Estate | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,503		1,503		$ 836
Commercial Land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	11,203		11,203
Commercial Land | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,497		5,497
Commercial Land | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,706		5,706
Commercial Land | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	11,203		11,203
Commercial Land | Agriculture | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,497		5,497
Commercial Land | Agriculture | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	$ 5,706		$ 5,706

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Allowance for Loan and Lease Loss Methodology (Details)	Sep. 30, 2018 USD ($)
Receivables [Abstract]
Credit exposure threshold	$ 100,000

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Activity in the Allowance for Loan and Lease Losses by Portfolio Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018		Sep. 30, 2017
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	$ 29,350	$ 19,560	$ 24,190	[1]	$ 18,209
Charge offs	(2,469)	(1,008)	(4,109)		(2,741)
Recoveries	159	49	480		78
Provision	(243)	2,426	6,236		5,481
Allowance for Loan Losses, Ending Balance	26,797	21,027	26,797		21,027
Construction & Development
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	2,227	1,603	2,030		1,693
Charge offs	0	0	0		0
Recoveries	0	0	0		0
Provision	(555)	36	(358)		(54)
Allowance for Loan Losses, Ending Balance	1,672	1,639	1,672		1,639
Commercial Real Estate
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	11,408	7,494	9,180		5,897
Charge offs	(397)	(665)	(816)		(952)
Recoveries	141	4	174		17
Provision	(1,115)	1,565	1,499		3,436
Allowance for Loan Losses, Ending Balance	10,037	8,398	10,037		8,398
Commercial & Industrial
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	13,377	8,351	10,751		8,413
Charge offs	(1,966)	(343)	(3,187)		(1,754)
Recoveries	18	39	306		55
Provision	(148)	827	3,411		2,160
Allowance for Loan Losses, Ending Balance	11,281	8,874	11,281		8,874
Commercial Land
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	2,338	2,112	2,229		2,206
Charge offs	(106)	0	(106)		(35)
Recoveries	0	6	0		6
Provision	1,575	(2)	1,684		(61)
Allowance for Loan Losses, Ending Balance	$ 3,807	$ 2,116	$ 3,807		$ 2,116

[1] Derived from audited consolidated financial statements.

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Recorded Allowance for Loan Loans Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2017		Sep. 30, 2017	Jun. 30, 2017	Dec. 31, 2016
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	$ 6,636		$ 2,785
Loans and leases collectively evaluated for impairment	20,161		21,405
Total allowance for loan and lease losses	26,797	$ 29,350	24,190	[1]	$ 21,027	$ 19,560	$ 18,209
Loans and Leases Receivable :
Loans and leases individually evaluated for impairment	71,289		27,014
Loans and leases collectively evaluated for impairment	1,567,889		1,319,836
Total loans and leases receivable	1,639,178		1,346,850
Loans collectively evaluated for Impairment, unguaranteed credit exposure Less Than $100,000	17,300		14,800
Loans collectively evaluated for impairment, unguaranteed credit exposure less than $100,000, allowance	397		279
Loans Insured or Guaranteed by US Government Authorities
Loans and Leases Receivable :
Loans and leases individually evaluated for impairment	63,300		28,100
Total loans and leases receivable	192,400		99,700
Loans collectively evaluated for Impairment, unguaranteed credit exposure Less Than $100,000	15,900		13,200
Unguaranteed Exposure
Loans and Leases Receivable :
Loans collectively evaluated for Impairment, unguaranteed credit exposure Less Than $100,000	1,400		1,600
Construction & Development
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	11		157
Loans and leases collectively evaluated for impairment	1,661		1,873
Total allowance for loan and lease losses	1,672	2,227	2,030		1,639	1,603	1,693
Loans and Leases Receivable :
Loans and leases individually evaluated for impairment	2,172		1,237
Loans and leases collectively evaluated for impairment	211,755		162,016
Total loans and leases receivable	213,927		163,253
Commercial Real Estate
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	2,141		1,502
Loans and leases collectively evaluated for impairment	7,896		7,678
Total allowance for loan and lease losses	10,037	11,408	9,180		8,398	7,494	5,897
Loans and Leases Receivable :
Loans and leases individually evaluated for impairment	34,842		17,105
Loans and leases collectively evaluated for impairment	637,776		502,545
Total loans and leases receivable	672,618		519,650
Commercial & Industrial
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	1,344		1,126
Loans and leases collectively evaluated for impairment	9,937		9,625
Total allowance for loan and lease losses	11,281	13,377	10,751		8,874	8,351	8,413
Loans and Leases Receivable :
Loans and leases individually evaluated for impairment	12,520		8,672
Loans and leases collectively evaluated for impairment	519,787		476,378
Total loans and leases receivable	532,307		485,050
Commercial Land
Allowance for Loan and Lease Losses:
Loans and leases individually evaluated for impairment	3,140		0
Loans and leases collectively evaluated for impairment	667		2,229
Total allowance for loan and lease losses	3,807	$ 2,338	2,229		$ 2,116	$ 2,112	$ 2,206
Loans and Leases Receivable :
Loans and leases individually evaluated for impairment	21,755		0
Loans and leases collectively evaluated for impairment	198,571		178,897
Total loans and leases receivable	$ 220,326		$ 178,897

[1] Derived from audited consolidated financial statements.

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Loans and Leases Classified as Impaired (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Financing Receivable, Impaired [Line Items]
Impaired loans	$ 88,548	$ 41,835
Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Impaired loans	24,256	16,624
Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	6	7
Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	7,159	4,551
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	10,057	8,571
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Impaired loans	3,217	733
Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	2,382	2,762
Commercial & Industrial | Other Industries
Financing Receivable, Impaired [Line Items]
Impaired loans	1,435
Construction & Development
Financing Receivable, Impaired [Line Items]
Impaired loans	2,172	1,237
Construction & Development | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	2,172	1,237
Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Impaired loans	40,365	23,974
Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	3,088	2,831
Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	18,757	4,315
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	2,543	1,562
Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	15,977	15,266
Commercial Land
Financing Receivable, Impaired [Line Items]
Impaired loans	21,755	0
Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	21,755	0
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	63,298	28,070
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Impaired loans	18,991	11,592
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	0	0
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	5,488	3,235
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	8,458	6,356
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Impaired loans	2,536	0
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	1,861	2,001
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Other Industries
Financing Receivable, Impaired [Line Items]
Impaired loans	648
Loans Insured or Guaranteed by US Government Authorities | Construction & Development
Financing Receivable, Impaired [Line Items]
Impaired loans	1,610	944
Loans Insured or Guaranteed by US Government Authorities | Construction & Development | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	1,610	944
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Impaired loans	29,498	15,534
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	2,282	1,237
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	13,275	2,967
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	2,126	1,562
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	11,815	9,768
Loans Insured or Guaranteed by US Government Authorities | Commercial Land
Financing Receivable, Impaired [Line Items]
Impaired loans	13,199	0
Loans Insured or Guaranteed by US Government Authorities | Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	13,199	0
Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	25,250	13,765
Unguaranteed Exposure | Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Impaired loans	5,265	5,032
Unguaranteed Exposure | Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	6	7
Unguaranteed Exposure | Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	1,671	1,316
Unguaranteed Exposure | Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	1,599	2,215
Unguaranteed Exposure | Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Impaired loans	681	733
Unguaranteed Exposure | Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	521	761
Unguaranteed Exposure | Commercial & Industrial | Other Industries
Financing Receivable, Impaired [Line Items]
Impaired loans	787
Unguaranteed Exposure | Construction & Development
Financing Receivable, Impaired [Line Items]
Impaired loans	562	293
Unguaranteed Exposure | Construction & Development | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	562	293
Unguaranteed Exposure | Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Impaired loans	10,867	8,440
Unguaranteed Exposure | Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	806	1,594
Unguaranteed Exposure | Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	5,482	1,348
Unguaranteed Exposure | Commercial Real Estate | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	417	0
Unguaranteed Exposure | Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	4,162	5,498
Unguaranteed Exposure | Commercial Land
Financing Receivable, Impaired [Line Items]
Impaired loans	8,556	0
Unguaranteed Exposure | Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	$ 8,556	$ 0

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Impaired Loans and Leases With Associated Reserves and No Associated Reserves (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	$ 86,760		$ 86,760		$ 37,290
Recorded Investment, With No Recorded Allowance	1,788		1,788		4,545
Recorded Investment, Total	88,548		88,548		41,835
Loans, Unpaid Principal Balance	93,161		93,161		45,695
Loans, Related Allowance Recorded	7,033		7,033		3,064
Loans, Average Balance	90,604	$ 36,940	89,248	$ 37,581
Loans, Interest Income Recognized	394	221	980	466
Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	23,306		23,306		14,842
Recorded Investment, With No Recorded Allowance	950		950		1,782
Recorded Investment, Total	24,256		24,256		16,624
Loans, Unpaid Principal Balance	27,483		27,483		18,566
Loans, Related Allowance Recorded	1,686		1,686		1,372
Loans, Average Balance	25,317	14,789	24,789	19,074
Loans, Interest Income Recognized	72	63	197	132
Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	0		0		0
Recorded Investment, With No Recorded Allowance	6		6		7
Recorded Investment, Total	6		6		7
Loans, Unpaid Principal Balance	6		6		7
Loans, Related Allowance Recorded	0		0		0
Loans, Average Balance	6	42	7	313
Loans, Interest Income Recognized	0	1	0	3
Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	7,093		7,093		3,521
Recorded Investment, With No Recorded Allowance	66		66		1,030
Recorded Investment, Total	7,159		7,159		4,551
Loans, Unpaid Principal Balance	7,402		7,402		5,643
Loans, Related Allowance Recorded	416		416		165
Loans, Average Balance	7,152	7,076	7,232	4,996
Loans, Interest Income Recognized	28	11	59	25
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	9,758		9,758		8,154
Recorded Investment, With No Recorded Allowance	299		299		417
Recorded Investment, Total	10,057		10,057		8,571
Loans, Unpaid Principal Balance	11,680		11,680		9,078
Loans, Related Allowance Recorded	415		415		521
Loans, Average Balance	10,325	4,266	10,180	7,998
Loans, Interest Income Recognized	4	26	31	52
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	3,217		3,217		662
Recorded Investment, With No Recorded Allowance	0		0		71
Recorded Investment, Total	3,217		3,217		733
Loans, Unpaid Principal Balance	3,740		3,740		725
Loans, Related Allowance Recorded	513		513		504
Loans, Average Balance	3,589	894	3,007	1,438
Loans, Interest Income Recognized	7	14	31	28
Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,259		2,259		2,505
Recorded Investment, With No Recorded Allowance	123		123		257
Recorded Investment, Total	2,382		2,382		2,762
Loans, Unpaid Principal Balance	2,657		2,657		3,113
Loans, Related Allowance Recorded	129		129		182
Loans, Average Balance	2,423	2,511	2,488	4,329
Loans, Interest Income Recognized	16	11	54	24
Commercial & Industrial | Other Industries
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	979		979
Recorded Investment, With No Recorded Allowance	456		456
Recorded Investment, Total	1,435		1,435
Loans, Unpaid Principal Balance	1,998		1,998
Loans, Related Allowance Recorded	213		213
Loans, Average Balance	1,822	0	1,875	0
Loans, Interest Income Recognized	17	0	22	0
Construction & Development
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,172		2,172		1,237
Recorded Investment, With No Recorded Allowance	0		0		0
Recorded Investment, Total	2,172		2,172		1,237
Loans, Unpaid Principal Balance	2,147		2,147		1,258
Loans, Related Allowance Recorded	11		11		157
Loans, Average Balance	2,162	602	2,162	120
Loans, Interest Income Recognized	12	2	63	2
Construction & Development | Healthcare
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,172		2,172		1,237
Recorded Investment, With No Recorded Allowance	0		0		0
Recorded Investment, Total	2,172		2,172		1,237
Loans, Unpaid Principal Balance	2,147		2,147		1,258
Loans, Related Allowance Recorded	11		11		157
Loans, Average Balance	2,162	602	2,162	120
Loans, Interest Income Recognized	12	2	63	2
Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	39,719		39,719		21,211
Recorded Investment, With No Recorded Allowance	646		646		2,763
Recorded Investment, Total	40,365		40,365		23,974
Loans, Unpaid Principal Balance	41,767		41,767		25,813
Loans, Related Allowance Recorded	2,196		2,196		1,535
Loans, Average Balance	41,333	21,526	40,494	18,188
Loans, Interest Income Recognized	272	156	652	332
Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,786		2,786		2,221
Recorded Investment, With No Recorded Allowance	302		302		610
Recorded Investment, Total	3,088		3,088		2,831
Loans, Unpaid Principal Balance	3,226		3,226		2,964
Loans, Related Allowance Recorded	16		16		260
Loans, Average Balance	3,098	2,512	3,115	2,030
Loans, Interest Income Recognized	24	13	88	30
Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	18,523		18,523		3,717
Recorded Investment, With No Recorded Allowance	234		234		598
Recorded Investment, Total	18,757		18,757		4,315
Loans, Unpaid Principal Balance	18,751		18,751		4,332
Loans, Related Allowance Recorded	1,174		1,174		192
Loans, Average Balance	18,765	3,079	17,535	2,940
Loans, Interest Income Recognized	150	11	230	24
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,543		2,543		1,562
Recorded Investment, With No Recorded Allowance	0		0		0
Recorded Investment, Total	2,543		2,543		1,562
Loans, Unpaid Principal Balance	2,835		2,835		1,933
Loans, Related Allowance Recorded	14		14		8
Loans, Average Balance	2,739	1,985	2,763	149
Loans, Interest Income Recognized	0	0	1	0
Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	15,867		15,867		13,711
Recorded Investment, With No Recorded Allowance	110		110		1,555
Recorded Investment, Total	15,977		15,977		15,266
Loans, Unpaid Principal Balance	16,955		16,955		16,584
Loans, Related Allowance Recorded	992		992		1,075
Loans, Average Balance	16,731	13,950	17,081	13,069
Loans, Interest Income Recognized	98	132	333	278
Commercial Land
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	21,563		21,563		0
Recorded Investment, With No Recorded Allowance	192		192		0
Recorded Investment, Total	21,755		21,755		0
Loans, Unpaid Principal Balance	21,764		21,764		58
Loans, Related Allowance Recorded	3,140		3,140		0
Loans, Average Balance	21,792	23	21,803	199
Loans, Interest Income Recognized	38	0	68	0
Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	21,563		21,563		0
Recorded Investment, With No Recorded Allowance	192		192		0
Recorded Investment, Total	21,755		21,755		0
Loans, Unpaid Principal Balance	21,764		21,764		58
Loans, Related Allowance Recorded	3,140		3,140		$ 0
Loans, Average Balance	21,792	23	21,803	199
Loans, Interest Income Recognized	$ 38	$ 0	$ 68	$ 0

XML

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Schedule of Troubled Debt Restructurings (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($) SecurityLoan	Sep. 30, 2017 USD ($) SecurityLoan	Sep. 30, 2018 USD ($) SecurityLoan	Sep. 30, 2017 USD ($) SecurityLoan
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan	5	2	6	3
Pre-modification recorded investment	$ 10,284	$ 559	$ 10,896	$ 821
Post-modification recorded investment	$ 10,284	$ 559	$ 10,896	$ 821
Interest Only
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan			1	0
Pre-modification recorded investment			$ 612	$ 0
Post-modification recorded investment			$ 612	$ 0
Interest Only | Construction & Development | Healthcare
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan			1	0
Pre-modification recorded investment			$ 612	$ 0
Post-modification recorded investment			$ 612	$ 0
Interest Only and Rate Concession
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan	4	0	4	0
Pre-modification recorded investment	$ 10,276	$ 0	$ 10,276	$ 0
Post-modification recorded investment	$ 10,276	$ 0	$ 10,276	$ 0
Interest Only and Rate Concession | Commercial Land | Agriculture
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan	4	0	4	0
Pre-modification recorded investment	$ 10,276	$ 0	$ 10,276	$ 0
Post-modification recorded investment	$ 10,276	$ 0	$ 10,276	$ 0
Extended Amortization
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan	1	0	1	0
Pre-modification recorded investment	$ 8	$ 0	$ 8	$ 0
Post-modification recorded investment	$ 8	$ 0	$ 8	$ 0
Extended Amortization | Commercial Land | Agriculture
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan	1	0	1	0
Pre-modification recorded investment	$ 8	$ 0	$ 8	$ 0
Post-modification recorded investment	$ 8	$ 0	$ 8	$ 0
Payment Deferral and Extended Amortization
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan			0	1
Pre-modification recorded investment			$ 0	$ 262
Post-modification recorded investment			$ 0	$ 262
Payment Deferral and Extended Amortization | Commercial & Industrial | Independent Pharmacies
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan			0	1
Pre-modification recorded investment			$ 0	$ 262
Post-modification recorded investment			$ 0	$ 262
Payment Deferral
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan	0	2	0	2
Pre-modification recorded investment	$ 0	$ 559	$ 0	$ 559
Post-modification recorded investment	$ 0	$ 559	$ 0	$ 559
Payment Deferral | Commercial & Industrial | Veterinary Industry
Financing Receivable, Modifications [Line Items]
Number of contracts | SecurityLoan	0	2	0	2
Pre-modification recorded investment	$ 0	$ 559	$ 0	$ 559
Post-modification recorded investment	$ 0	$ 559	$ 0	$ 559

XML

Equipment Leasing - Additional Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($) term	Sep. 30, 2017 USD ($)
Lessor, Lease, Description [Line Items]
Direct financing lease, interest income	$ 100	$ 14	$ 220	$ 21
Number of additional terms | term			2
Premises and equipment, net	144,900		$ 144,900
Premises and equipment, gross	153,000		153,000
Premises and equipment, accumulated depreciation	8,100		8,100
Premises and equipment, depreciation expense	$ 2,200	$ 840	$ 5,900	$ 1,100
Minimum
Lessor, Lease, Description [Line Items]
Lessor, term of contract			3 years
Term of contract	10 years		10 years
Useful life			20 years
Residual value (as a percent)	20.00%		20.00%
Maximum
Lessor, Lease, Description [Line Items]
Lessor, term of contract			7 years
Term of contract	15 years		15 years
Useful life			25 years
Residual value (as a percent)	40.00%		40.00%

XML

Equipment Leasing - Direct Financing Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Leases [Abstract]
Gross direct finance lease payments receivable	$ 6,548	$ 2,399
Less – unearned interest	(1,116)	(373)
Net Investment in Direct Financing and Sales Type Leases	$ 5,432	$ 2,026

XML

Equipment Leasing - Finance Lease Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Leases [Abstract]
2018	$ 325
2019	1,384
2020	1,373
2021	1,287
2022	1,107
Thereafter	1,072
Total	$ 6,548	$ 2,399

XML

Equipment Leasing - Operating Lease Maturity (Details) $ in Thousands	Sep. 30, 2018 USD ($)
Future Minimum Lease Payments Under Non-cancelable Operating Leases
2018	$ 1,765
2019	8,284
2020	8,341
2021	8,385
2022	8,417
Thereafter	53,939
Total	$ 89,131

XML

Servicing Assets - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Servicing Assets at Fair Value [Line Items]
Unpaid principal balance of loans serviced for others requiring recognition of a servicing asset	$ 2,700		$ 2,440
Unpaid principal balances of loan serviced for others	$ 2,780		$ 2,540
Weighted Average
Servicing Assets at Fair Value [Line Items]
Fair value of servicing rights, discount rate	16.10%	12.60%
Fair value of servicing rights, prepayment rate	11.10%	7.30%

XML

Servicing Assets - Summary of Activity Pertaining to Servicing Rights (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018		Sep. 30, 2017
Servicing Asset at Fair Value, Amount [Roll Forward]
Balance at beginning of period	$ 52,689	$ 53,675	$ 52,298	[1]	$ 51,994
Additions, net	5,558	3,527	14,634		9,412
Fair value changes:
Due to changes in valuation inputs or assumptions	(5,336)	(789)	(7,336)		342
Decay due to increases in principal paydowns or runoff	(3,650)	(3,021)	(10,335)		(8,356)
Balance at end of period	$ 49,261	$ 53,392	$ 49,261		$ 53,392

[1] Derived from audited consolidated financial statements.

XML

Borrowings - Total Short Term Borrowings (Details) - USD ($)	Oct. 20, 2017	Apr. 18, 2017	Sep. 30, 2018	Dec. 31, 2017	Sep. 18, 2014
Short-term Debt [Line Items]
Short term borrowings			$ 0	$ 0
Revolving Line of Credit with Unaffiliated Commercial Bank | Line of Credit
Short-term Debt [Line Items]
Short term borrowings			0	0
Line of credit, maximum borrowing capacity	$ 20,000,000
Debt instrument term	12 months
Remaining available credit facility			20,000,000
Revolving Line of Credit with Unaffiliated Commercial Bank | Line of Credit | LIBOR
Short-term Debt [Line Items]
Basis spread on variable rate	1.75%
Note Payable Revolving Line of Credit with Unaffiliated Commercial Bank | Line of Credit
Short-term Debt [Line Items]
Short term borrowings			0	$ 0
Line of credit, maximum borrowing capacity		$ 25,000,000			$ 8,100,000.0
Debt instrument term		24 months
Remaining available credit facility			$ 25,000,000
Note Payable Revolving Line of Credit with Unaffiliated Commercial Bank | Line of Credit | Prime Rate
Short-term Debt [Line Items]
Basis spread on variable rate		0.50%

XML

Borrowings - Total Long Term Borrowings (Details)	Aug. 17, 2018 USD ($)	Feb. 23, 2015 USD ($) SecurityLoan	Sep. 11, 2014 USD ($)	Sep. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)		Oct. 31, 2017 USD ($)
Long term borrowings
Long term borrowings				$ 1,506,000	$ 26,564,000	[1]
Construction Line of Credit for Main Campus Construction | Line of Credit
Long term borrowings
Long term borrowings				0	22,990,000
Line of credit, maximum borrowing capacity			$ 24,000,000
Debt instrument, fixed interest rate			3.95%
Debt instrument term			84 months
Line of credit facility, periodic payment			$ 146,000
Related Party Loans Transfered to Unaffiliated Commercial Bank | Notes Payable to Banks
Long term borrowings
Long term borrowings				$ 1,489,000	3,574,000
Debt instrument term		60 months
Number of related party loans transferred | SecurityLoan		2
Debt instrument, face amount		$ 4,700,000.0
Repayments of debt	$ 1,300,000
Debt instrument, interest rate effective percentage				6.00%
Collateral amount				$ 1,500,000
Related Party Loans Transfered to Unaffiliated Commercial Bank | Notes Payable to Banks | Prime Rate
Long term borrowings
Basis spread on variable rate		1.00%
Capital Lease with Unaffiliated Lease Company | Capital Lease Obligations
Long term borrowings
Capital lease obligation				$ 17,000	$ 0
Capital lease obligations, noncurrent							$ 19,000
Term of contract							60 months
Option to purchase equipment, amount							$ 1.00

[1] Derived from audited consolidated financial statements.

XML

Borrowings - Narrative (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Short term borrowings	$ 0	$ 0
Repurchased agreements, borrowing capacity	5,000,000	5,000,000
Repurchases agreements, outstanding balance	0	0
Federal Home Loan Bank of Atlanta
Debt Instrument [Line Items]
FHLB maximum amount available	854,200,000
Federal Funds Purchased
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity	72,500,000	47,500,000
Short term borrowings	0	0
Federal Reserve Bank Advances | Federal Reserve Bank
Debt Instrument [Line Items]
Short term borrowings	0	0
Collateral amount	376,900,000	348,500,000
Remaining available credit facility	$ 210,100,000	$ 189,100,000

XML

Fair Value of Financial Instruments - Recorded Amount of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Dec. 31, 2017		Jun. 30, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	$ 374,284	$ 374,284			$ 93,355	[1]
Servicing assets	49,261	49,261	$ 53,392	$ 52,689	52,298	[1]	$ 53,675	$ 51,994
Write off of contingent liability	1,600	1,600
Business combination contingent consideration fair value adjustment		(260)	350
Contingent consideration, liability			$ 4,300
US treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	4,934	4,934
US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	33,075	33,075			22,624
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	336,275	336,275			68,696
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability					1,900
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	49,261	49,261			52,298
Equity warrant assets	538	538
Total assets at fair value	426,151	426,151			145,653
Contingent consideration liability					1,900
Total liabilities at fair value					1,900
Recurring | US treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	4,934	4,934
Recurring | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	33,075	33,075			22,624
Recurring | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	336,275	336,275			68,696
Recurring | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund					2,035
Mutual fund	2,068	2,068
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	0	0			0
Equity warrant assets	0	0
Total assets at fair value	0	0			0
Contingent consideration liability					0
Total liabilities at fair value					0
Recurring | Level 1 | US treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0	0
Recurring | Level 1 | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0	0			0
Recurring | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0	0			0
Recurring | Level 1 | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund					0
Mutual fund	0	0
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	0	0			0
Equity warrant assets	0	0
Total assets at fair value	376,352	376,352			93,355
Contingent consideration liability					0
Total liabilities at fair value					0
Recurring | Level 2 | US treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	4,934	4,934
Recurring | Level 2 | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	33,075	33,075			22,624
Recurring | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	336,275	336,275			68,696
Recurring | Level 2 | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund					2,035
Mutual fund	2,068	2,068
Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	49,261	49,261			52,298
Equity warrant assets	538	538
Total assets at fair value	49,799	49,799			52,298
Contingent consideration liability					1,900
Total liabilities at fair value					1,900
Recurring | Level 3 | US treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0	0
Recurring | Level 3 | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0	0			0
Recurring | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0	0			0
Recurring | Level 3 | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund					$ 0
Mutual fund	$ 0	$ 0

[1] Derived from audited consolidated financial statements.

XML

Fair Value of Financial Instruments - Recorded Amount of Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis (Details) - Non-recurring Fair Value - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans and leases	$ 79,727	$ 34,493
Foreclosed assets	1,429	1,281
Total assets at fair value	81,156	35,774
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans and leases	0	0
Foreclosed assets	0	0
Total assets at fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans and leases	0	0
Foreclosed assets	0	0
Total assets at fair value	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans and leases	79,727	34,493
Foreclosed assets	1,429	1,281
Total assets at fair value	$ 81,156	$ 35,774

XML

Fair Value of Financial Instruments - Analysis of Level 3 Valuation Techniques (Details) - Level 3 $ in Thousands	12 Months Ended
	Dec. 31, 2017 USD ($)	Sep. 30, 2018 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration liability, fair value	$ 1,900
Impaired Loans and Leases
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, fair value	$ 34,493	$ 79,727
Impaired Loans and Leases | Discounted appraisals Discounted expected cash flows | Minimum | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Impaired loans, measurement input	0.10	0.10
Impaired Loans and Leases | Discounted appraisals Discounted expected cash flows | Maximum | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Impaired loans, measurement input	0.25	0.48
Impaired Loans and Leases | Discounted appraisals | Weighted Average | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Impaired loans, measurement input	0.0626	0.0616
Foreclosed Assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, fair value	$ 1,281	$ 1,429
Foreclosed Assets | Discounted appraisals Discounted expected cash flows | Minimum | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Foreclosed assets, measurement input	0.10	0.09
Foreclosed Assets | Discounted appraisals Discounted expected cash flows | Maximum | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Foreclosed assets, measurement input	0.37	0.37
Equity Warrant Assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, fair value		$ 538
Equity Warrant Assets | Discounted appraisals Discounted expected cash flows | Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input		0.2000
Equity Warrant Assets | Discounted appraisals Discounted expected cash flows | Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input		0.0285
Equity Warrant Assets | Discounted appraisals Discounted expected cash flows | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input		0.20
Equity Warrant Assets | Discounted appraisals Discounted expected cash flows | Minimum | Expected Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, term		9 years
Equity Warrant Assets | Discounted appraisals Discounted expected cash flows | Maximum | Expected Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, term		10 years
Contingent Consideration Liability | Discounted appraisals Discounted expected cash flows | Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration liability, measurement input	0.2500
Contingent Consideration Liability | Discounted appraisals Discounted expected cash flows | Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration liability, measurement input	0.0143
Contingent Consideration Liability | Discounted appraisals Discounted expected cash flows | Expected Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration liability, term	3 years
Contingent Consideration Liability | Discounted appraisals Discounted expected cash flows | Expected Dividend Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration liability, measurement input	0.0051

XML

Fair Value of Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2017		Sep. 30, 2017	Jun. 30, 2017	Dec. 31, 2016
Financial assets
Investment securities, available-for-sale	$ 374,284		$ 93,355	[1]
Servicing assets	49,261	$ 52,689	52,298	[1]	$ 53,392	$ 53,675	$ 51,994
Carrying Amount
Financial assets
Cash and due from banks	368,565		295,271
Certificates of deposit with other banks	750		3,000
Investment securities, available-for-sale	374,284		93,355
Loans held for sale	646,475		680,454
Loans and leases, net of allowance for loan and lease losses	1,604,540		1,319,783
Servicing assets	49,261		52,298
Accrued interest receivable	14,147		10,160
Financial liabilities
Deposits	2,924,288		2,260,263
Accrued interest payable	410		367
Long term borrowings	1,506		26,564
Total Fair Value
Financial assets
Cash and due from banks	368,565		295,271
Certificates of deposit with other banks	748		2,993
Investment securities, available-for-sale	374,284		93,355
Loans held for sale	649,054		706,972
Loans and leases, net of allowance for loan and lease losses	1,594,589		1,319,615
Servicing assets	49,261		52,298
Accrued interest receivable	14,147		10,160
Financial liabilities
Deposits	2,871,159		2,232,370
Accrued interest payable	410		367
Long term borrowings	1,507		27,390
Total Fair Value | Level 1
Financial assets
Cash and due from banks	368,565		295,271
Certificates of deposit with other banks	748		2,993
Investment securities, available-for-sale	0		0
Loans held for sale	0		0
Loans and leases, net of allowance for loan and lease losses	0		0
Servicing assets	0		0
Accrued interest receivable	14,147		10,160
Financial liabilities
Deposits	0		0
Accrued interest payable	410		367
Long term borrowings	0		0
Total Fair Value | Level 2
Financial assets
Cash and due from banks	0		0
Certificates of deposit with other banks	0		0
Investment securities, available-for-sale	374,284		93,355
Loans held for sale	0		0
Loans and leases, net of allowance for loan and lease losses	0		0
Servicing assets	0		0
Accrued interest receivable	0		0
Financial liabilities
Deposits	2,871,159		2,232,370
Accrued interest payable	0		0
Long term borrowings	0		0
Total Fair Value | Level 3
Financial assets
Cash and due from banks	0		0
Certificates of deposit with other banks	0		0
Investment securities, available-for-sale	0		0
Loans held for sale	649,054		706,972
Loans and leases, net of allowance for loan and lease losses	1,594,589		1,319,615
Servicing assets	49,261		52,298
Accrued interest receivable	0		0
Financial liabilities
Deposits	0		0
Accrued interest payable	0		0
Long term borrowings	$ 1,507		$ 27,390

[1] Derived from audited consolidated financial statements.

XML

Commitments and Contingencies - Summary of Commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	$ 1,455,658	$ 1,835,806
Commitments to extend credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	1,432,771	1,701,137
Standby letters of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	2,279	2,298
Solar purchase commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	10,158	106,921
Airplane purchase agreement commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	$ 10,450	$ 25,450

XML

Commitments and Contingencies - Additional Information (Details)	9 Months Ended
	Sep. 30, 2018 USD ($) Customer	Dec. 31, 2017 USD ($)
Concentration Risk [Line Items]
Commitment letters expiration period (in days)	90 days
Commitments for on-balance sheet instruments	$ 3,000,000	$ 3,500,000
Maximum retained credit exposure	7,500,000.0
Future minimum lease payments under non-cancelable operating leases	$ 89,100,000
Ten Relationships
Concentration Risk [Line Items]
Number of relationships that have retained unguaranteed exposure | Customer	10
Retained credit exposure	$ 121,100,000
Retained exposure, amount disbursed	102,300,000
Four Relationships
Concentration Risk [Line Items]
Future minimum lease payments under non-cancelable operating leases	$ 67,400,000

XML

Stock Plans - Narrative (Details) - USD ($)					3 Months Ended		9 Months Ended
	Aug. 10, 2018	May 15, 2018	May 14, 2018	May 24, 2016	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense							$ 1,310,000	$ 1,496,000
Intrinsic value of options exercised							$ 3,300,000	$ 1,100,000
Stock options granted (in shares)					0	0	0	0
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense					$ 470,000	$ 536,000	$ 1,200,000	$ 1,400,000
Unrecognized compensation costs, stock options					6,600,000		$ 6,600,000
Unrecognized compensation costs period recognized							2 years 3 months 22 days
Market Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs period recognized							2 years 7 months 28 days
Minimum required consecutive trading days that common stock must close at or above required share price (in days)				20 days
Performance awards units earned as a percent of units awarded				100.00%
Granted (in shares)	410,000		75,000				485,000
Measurement period	7 years		7 years
Expected term			3 years 3 months 18 days
Risk free interest rate	2.78%		2.96%
Expected volatility rate	28.10%		27.00%
Expected dividend rate	0.40%		0.42%
Share-based compensation expense					1,600,000	1,300,000	$ 3,500,000	3,700,000
Unrecognized compensation costs					18,400,000		$ 18,400,000
Market Restricted Stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price threshold for performance criteria (in dollars per share)				$ 34.00
Expected term	1 year 7 months 6 days
Market Restricted Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price threshold for performance criteria (in dollars per share)				$ 55.00
Expected term	3 years 6 months
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs period recognized							5 years 2 months 9 days
Granted (in shares)							230,599
Share-based compensation expense					401,000	191,000	$ 2,200,000	517,000
Unrecognized compensation costs					6,600,000		6,600,000
2015 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common voting shares authorized (in shares)		8,750,000		7,000,000
Options or restricted shares of expiration period (in years)		10 years
Percentage of fair market value of common stock		100.00%
Option vesting period (in years)		3 years
Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense					$ 31,000	$ 36,000	60,000	$ 79,000
Maximum annual purchase per employee							$ 25,000
Purchase date discount							15.00%

XML

Stock Plans - Stock Option Activity (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Shares, outstanding, beginning balance (in shares)			3,058,459	3,478,208
Shares, exercised (in shares)			171,333	76,285
Shares, forfeited (in shares)			174,845	203,671
Shares, granted (in shares)	0	0	0	0
Shares, outstanding, ending balance (in shares)	2,712,281	3,198,252	2,712,281	3,198,252
Shares, exercisable (in shares)	813,730	703,425	813,730	703,425
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, outstanding, beginning balance (in dollars per share)			$ 11.30	$ 11.51
Weighted average exercise price, exercised (in dollars per share)			9.26	7.89
Weighted average exercise price, forfeited (in dollars per share)			13.69	14.12
Weighted average exercise price, granted (in dollars per share)			0.00	0.00
Weighted average exercise price, outstanding, ending balance (in dollars per share)	$ 11.27	$ 11.43	11.27	11.43
Weighted average exercise price, exercisable (in dollars per share)	$ 10.67	$ 10.41	$ 10.67	$ 10.41
Weighted average remaining contractual term, outstanding			6 years 3 months 11 days	7 years 3 months 22 days
Weighted average remaining contractual term, exercisable			6 years 1 month 10 days	7 years 22 days
Aggregate intrinsic value, outstanding	$ 47,005,905	$ 38,411,802	$ 47,005,905	$ 38,411,802
Aggregate intrinsic value, exercisable	$ 14,587,733	$ 9,171,805	$ 14,587,733	$ 9,171,805

XML

Stock Plans - Summary of Non-vested Stock Option Activity (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Shares, non-vested, beginning balance (in shares)			2,364,999	3,016,100
Shares, granted (in shares)	0	0	0	0
Shares, vested (in shares)			(291,603)	(317,602)
Shares, forfeited (in shares)			(174,845)	(203,671)
Shares, non-vested, ending balance (in shares)	1,898,551	2,494,827	1,898,551	2,494,827
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value, non-vested, beginning balance (in dollars per share)			$ 4.65	$ 4.78
Weighted average grant date fair value, granted (in dollars per share)			0.00	0.00
Weighted average grant date fair value, vested (in dollars per share)			3.95	4.17
Weighted average grant date fair value, forfeited (in dollars per share)			5.98	6.03
Weighted average grant date fair value, non-vested, ending balance (in dollars per share)	$ 4.63	$ 4.75	$ 4.63	$ 4.75

XML

Stock Plans - Restricted Stock Unit Activity (Details) - $ / shares			9 Months Ended
	Aug. 10, 2018	May 14, 2018	Sep. 30, 2018
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares, outstanding, beginning balance (in shares)			181,814
Granted (in shares)			230,599
Vested (in shares)			83,829
Forfeited (in shares)			38,793
Shares, outstanding, ending balance (in shares)			289,791
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Shares outstanding, weighted average grant date fair value, beginning balance (in dollars per share)			$ 20.03
Shares granted, weighted average grant date fair value (in dollars per share)			28.72
Shares vested, weighted average grant date fair value (in dollars per share)			23.68
Shares forfeited, weighted average grant date fair value (in dollars per share)			22.96
Shares outstanding, weighted average grant date fair value, ending balance (in dollars per share)			$ 25.50
Market Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares, outstanding, beginning balance (in shares)			2,532,808
Granted (in shares)	410,000	75,000	485,000
Vested (in shares)			0
Forfeited (in shares)			223,128
Shares, outstanding, ending balance (in shares)			2,794,680
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Shares outstanding, weighted average grant date fair value, beginning balance (in dollars per share)			$ 8.78
Shares granted, weighted average grant date fair value (in dollars per share)			15.73
Shares vested, weighted average grant date fair value (in dollars per share)			0.00
Shares forfeited, weighted average grant date fair value (in dollars per share)			9.08
Shares outstanding, weighted average grant date fair value, ending balance (in dollars per share)			$ 9.96